<SEC-DOCUMENT>0001193125-21-338512.txt : 20211123
<SEC-HEADER>0001193125-21-338512.hdr.sgml : 20211123
<ACCEPTANCE-DATETIME>20211123162803
ACCESSION NUMBER:		0001193125-21-338512
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		22
CONFORMED PERIOD OF REPORT:	20211117
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20211123
DATE AS OF CHANGE:		20211123

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RENASANT CORP
		CENTRAL INDEX KEY:			0000715072
		STANDARD INDUSTRIAL CLASSIFICATION:	STATE COMMERCIAL BANKS [6022]
		IRS NUMBER:				640676974
		STATE OF INCORPORATION:			MS
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-13253
		FILM NUMBER:		211438839

	BUSINESS ADDRESS:	
		STREET 1:		209 TROY STREET
		CITY:			TUPELO
		STATE:			MS
		ZIP:			38804-4827
		BUSINESS PHONE:		(662) 680-1001

	MAIL ADDRESS:	
		STREET 1:		P.O. BOX 709
		CITY:			TUPELO
		STATE:			MS
		ZIP:			38802-0709

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PEOPLES HOLDING CO
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d242176d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:rnst="http://www.renasantbank.com/20211117" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric id="Hidden_dei_EntityRegistrantName" name="dei:EntityRegistrantName" contextRef="duration_2021-11-17_to_2021-11-17">RENASANT CORP</ix:nonNumeric> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2021-11-17_to_2021-11-17">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2021-11-17_to_2021-11-17">0000715072</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="rnst-20211117.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2021-11-17_to_2021-11-17"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0000715072</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2021-11-17</xbrli:startDate> <xbrli:endDate>2021-11-17</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2021-11-17_to_2021-11-17">8-K</ix:nonNumeric></span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 OR 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2021-11-17_to_2021-11-17" format="ixt:datemonthdayyearen">November&#160;17, 2021</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of report (Date of earliest event reported)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <span style=" -sec-ix-hidden:Hidden_dei_EntityRegistrantName">RENASANT CORPORATION</span> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2021-11-17_to_2021-11-17" format="ixt-sec:stateprovnameen">Mississippi</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2021-11-17_to_2021-11-17">001-13253</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2021-11-17_to_2021-11-17">64-0676974</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(I.R.S. Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2021-11-17_to_2021-11-17">209 Troy Street</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2021-11-17_to_2021-11-17">Tupelo</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2021-11-17_to_2021-11-17" format="ixt-sec:stateprovnameen">Mississippi</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2021-11-17_to_2021-11-17">38804-4827</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of principal executive offices)(Zip Code)</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2021-11-17_to_2021-11-17">(662)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2021-11-17_to_2021-11-17">680-1001</ix:nonNumeric></span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2021-11-17_to_2021-11-17" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2021-11-17_to_2021-11-17" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2021-11-17_to_2021-11-17" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%">&#160;</td>
<td style="width:5%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2021-11-17_to_2021-11-17" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2021-11-17_to_2021-11-17">Common stock, $5.00 par value per share</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2021-11-17_to_2021-11-17">RNST</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2021-11-17_to_2021-11-17" format="ixt-sec:exchnameen">The NASDAQ Stock Market LLC</ix:nonNumeric></span></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 (17 CFR <span style="white-space:nowrap">&#167;240.12b-2).</span> Emerging growth company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2021-11-17_to_2021-11-17" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;1.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Entry into a Material Definitive Agreement. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic">Underwriting Agreement</span></span><span style="font-style:italic">.</span> On November&#160;17, 2021, Renasant Corporation (the &#8220;Company&#8221;) entered into an underwriting agreement (the &#8220;Underwriting Agreement&#8221;) with Keefe, Bruyette&#160;&amp; Woods, Inc., as representative of the underwriters listed on Schedule I to the Underwriting Agreement, for the issuance and sale of $200&#160;million aggregate principal amount of its 3.00% <span style="white-space:nowrap"><span style="white-space:nowrap">Fixed-to-Floating</span></span> Rate Subordinated Notes due 2031 (the &#8220;Notes&#8221;), at a public offering price equal to 100% of the aggregate principal amount of the Notes. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The offering of the Notes closed on November&#160;23, 2021. The net proceeds from the sale of the Notes to the Company were approximately $197&#160;million, after giving effect to the underwriting discount of 1.25% and estimated expenses of the offering of the Notes. The Company intends to use the net proceeds from this offering for general corporate purposes, which may include providing capital to support the Company&#8217;s organic growth or growth through strategic acquisitions, redeeming or repaying indebtedness, financing investments, capital expenditures and for investments in Renasant Bank, the Company&#8217;s wholly-owned subsidiary, as regulatory capital. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes have been offered pursuant to a prospectus supplement, dated November&#160;17, 2021, to the prospectus dated October&#160;12, 2021, that was filed as part of the Registration Statement on Form <span style="white-space:nowrap">S-3</span> (File <span style="white-space:nowrap">No.&#160;333-260188)</span> under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), which registration statement was filed with the Securities and Exchange Commission (&#8220;SEC&#8221;) and automatically became effective on October&#160;12, 2021. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Underwriting Agreement contains representations, warranties and covenants customary in agreements of this type. These representations, warranties and covenants are not representations of factual information to investors about the Company or its subsidiaries, and the sale of the Notes is not a representation that there has not been any change in the condition of the Company. The Company also agreed to indemnify the underwriters against certain liabilities arising out of or in connection with the sale of the Notes. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing description of the Underwriting Agreement is not complete and is qualified in its entirety by reference to the complete text of the Underwriting Agreement, a copy of which is attached as Exhibit 1.1 to this Current Report on Form <span style="white-space:nowrap">8-K</span> and incorporated herein by reference. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><span style="font-weight:bold"><span style="font-style:italic">Indenture and Notes</span></span>. The Notes have been issued under a Subordinated Indenture dated as of August&#160;22, 2016 (the &#8220;Base Indenture&#8221;) by and between the Company and Wilmington Trust, National Association, as trustee (the &#8220;Trustee&#8221;), as supplemented by that certain Fourth Supplemental Indenture dated as of November&#160;23, 2021, between the Company and the Trustee (the &#8220;Fourth Supplemental Indenture&#8221; and together with the Base Indenture, as previously supplemented by that certain First Supplemental Indenture dated as of August&#160;22, 2016 between the Company and the Trustee, that certain Second Supplemental Indenture dated as of August&#160;22, 2016 between the Company and the Trustee and that certain Third Supplemental Indenture dated as of September&#160;3, 2020 between the Company and the Trustee, the &#8220;Indenture&#8221;). The terms of the Notes are set forth in, and such Notes are governed by, the Base Indenture and the Fourth Supplemental Indenture. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes will mature on December&#160;1, 2031. From and including November&#160;23, 2021, to but excluding December&#160;1, 2026 or the date of earlier redemption, the Company will pay interest on the Notes semi-annually in arrears on each June&#160;1 and December&#160;1 commencing June&#160;1, 2022, at a fixed annual interest rate equal to 3.00%. From and including December&#160;1, 2026, to but excluding the maturity date or earlier redemption date, the Company will pay interest on the Notes at a floating per annum rate equal to a Benchmark rate (which is expected to be Three-Month Term SOFR) (each as defined in the Indenture), plus 191 basis points, payable quarterly in arrears on each March&#160;1, June&#160;1, September&#160;1 and December&#160;1 commencing on March&#160;1, 2027; provided, however, that in the event the Benchmark rate is less than zero, the Benchmark rate shall be deemed to be zero. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company may, beginning with the interest payment date of December&#160;1, 2026, and on any interest payment date thereafter, redeem the Notes, in whole or in part, from time to time, subject to obtaining the prior approval of the Board of Governors of the Federal Reserve System (the &#8220;Federal Reserve&#8221;) (or, as and if applicable, the rules of any appropriate successor bank regulatory agency) to the extent such approval is then required under the rules of the Federal Reserve (or such successor bank regulatory agency), at a redemption price equal to 100% of the principal </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
amount of the Notes being redeemed plus accrued and unpaid interest to, but excluding, the date of redemption. The Company may also redeem the Notes at any time prior to their maturity, including prior to December&#160;1, 2026, in whole, but not in part, subject to obtaining the prior approval of the Federal Reserve (or, as and if applicable, the rules of any appropriate successor bank regulatory agency) to the extent such approval is then required under the rules of the Federal Reserve (or such successor bank regulatory agency), if (i)&#160;a change or prospective change in law occurs that could prevent us from deducting interest payable on the Notes for U.S. federal income tax purposes, (ii)&#160;a subsequent event occurs that could preclude the Notes from being recognized as Tier 2 Capital for regulatory capital purposes, or (iii)&#160;the Company is required to register as an investment company under the Investment Company Act of 1940, as amended, in each case, at a redemption price equal to 100% of the principal amount of the Notes plus any accrued and unpaid interest to, but excluding, the redemption date. There is no sinking fund for the benefit of the Notes, and the Notes are not convertible into, or exchangeable for, equity securities, other securities, or assets or property of the Company or its subsidiaries. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There is no automatic acceleration, or right of acceleration, in the case of default in the payment of principal of, premium, if any, or interest on the Notes, or in the performance of any of the Company&#8217;s other obligations under the Notes or the Indenture. The Indenture provides that holders of the Notes may accelerate payment of indebtedness only upon the Company&#8217;s or Renasant Bank&#8217;s insolvency, receivership, conservatorship, reorganization or similar proceedings, or if there is a liquidation or winding up of the Company&#8217;s business. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are the unsecured, subordinated obligations of the Company and rank (i)&#160;junior in right of payment and upon the Company&#8217;s liquidation to any of the Company&#8217;s existing and all future Senior Indebtedness (as defined in the Indenture); (ii) junior in right of payment and upon the Company&#8217;s liquidation to any of the Company&#8217;s existing and all of its future general creditors; (iii)&#160;equal in right of payment and upon the Company&#8217;s liquidation with any of the Company&#8217;s existing and all of its future indebtedness the terms of which provide that such indebtedness ranks equally with the Notes; and (iv)&#160;senior in right of payment and upon the Company&#8217;s liquidation to any of the Company&#8217;s existing junior subordinated debentures and any of its future indebtedness the terms of which provide that such indebtedness ranks junior in right of payment to note indebtedness such as the Notes. The Notes are effectively subordinated to the Company&#8217;s future secured indebtedness to the extent of the value of the collateral securing such indebtedness, and structurally subordinated to the existing and future indebtedness of the Company&#8217;s subsidiaries, including, without limitation, depositors of Renasant Bank, liabilities to general creditors and liabilities arising in the ordinary course of business or otherwise. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing descriptions of the Base Indenture, the Fourth Supplemental Indenture and the Notes are not complete and are each qualified in their entirety by reference to the complete text of the Fourth Supplemental Indenture and the form of the Note, copies of which are attached as Exhibits 4.2 and 4.3, respectively, to this Current Report on Form <span style="white-space:nowrap">8-K</span> and incorporated herein by reference and the Base Indenture, which is incorporated herein by reference as Exhibit 4.1 hereto. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;2.03.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Creation of a Direct Financial Obligation or an Obligation under an <span style="white-space:nowrap">Off-Balance</span> Sheet Arrangement of a Registrant. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information set forth in Item 1.01 is incorporated herein by reference. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;7.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Regulation FD Disclosure. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On November&#160;17, 2021, the Company issued a press release announcing the pricing of its offering of the Notes, which is furnished hereto as Exhibit 99.1. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Current Report on Form <span style="white-space:nowrap">8-K,</span> including the Exhibits hereto, shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the Notes, in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. Any offering of the Notes is being made only by means of a written prospectus meeting the requirements of Section&#160;10 of the Securities Act. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d)&#160;&#160;&#160;&#160;<span style="font-style:italic">Exhibits</span>. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:96%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:93%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Exhibit<br />No.</p></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap" align="center"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:inline-block; font-size:8pt; font-family:Times New Roman;text-align:center">Description of Exhibit</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;1.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d242176dex11.htm">Underwriting Agreement, dated November&#160;17, 2021, by and between Renasant Corporation and Keefe, Bruyette&#160;&amp; Woods, Inc., as representative of the underwriters named therein. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;4.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="http://www.sec.gov/Archives/edgar/data/715072/000119312516687445/d240854dex41.htm">Subordinated Indenture dated August&#160;22, 2016 between Renasant Corporation and Wilmington Trust, National Association, as Trustee, incorporated herein by reference to Exhibit 4.1 of the Current Report on Form <span style="white-space:nowrap">8-K</span> of Renasant Corporation filed with the SEC on August&#160;22, 2016. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;4.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d242176dex42.htm">Fourth Supplemental Indenture dated November&#160;23, 2021 between Renasant Corporation and Wilmington Trust, National Association, as Trustee. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;4.3</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d242176dex42.htm">Form of 3.00% <span style="white-space:nowrap"><span style="white-space:nowrap">Fixed-to-Floating</span></span> Rate Subordinated Note due 2031 (included in Exhibit 4.2). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;5.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d242176dex51.htm">Opinion of Phelps Dunbar LLP regarding the legality of the Notes, under Mississippi law. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">&#160;&#160;5.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d242176dex52.htm">Opinion of Covington&#160;&amp; Burling LLP regarding the legality of the Notes, under New York law. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">23.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d242176dex51.htm">Consent of Phelps Dunbar LLP (included in Exhibit 5.1). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">23.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d242176dex52.htm">Consent of Covington&#160;&amp; Burling LLP (included in Exhibit 5.2). </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d242176dex991.htm">Press release dated November&#160;17, 2021. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">The cover page of Renasant&#8217;s Form <span style="white-space:nowrap">8-K</span> is formatted in Inline XBRL.</td></tr>
</table> <p style="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This report, including the exhibits included herewith, may contain, or incorporate by reference, statements about the Company that constitute &#8220;forward-looking statements&#8221; within the meaning of Section&#160;27A of the Securities Act of 1933, as amended, and Section&#160;21E of the Securities Exchange Act of 1934, as amended. Statements preceded by, followed by or that otherwise include the words &#8220;believes,&#8221; &#8220;expects,&#8221; &#8220;projects,&#8221; &#8220;anticipates,&#8221; &#8220;intends,&#8221; &#8220;estimates,&#8221; &#8220;plans,&#8221; &#8220;potential,&#8221; &#8220;possible,&#8221; &#8220;may increase,&#8221; &#8220;may fluctuate,&#8221; &#8220;will likely result,&#8221; and similar expressions, or future or conditional verbs such as &#8220;will,&#8221; &#8220;should,&#8221; &#8220;would&#8221; and &#8220;could,&#8221; are generally forward-looking in nature and not historical facts. Forward-looking statements include information about the Company&#8217;s future financial performance, business strategy, projected plans and objectives and are based on the current beliefs and expectations of management. The Company believes these forward-looking statements are reasonable, but they are all inherently subject to significant business, economic and competitive risks and uncertainties, many of which are beyond the Company&#8217;s control. In addition, these forward-looking statements are subject to assumptions about future business strategies and decisions that are subject to change. Actual results may differ from those indicated or implied in the forward-looking statements; such differences may be material. Any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties and accordingly, undue reliance should not be placed on these forward-looking statements, which speak only as of the date they are made. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Important factors currently known to management that could cause the Company&#8217;s actual results to differ materially from those in forward-looking statements include the following: (i)&#160;the continued impact of the <span style="white-space:nowrap">COVID-19</span> pandemic and related governmental response measures on the U.S. economy and the economies of the markets in which the Company operates; (ii)&#160;the Company&#8217;s ability to efficiently integrate acquisitions into its operations, retain the customers of these businesses, grow the acquired operations and realize the cost savings expected from an acquisition to the extent and in the timeframe anticipated by management; (iii)&#160;the effect of economic conditions and interest rates on a national, regional or international basis; (iv)&#160;timing and success of the implementation of changes in operations to achieve enhanced earnings or effect cost savings; (v)&#160;competitive pressures in the consumer finance, commercial finance, insurance, financial services, asset management, retail banking, mortgage lending and auto lending industries; (vi)&#160;the financial resources of, and products available from, competitors; (vii)&#160;changes in laws and regulations as well as changes in accounting standards; (viii)&#160;changes in policy by regulatory agencies; (ix)&#160;changes in the securities and </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
foreign exchange markets; (x)&#160;the Company&#8217;s potential growth, including its entrance or expansion into new markets, and the need for sufficient capital to support that growth; (xi)&#160;changes in the quality or composition of the Company&#8217;s loan or investment portfolios, including adverse developments in borrower industries or in the repayment ability of individual borrowers; (xii)&#160;an insufficient allowance for credit losses as a result of inaccurate assumptions; (xiii)&#160;general economic, market or business conditions, including the impact of inflation; (xiv)&#160;changes in demand for loan products and financial services; (xv)&#160;concentration of credit exposure; (xvi)&#160;changes or the lack of changes in interest rates, yield curves and interest rate spread relationships; (xvii)&#160;increased cybersecurity risk, including potential network breaches, business disruptions or financial losses; (xviii)&#160;civil unrest, natural disasters, epidemics and other catastrophic events in the Company&#8217;s geographic area; (xix)&#160;the impact, extent and timing of technological changes; and (xx)&#160;other circumstances, many of which are beyond management&#8217;s control. </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company undertakes no obligation, and specifically disclaims any obligation, to update or revise forward-looking statements, whether as a result of new information or to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results over time, except as required by federal securities laws. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURES </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:45%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:3%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:45%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="3" style="vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">RENASANT CORPORATION</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Date: November&#160;23, 2021</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ C. Mitchell Waycaster</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">C. Mitchell Waycaster</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">President and Chief Executive Officer</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>d242176dex11.htm
<DESCRIPTION>EX-1.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-1.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 1.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Execution Version </I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">$200,000,000.00 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3.00% Fixed to
Floating Rate Subordinated Notes due 2031 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">RENASANT CORPORATION </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>UNDERWRITING AGREEMENT </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">November&nbsp;17, 2021 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Keefe, Bruyette&nbsp;&amp;
Woods, Inc. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As Representative of the several </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Underwriters
named in Schedule I hereto </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">c/o Keefe, Bruyette&nbsp;&amp; Woods, Inc. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">787 Seventh Avenue, 4th Floor </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, NY 10019 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Renasant Corporation, a Mississippi
corporation (the &#147;Company&#148;), confirms its agreement (the &#147;Agreement&#148;) with Keefe, Bruyette&nbsp;&amp; Woods, Inc. (&#147;KBW&#148;) and each of the other Underwriters named in Schedule I hereto (collectively, the
&#147;Underwriters,&#148; which term shall also include any underwriter substituted as provided pursuant to Section&nbsp;10 hereof), for whom KBW is acting as representative (in such capacity, the &#147;Representative&#148;), with respect to the
issue and sale by the Company and the purchase by the Underwriters, acting severally and not jointly, of $200,000,000.00 aggregate principal amount of its 3.00% Fixed to Floating Rate Subordinated Notes due 2031 (the &#147;Securities&#148;). The
Securities will be issued in book-entry only form to Cede&nbsp;&amp; Co. as nominee of The Depository Trust Company (&#147;DTC&#148;) pursuant to the Letter of Representations, to be dated as of the Closing Time (as defined in Section&nbsp;2
hereof), between the Company and DTC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Securities will be issued pursuant to the Subordinated Indenture between the Company and Wilmington Trust,
National Association, as Trustee (the &#147;Trustee&#148;), dated as of August&nbsp;22, 2016, as supplemented by a supplemental indenture thereto to be dated as of November 23, 2021, between the Company and the Trustee (collectively, the
&#147;Indenture&#148;). The Indenture and this Agreement are hereinafter referred to collectively as the &#147;Operative Documents.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has
filed with the Securities and Exchange Commission (the &#147;Commission&#148;) an &#147;automatic shelf registration statement&#148; (as defined in Rule 405 of the rules and regulations (the &#147;1933 Act Regulations&#148;) of the Commission under
the Securities Act of 1933, as amended (the &#147;1933 Act&#148;)) on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (No. <FONT STYLE="white-space:nowrap">333-260188)</FONT> covering the public offering and sale from time to time of certain
securities of the Company, including the Securities, under the 1933 Act and the 1933 Act Regulations, which registration statement, and any post-effective amendment thereto, became effective upon filing under Rule 462(e) of the 1933 Act Regulations
(&#147;Rule 462(e)&#148;). Such registration statement, at any given time, including any amendments thereto existing at such time, the exhibits and any schedules thereto on file with the Commission at such time, the
</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
information incorporated by reference therein pursuant to Item 12 of Form <FONT STYLE="white-space:nowrap">S-3</FONT> under the 1933 Act at such time and the information otherwise deemed to be a
part thereof or included therein at such time by the 1933 Act Regulations, is referred to herein as the &#147;Registration Statement.&#148; Promptly after execution and delivery of this Agreement, the Company will prepare and file a prospectus
supplement with respect to the Securities with the Commission in accordance with the provisions of Rule 430B of the 1933 Act Regulations (&#147;Rule 430B&#148;) and Rule 424(b) of the 1933 Act Regulations (&#147;Rule 424(b)&#148;). Any information
included in each such prospectus supplement that was omitted from the Registration Statement or any post-effective amendment thereto that is deemed to be part thereof and included therein pursuant to Rule 430B is referred to herein as the &#147;Rule
430B Information.&#148; The final prospectus and each prospectus supplement relating to the Securities, in the form first furnished to the Underwriters for use in connection with the offering and sale of the Securities, including the documents
incorporated by reference or deemed to be incorporated by reference therein pursuant to Item 12 of Form <FONT STYLE="white-space:nowrap">S-3</FONT> under the 1933 Act, in the form first furnished to the Underwriters for use in connection with the
offering of the Securities, are collectively referred to herein as the &#147;Prospectus.&#148; Each prospectus and related prospectus supplement used in connection with the offering of the Securities that omitted the Rule 430B Information is herein
called a &#147;preliminary prospectus.&#148; For purposes of this Agreement, all references to the Registration Statement, the Prospectus, any preliminary prospectus or any Issuer Free Writing Prospectus or any amendment or supplement to any of the
foregoing shall be deemed to include the copy filed with the Commission pursuant to its Electronic Data Gathering, Analysis and Retrieval system (or any successor system) (&#147;EDGAR&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">All references in this Agreement to financial statements and schedules and other information which is &#147;contained,&#148; &#147;included&#148; or
&#147;stated&#148; (or other references of like import) in the Registration Statement, the Prospectus or any preliminary prospectus shall be deemed to include all such financial statements and schedules and other information which are incorporated
by reference in or otherwise deemed by the 1933 Act Regulations to be a part of or included in the Registration Statement, the Prospectus or any preliminary prospectus, as the case may be, prior to the Applicable Time (as defined in
Section&nbsp;1(ii) hereof); and all references in this Agreement to amendments or supplements to the Registration Statement, the Prospectus or any preliminary prospectus shall be deemed to include the filing of any document under the Securities
Exchange Act of 1934, as amended (the &#147;1934 Act&#148;), and the rules and regulations promulgated thereunder (the &#147;1934 Act Regulations&#148;) which is incorporated by reference in or otherwise deemed by the 1933 Act Regulations to be a
part of or included in the Registration Statement, the Prospectus or any preliminary prospectus, as the case may be, after the Applicable Time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In all
dealings hereunder, the Representative shall act on behalf of each of the Underwriters, and the parties hereto shall be entitled to act and rely upon any statement, request, notice or agreement on behalf of any Underwriter made or given by the
Representative. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;1. Representations and Warranties. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company represents and warrants to each of the Underwriters as of the date hereof, as of the Applicable Time and as of the Closing Time, and agrees with
each of the Underwriters, as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <U>Status as Well Known Seasoned Issuer</U>. (1)&nbsp;At the time of filing the Registration
Statement, (2)&nbsp;at the time of each subsequent amendment to the Registration Statement for the purposes of complying with Section&nbsp;10(a)(3) of the 1933 Act (whether such amendment was by post-effective amendment, incorporated report filed
pursuant to Section&nbsp;13 or 15(d) of the 1934 Act or form of prospectus), (3) at the time the Company or any person acting on its behalf (within the meaning, for this subsection only, of Rule 163(c) of the 1933 Act Regulations) made any offer
relating to the Securities in reliance on the exemption of Rule 163 of the 1933 Act Regulations (&#147;Rule 163&#148;) and (4)&nbsp;at the Applicable Time, the Company was and is a &#147;well-known seasoned issuer&#148; (as defined in Rule 405),
including not having been and not being an &#147;ineligible issuer&#148; (as defined in Rule 405). The Registration Statement is an &#147;automatic shelf registration statement&#148; (as defined in Rule 405), and the Securities, as of the date of
their registration on the Registration Statement, were, and, as of the date hereof and as of the Closing Time, remain, eligible for registration by the Company on an &#147;automatic shelf registration statement&#148; under Rule 405. The Company has
not received from the Commission any notice pursuant to Rule 401(g)(2) of the 1933 Act Regulations objecting to the use of the automatic shelf registration statement form. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">At the earliest time that the Company or another offering participant made a bona fide offer (within the meaning of Rule 164(h)(2) of the
1933 Act Regulations) of the Securities, the Company was not nor is an &#147;ineligible issuer&#148; (as defined in Rule 405). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii)
<U>Registration Statement, Prospectus and Disclosure Package at Time of Sale</U>. The Registration Statement became effective upon filing under Rule 462(e) on October&nbsp;12, 2021 and any post-effective amendment to the Registration Statement also
become effective upon filing under Rule 462(e). No stop order suspending the effectiveness of the Registration Statement has been issued under the 1933 Act and no proceedings for that purpose have been instituted or are pending or, to the knowledge
of the Company, are contemplated by the Commission, and any request on the part of the Commission for additional information has been complied with. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any offer that is a written communication relating to the Securities made by the Company or any person acting on its behalf (within the
meaning, for this subsection only, of Rule 163(c) of the 1933 Act Regulations) prior to the filing of the Registration Statement or any amendment thereto has been filed with the Commission in accordance with the exemption provided by Rule 163 and
otherwise complied with the requirements of Rule 163, including, without limitation, the legending requirement, to qualify such offer for the exemption from Section&nbsp;5(c) of the 1933 Act provided by Rule 163. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">At the time the Registration Statement became effective, at each deemed effective date with respect to the Securities pursuant to Rule
430B(f)(2) of the 1933 Act Regulations and at the Closing Time, the Registration Statement complied, complies and will comply in all material respects with the requirements of the 1933 Act, the 1933 Act Regulations, the Trust Indenture Act of 1939,
as amended (the &#147;1939 Act&#148;), and the rules and regulations of the Commission under the 1939 Act (the &#147;1939 Act Regulations&#148;), and did not, does not and will not contain an untrue statement of a material fact or omit to state a
material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. Neither the Prospectus nor any amendment or supplement thereto, when read
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
together with the Prospectus, at the time the Prospectus or any such amendment or supplement was issued or at the Closing Time, included or will include an untrue statement of a material fact or
omitted or will omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. Each preliminary prospectus and the Prospectus complied, when filed with
the Commission, in all material respects with the 1933 Act, 1933 Act Regulations and the 1939 Act, and each preliminary prospectus and the Prospectus delivered to the Underwriters for use in connection with the offering of the Securities was
identical to the electronically transmitted copies thereof filed with the Commission pursuant to EDGAR, except to the extent permitted by Regulation <FONT STYLE="white-space:nowrap">S-T.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of the Applicable Time, any Issuer General Use Free Writing Prospectus (as defined below) and the Statutory Prospectus (as defined below),
when considered together (collectively, as of the Applicable Time, the &#147;Disclosure Package&#148;), did not include any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in
the light of the circumstances under which they were made, not misleading. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As used in this subsection and elsewhere in this Agreement:
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Applicable Time&#148; means 3:30 p.m. (New York City time) on November&nbsp;17, 2021, or such other time as agreed by the Company
and the Representative. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Statutory Prospectus&#148; as of any time means the applicable prospectus relating to the Securities that
is, immediately prior to that time, either included in the Registration Statement or deemed to be a part thereof, including any document incorporated therein by reference immediately prior to that time and any preliminary prospectus deemed to be a
part thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Issuer Free Writing Prospectus&#148; means any &#147;issuer free writing prospectus&#148; (as defined in clause
(h)(1) of Rule 433 of the 1933 Act Regulations (&#147;Rule 433&#148;)) relating to the Securities that (i)&nbsp;is required to be filed with the Commission by the Company, (ii)&nbsp;is a &#147;road show that is a written communication&#148; within
the meaning of Rule 433(d)(8)(i), whether or not required to be filed with the Commission or (iii)&nbsp;is exempt from filing pursuant to Rule 433(d)(5)(i) because it contains a description of the Securities or of the offering that does not reflect
the final terms, in each case in the form filed or required to be filed with the Commission or, if not required to be filed, in the form retained in the records of the Company pursuant to Rule 433(g). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Issuer General Use Free Writing Prospectus&#148; means any Issuer Free Writing Prospectus that is intended for general distribution to
prospective investors (other than a &#147;bona fide electronic road show,&#148; as defined in Rule 433), as evidenced by its being specified in Schedule II hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any Issuer Free Writing Prospectus, as of its issue date and at all subsequent times through the completion of the offer and sale of the
Securities or until any earlier date that the Company notified or notifies the Representative in writing, did not, does not and will not include any information that conflicted, conflicts or will conflict with the information contained in the
Registration Statement or the Prospectus, including any document incorporated therein by reference and any preliminary or other prospectus deemed to be a part thereof that has not been superseded or modified. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The representations and warranties in this subsection shall not apply to statements in or
omissions from the Registration Statement or the Prospectus made in reliance upon and in conformity with any Underwriters&#146; Information (as defined in Section&nbsp;6(a)(iii) hereof). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) <U>Incorporated Documents</U>. The documents incorporated or deemed to be incorporated by reference in the preliminary prospectus or the
Prospectus, when read together with the other information in the preliminary prospectus or the Prospectus, at the time the Registration Statement became effective or such documents were filed with the Commission, as the case may be, did not, and at
the earlier of the time the Prospectus was first used and the first &#147;time of sale,&#148; within the meaning of Rule 159 under the 1933 Act Regulations, of Securities in this offering and at the Closing Time will not, include an untrue statement
of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. The documents incorporated or deemed to be incorporated by reference
in the Prospectus, when filed with the Commission, conformed or will conform, as the case may be, in all material respects to the applicable requirements of the 1934 Act and the 1934 Act Regulations. There are no material contracts or documents
which are required to be described in the Registration Statement, the Disclosure Package, the Prospectus or the documents incorporated by reference therein or required to be filed as exhibits thereto which have not been so properly described or
filed as required. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) <U>Independent Accountants</U>. HORNE LLP, the accounting firm who certified the financial statements and
supporting schedules of the Company included in the Registration Statement and the Prospectus, is an independent registered public accounting firm as required by the 1933 Act and the 1933 Act Regulations and the rules of the Public Company
Accounting Oversight Board. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) <U>Financial Statements</U>. The consolidated historical financial statements, together with the related
schedules and notes, included in the preliminary prospectus, the Prospectus, the Disclosure Package and the Registration Statement comply with the requirements of the 1933 Act and present fairly, in all material respects, the financial position of
the Company and its consolidated subsidiaries at the dates indicated, and the statements of income, comprehensive income, changes in shareholders&#146; equity and cash flows of the Company and its consolidated subsidiaries for the periods specified.
Said financial statements have been prepared in conformity with generally accepted accounting principles in the United States (&#147;GAAP&#148;) applied on a consistent basis throughout the periods involved. The supporting schedules, if any,
included therein present fairly, in all material respects, in accordance with GAAP the information required to be stated therein. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi)
<U>Interactive Data</U>. The interactive data in eXtensible Business Reporting Language included or incorporated by reference in the Registration Statement fairly presents the information called for in all material respects and has been prepared in
accordance with the requirements of the 1933 Act and the Commission&#146;s rules and guidelines applicable thereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vii) <U>No Material Adverse Change in Business</U>. Since the respective dates as of which
information is given in the Prospectus, the Disclosure Package and the Registration Statement, except as otherwise stated therein, (1)&nbsp;neither the Company nor any of its subsidiaries has incurred any losses or interference with its business
from fire, explosion, flood, earthquakes, accident or other calamity, whether or not covered by insurance, or from any strike, labor dispute or court or governmental action, order or decree that are material, individually or in the aggregate, to the
Company and the subsidiaries, taken as a whole, (2)&nbsp;there has been no material adverse change, or any development which could reasonably be expected to have a material adverse change, in the condition, financial or otherwise, or in the
earnings, properties, business affairs or prospects of the Company and its subsidiaries, considered as one enterprise, whether or not arising in the ordinary course of business (a &#147;Material Adverse Effect&#148;), (3) neither the Company nor any
of its subsidiaries has entered into any transaction, other than in the ordinary course of business, that is material to the Company and its subsidiaries, considered as one enterprise, (4)&nbsp;there has not been any material change in the capital
stock of the Company or any of its Significant Subsidiaries (as defined below) (other than issuances or other transfers of capital stock in the ordinary course of business pursuant to the Company&#146;s employee benefit plans (including its equity
incentive plans), the Company&#146;s dividend reinvestment plan and employee stock purchase plan or repurchases of common stock by the Company pursuant to a share repurchase program disclosed in the Prospectus) or any material increase in the long
term indebtedness of the Company or its Significant Subsidiaries, and (5)&nbsp;except for its quarterly cash dividend in the amount of $0.22 per share declared on November&nbsp;10, 2021 and payable on January&nbsp;1, 2022 to shareholders of record
as of the close of business on December&nbsp;17, 2021, the Company has not declared, paid or made any dividend or distribution of any kind on any class of its capital stock (each of clauses (1), (2), (3), (4) and (5), a &#147;Material Adverse
Change&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(viii) <U>Regulatory Enforcement Matters</U>. Except as disclosed in the Registration Statement, the Prospectus and the
Disclosure Package, neither the Company nor any of its subsidiaries is subject or is party to, or has received any written notice that any of them may or will become subject or party to any investigation with respect to, any <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">cease-and-desist</FONT></FONT> order, written agreement, consent agreement, memorandum of understanding or other regulatory enforcement action, proceeding or order with or by, or is a party
to any commitment letter or similar undertaking to, or is subject to any directive by, or has been a recipient of any supervisory letter from, or has adopted any board resolutions at the request of, any Regulatory Agency (as defined below) that in
any material respect (considered on a consolidated basis) currently relates to or restricts the conduct of their business or that in any manner relates to their capital adequacy, their credit policies, or their management (each, a &#147;Regulatory
Agreement&#148;), nor has the Company or any of its subsidiaries been advised in writing by any Regulatory Agency that it is considering issuing or requesting any such Regulatory Agreement, where any such Regulatory Agreement could reasonably be
expected to have a Material Adverse Effect. Except as disclosed in the Registration Statement, the Prospectus and the Disclosure Package, there is no unresolved violation, criticism or exception by any Regulatory Agency with respect to any report or
statement relating to any examination of the Company or any of its subsidiaries which, in the reasonable judgment of the Company, is expected to result in a Material Adverse Effect or is expected to prevent or materially delay the transactions
contemplated by this Agreement. As used herein, the term &#147;Regulatory Agency&#148; means any federal or state agency charged with the supervision or regulation of depository institutions, or holding companies of depository institutions, or
engaged in the insurance of depository institution deposits, or engaged in the regulation and enforcement of consumer financial services, or any court, administrative agency or commission or other federal or state governmental agency, authority or
instrumentality having supervisory or regulatory authority with respect to the Company or any of its subsidiaries. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ix) <U>Good Standing of the Company</U>. The Company has been duly organized and is validly
existing as a corporation in good standing under the laws of the State of Mississippi and has corporate power and authority to own, lease and operate its properties and to conduct its business as described in the Registration Statement, the
Prospectus and the Disclosure Package, to enter into and perform its obligations under each of the Operative Documents to which it is a party, and to issue the Securities, and is duly qualified as a foreign corporation to transact business and is in
good standing in each other jurisdiction in which such qualification or license is required, whether by reason of the ownership or leasing of property or the conduct of business, except where the failure to so qualify or be in good standing would
not result in a Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(x) <U>Financial Holding Company</U>. The Company is duly registered as a bank holding company
under the Bank Holding Company Act of 1956, as amended (the &#147;BHC Act&#148;), does not (directly or indirectly) own or control the stock or voting securities of any depository institution other than the Bank Subsidiary (as defined below), and
its direct and indirect activities and investments are authorized for a bank holding company and its subsidiaries pursuant to the BHC Act. The Company is &#147;well capitalized&#148; as that term is defined at 12 CFR part 225. The Company has not
elected to become a &#147;financial holding company&#148; as such term is defined in 12 C.F.R. &#167; 225.81. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xi) <U>Subsidiaries</U>.
Each &#147;significant subsidiary&#148; of the Company (as such term is defined in Rule <FONT STYLE="white-space:nowrap">1-02</FONT> of Regulation <FONT STYLE="white-space:nowrap">S-X)</FONT> (each, a &#147;Significant Subsidiary&#148; and,
collectively, the &#147;Significant Subsidiaries&#148;) has been duly organized and is validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization, has corporate or similar power and authority to
own, lease and operate its properties and to conduct its business as described in the Registration Statement, the Prospectus and the Disclosure Package and is duly qualified and licensed to transact business and is in good standing in each foreign
jurisdiction in which such qualification is required, whether by reason of the ownership or leasing of property or the conduct of business, except where the failure to so qualify or to be in good standing would not result in a Material Adverse
Effect. The only Significant Subsidiary of the Company is Renasant Bank (the &#147;Bank Subsidiary&#148;). The Bank Subsidiary is a member in good standing of its applicable Federal Home Loan Bank. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xii) <U>Capital Stock Duly Authorized and Validly Issued</U>. All of the issued and outstanding shares of capital stock of the Company have
been duly authorized and validly issued and are fully paid and nonassessable. All of the issued and outstanding shares of capital stock of the Bank Subsidiary have been duly authorized and validly issued, are fully paid and nonassessable (except as
provided in Mississippi Code section <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">81-5-27)</FONT></FONT> and are owned by the Company, directly or through one or more other subsidiaries, free and clear of any security interest,
mortgage, pledge, lien, encumbrance, claim or equitable right. None of the issued and outstanding shares of capital stock of the Company or the Bank Subsidiary were issued in violation of any preemptive or similar rights of any shareholder of the
Company or the Bank Subsidiary, as the case may be, arising by operation of law, or under the certificate of incorporation, bylaws or other organizational documents of the Company or the Bank Subsidiary or under any agreement to which the Company or
the Bank Subsidiary is a party. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xiii) <U>Capitalization</U>. The authorized, issued and outstanding capital stock and
consolidated long term debt (i.e., a maturity greater than one year) of the Company as of September&nbsp;30, 2021 is as set forth in the Prospectus in the column entitled &#147;Actual&#148; under &#147;Capitalization.&#148; There have not been any
subsequent issuances of capital stock of the Company since such date (except issuances of common stock pursuant to exercises of employee stock options, issuances pursuant to employee benefit plans (including awards of restricted stock to Company
employees pursuant to the Company&#146;s equity incentive plans) and pursuant to the Company&#146;s dividend reinvestment plan and employee stock purchase plans). There have not been any additional long term borrowings by the Company or its
consolidated subsidiaries since such date, except, with respect to the Bank Subsidiary, pursuant to Federal Home Loan Bank advances or securities sold under agreements to repurchase by the Bank Subsidiary in its ordinary course of business. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xiv) <U>Authorization of Agreement</U>. This Agreement has been duly authorized, executed and delivered by the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xv) <U>Authorization of Indenture</U>. The Indenture has been duly authorized by the Company and, when executed and delivered by the Company,
the Indenture will constitute a valid, legal and binding agreement of the Company, enforceable against the Company in accordance with its terms, except to the extent that enforceability may be limited by (1)&nbsp;bankruptcy, insolvency,
reorganization, moratorium, fraudulent conveyance or other similar laws now or hereafter in effect relating to creditors&#146; rights generally, (2)&nbsp;general principles of equity (regardless of whether enforceability is considered in a
proceeding at law or in equity) and (3)&nbsp;with respect to the rights to indemnity or contribution, including but not limited to, indemnification and contribution provisions set forth in this Agreement, federal or state securities law or the
public policy underlying such laws (collectively, the &#147;Enforceability Exceptions&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xvi) <U>Authorization of Securities</U>.
The Securities have been duly authorized by the Company and, at the Closing Time, will have been duly executed by the Company and, when authenticated in the manner provided for in the Indenture and delivered by the Company against payment therefor
as described in the Prospectus or as contemplated in the Indenture, will constitute valid, legal and binding obligations of the Company, enforceable against the Company in accordance with their terms, except to the extent that enforceability may be
limited by the Enforceability Exceptions; the Securities will be in the form contemplated by, and will be entitled to the benefits of, the Indenture. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xvii) <U>Qualification under 1939 Act</U>. The Indenture has been duly qualified with respect to the Securities under the 1939 Act. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xviii) <U>Not an Investment Company</U>. The Company is not, and immediately following consummation of the transactions contemplated hereby
and the application of the net proceeds as described in the Registration Statement, the Prospectus and the Disclosure Package, the Company will not be, an &#147;investment company&#148; or an entity controlled by an &#147;investment company,&#148;
in each case within the meaning of Section&nbsp;3(a) of the Investment Company Act of 1940, as amended (the &#147;1940 Act&#148;), without regard to Section&nbsp;3(c) of the 1940 Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xix) <U>Descriptions of Securities</U>. The Securities will conform, in all material
respects, to all statements relating thereto contained in the Registration Statement, the Prospectus and the Disclosure Package. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xx)
<U>Absence of Defaults and Conflicts</U>. Neither the Company nor any of its subsidiaries is (1)&nbsp;in violation of its charter, bylaws or other organizational document, (2)&nbsp;in default in the performance or observance of any obligation,
agreement, covenant or condition contained in any contract, indenture, mortgage, deed of trust, loan or credit agreement, note, lease or other agreement or instrument to which it is a party or by which it or any of them may be bound or to which any
of its assets is subject (collectively, &#147;Agreements and Instruments&#148;), except for such defaults that would not, individually or in the aggregate, result in a Material Adverse Effect, or (3)&nbsp;except as disclosed in the Registration
Statement, the Prospectus and the Disclosure Package, in violation of any U.S. or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> federal, state or local statute, law (including, without limitation, common law) or ordinance, or any judgment,
decree, rule, regulation, order or injunction of any U.S. or <FONT STYLE="white-space:nowrap">non-U.S.</FONT> federal, state, local or other governmental or regulatory authority, governmental or regulatory agency or body, court, arbitrator or
self-regulatory organization applicable to the Company or its Bank Subsidiary or any of their respective properties, assets or operations (each, a &#147;Governmental Entity&#148;), except for any such default or violation that would not,
individually or in the aggregate, have a Material Adverse Effect. The execution, delivery and performance of the Operative Documents and the Securities by the Company, the issuance, sale and delivery of the Securities, the consummation of the
transactions contemplated by the Operative Documents and the Securities and in the Registration Statement, the Prospectus and the Disclosure Package (including the use of the proceeds from the sale of the Securities), and compliance by the Company
with the terms of the Operative Documents and the Securities have been duly authorized by all necessary corporate action on the part of the Company, and do not and will not, whether with or without the giving of notice or passage of time or both,
(1)&nbsp;violate, conflict with or constitute a breach of, or default or Repayment Event (as defined below) under, or result in the creation or imposition of any, security interest, mortgage, pledge, lien, charge, encumbrance, claim or equitable
right upon any assets of the Company or its Bank Subsidiary pursuant to, any of the Agreements and Instruments, (2)&nbsp;result in any violation of any provision of the charter, bylaws or other organizational document of the Company or its Bank
Subsidiary or (3)&nbsp;result in any violation by the Company or its Bank Subsidiary of any applicable law, statute, rule, regulation, judgment, order, writ or decree of any Governmental Entity, except in the case of clauses (1)&nbsp;and (3), as
would not, individually or in the aggregate, result in a Material Adverse Effect. As used herein, a &#147;Repayment Event&#148; means any event or condition that gives, or with the giving of notice or lapse of time would give, the holder of any
note, debenture or other evidence of indebtedness (or any person acting on such holder&#146;s behalf) the right to require the repurchase, redemption or repayment of all or a portion of such indebtedness by the Company or any of its subsidiaries or
any of their respective properties. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xxi) <U>Absence of Labor Dispute</U>. No labor dispute with the employees of the Company or the Bank
Subsidiary exists or, to the knowledge of the senior management of the Company, is contemplated or threatened, which would reasonably be expected to have a Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xxii) <U>Compliance With ERISA</U>. Each of the Company, its subsidiaries and each ERISA
Affiliate (as hereinafter defined) has fulfilled its obligations, if any, under the minimum funding standards of Section&nbsp;302 of the United States Employee Retirement Income Security Act of 1974, as amended (&#147;ERISA&#148;), with respect to
each &#147;pension plan&#148; (as defined in Section&nbsp;3(2) of ERISA), subject to Section&nbsp;302 of ERISA, which the Company, its subsidiaries or any ERISA Affiliate sponsors or maintains, or with respect to which it has (or within the last
three years had) any obligation to make contributions, and each such plan is in compliance in all respects with the presently applicable provisions of ERISA and the Internal Revenue Code of 1986, as amended (the &#147;Code&#148;), except where such
failure to fulfill its obligations or such <FONT STYLE="white-space:nowrap">non-compliance</FONT> would not result in a Material Adverse Effect. None of the Company, its subsidiaries or any ERISA Affiliate has incurred any unpaid liability to the
Pension Benefit Guaranty Corporation (other than for the payment of premiums in the ordinary course) or to any such plan under Title IV of ERISA, except where such unpaid liability would not result in a Material Adverse Effect. No prohibited
transaction, within the meaning of Section&nbsp;406 of ERISA or Section&nbsp;4975 of the Code, has occurred with respect to any such plan, excluding transactions effected pursuant to a statutory or administrative exemption, that could reasonably be
expected to result in a material liability to the Company and its subsidiaries taken as a whole. &#147;ERISA Affiliate&#148; means a corporation, trade or business that is, along with the Company or any subsidiary, a member of a controlled group of
corporations or a controlled group of trades or businesses, as described in Section&nbsp;414 of the Code or Section&nbsp;4001 of ERISA. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xxiii) <U>Absence of Proceedings</U>. Except as disclosed in the Registration Statement, the Prospectus and the Disclosure Package, there is
no action, suit, proceeding, inquiry or investigation before or brought by any Governmental Entity, now pending, or, to the knowledge of the Company, threatened against or affecting the Company or any of its subsidiaries, which (1)&nbsp;is required
to be disclosed in the Registration Statement or the Prospectus; (2)&nbsp;would reasonably be expected to have a Material Adverse Effect or (3)&nbsp;would reasonably be expected to materially and adversely affect the consummation of the transactions
contemplated by this Agreement, the other Operative Documents or the Securities or the performance by the Company of its obligations hereunder or thereunder. Except as described in the Registration Statement, the Prospectus and the Disclosure
Package, there are no legal or governmental proceedings to which the Company or any of its subsidiaries is a party or of which any of their respective assets is the subject, including ordinary routine litigation incidental to the business, which
would, in the aggregate, reasonably be expected to have a Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xxiv) <U>Absence of Further Requirements</U>. No
filing with, or authorization, approval, consent, license, order, registration, qualification or decree of, any Governmental Entity, other than those that have been made or obtained, is necessary or required for the authority, execution, delivery or
performance by the Company of its obligations under the Operative Documents or the Securities, or the consummation by the Company of the transactions contemplated thereunder, except as may be required under state securities laws. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xxv) <U>Possession of Licenses and Permits</U>. The Company and its subsidiaries possess
such permits, licenses, approvals, consents and other authorizations (collectively, &#147;Governmental Licenses&#148;) issued by the appropriate Governmental Entities that are necessary to conduct their respective businesses as described in the
Registration Statement, the Prospectus and the Disclosure Package, and have made all declarations and filings with the appropriate Governmental Entities that are necessary for the conduct of their respective businesses as described in the
Registration Statement, the Prospectus and the Disclosure Package, except where the failure to possess such Governmental Licenses or make such declarations or filings would not, individually or in the aggregate, have a Material Adverse Effect. The
Company and its subsidiaries are in compliance with the terms and conditions of all such Governmental Licenses, except where the failure so to comply would not, individually or in the aggregate, have a Material Adverse Effect. All of the
Governmental Licenses are valid and in full force and effect, except when the invalidity of such Governmental Licenses or the failure of such Governmental Licenses to be in full force and effect would not, individually or in the aggregate, have a
Material Adverse Effect. None of the Company or any of its subsidiaries has received any written notice of proceedings relating to the revocation or modification of any such Governmental Licenses which would, individually or in the aggregate,
reasonably be expected to have a Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xxvi) <U>Conduct of Business</U>. Except as otherwise disclosed in the
Registration Statement, the Prospectus and the Disclosure Package, each of the Company and the Bank Subsidiary is conducting its business in compliance with all laws, rules, regulations, decisions, directives and orders, and all regulations and
orders of, or agreements with, Governmental Entities applicable to it, except where failure to so comply would not, individually or in the aggregate, have a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xxvii) <U>Environmental Matters</U>. Each of the Company and its subsidiaries are in compliance with all applicable federal, state and local
laws, rules and regulations, and decisions and orders relating to the protection of human health and safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants, including, without limitation, those applicable to
emissions to the environment, waste management and waste disposal (collectively, the &#147;Environmental Laws&#148;), except where such noncompliance would not, individually or in the aggregate, have a Material Adverse Effect, and, to the knowledge
of the Company, there are no circumstances that would prevent, interfere with or materially increase the cost of such compliance in the future. There is no claim under any Environmental Law, including common law, pending or, to the knowledge of the
Company, threatened against the Company or any of its subsidiaries (an &#147;Environmental Claim&#148;), which would have a Material Adverse Effect, and, to the knowledge of the Company, under applicable law, there are no past or present actions,
activities, circumstances, events or incidents, including without limitation, releases of any material into the environment, that are reasonably likely to form the basis of any Environmental Claim against the Company or the Bank Subsidiary which
would, individually or in the aggregate, have a Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xxviii) <U>Title to Property</U>. Each of the Company and its
subsidiaries has good and marketable title in fee simple to all of its real and personal properties, reflected as owned in the consolidated financial statements or as described in the Prospectus, in each case free and clear of all liens,
encumbrances, claims and defects, except as (1)&nbsp;reflected in such consolidated financial statements, (2)&nbsp;do not materially interfere with the use made and proposed to be made of such property by the Company or such subsidiary or
(3)&nbsp;which would not, individually or in the aggregate, have a Material Adverse Effect. All of the leases and subleases under which the Company or any of its subsidiaries holds properties used in its business are in full force and
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
effect, except where the failure of such leases and subleases to be in full force and effect would not, individually or in the aggregate, have a Material Adverse Effect. None of the Company or
any of its subsidiaries has any notice of any claim of any sort that has been asserted by anyone adverse to the rights of the Company or any of its subsidiaries under any of the leases or subleases mentioned above, or affecting or questioning the
rights of such entity to the continued possession of the leased or subleased premises under any such lease or sublease, except any claim that would not, individually or in the aggregate, have a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xxix) <U>Intellectual Property</U>. Each of the Company and its subsidiaries owns or possesses all necessary and adequate patents, patent
rights, licenses, inventions, copyrights, <FONT STYLE="white-space:nowrap">know-how</FONT> (including trade secrets and other unpatented and/or unpatentable proprietary or confidential information, systems or procedures), trademarks, service marks,
trade names or other intellectual property (collectively, &#147;Intellectual Property&#148;) presently employed by it in connection with the business now operated by it or reasonably necessary in order to conduct such business, and none of the
Company or any of its subsidiaries has received any notice or is otherwise aware of any infringement of or conflict with asserted rights of others with respect to any Intellectual Property or any facts or circumstances which would render any
Intellectual Property invalid or inadequate to protect the interest of the Company or any of its subsidiaries therein, except where the failure to possess such Intellectual Property or where such infringement or conflict (if the subject of any
unfavorable decision, ruling or finding) or invalidity or inadequacy, individually or in the aggregate, would not have a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xxx) <U>Taxes</U>. The Company and each Significant Subsidiary has: (1)&nbsp;timely (after taking account of any governmental orders extending
the time for filing) filed all tax returns, information returns, and similar reports that are required to be filed and all such returns are true, correct and complete, and (2)&nbsp;timely paid in full all federal, state, local and foreign taxes
required to be paid by it and any other assessment, fine or penalty levied against it, except to the extent any such tax, assessment, fine or penalty that is currently being contested in good faith and for which adequate reserves have been made
under GAAP, except where the failure to timely file such tax returns or to timely pay such tax, assessment, fine or penalty would not, individually or in the aggregate, result in a Material Adverse Effect. Giving effect to any applicable extensions
and except as otherwise disclosed in the Registration Statement, the Prospectus and the Disclosure Package, there is no material tax deficiency that has been, or could reasonably be expected to be, asserted against the Company or the Bank Subsidiary
or any of their respective assets. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xxxi) <U>Insurance</U>. The Company and the Bank Subsidiary have insurance covering their respective
assets, operations, personnel and businesses, including business interruption insurance, which insurance is in such amounts and insures against such losses and risks as are adequate to protect the Company and the Bank Subsidiary and their respective
assets, operations, personnel and businesses; and neither the Company nor the Bank Subsidiary has (i)&nbsp;received notice from any insurer or agent of such insurer that capital improvements or other expenditures are required or necessary to be made
in order to continue such insurance or (ii)&nbsp;any reason to believe that it will not be able to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage at reasonable cost from similar insurers as may
be necessary to continue its business. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xxxii) <U>Payment of Dividends</U>. No subsidiary of the Company is currently prohibited,
directly or indirectly, from paying any dividends to the Company, from making any other distribution on such subsidiary&#146;s capital stock, from transferring any of its property or assets to the Company or any other subsidiary of the Company, or
from repaying to the Company any loans or advances to such subsidiary from the Company, except as disclosed in each of the Prospectus and the Disclosure Package. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xxxiii) <U>Sarbanes-Oxley Act</U>. The Company and its directors and officers, in their capacities as such, are in compliance in all material
respects with all applicable provisions of the Sarbanes-Oxley Act of 2002 and all rules and regulations promulgated thereunder or implementing the provisions thereof with which the Company or any of its directors or officers is required to comply.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xxxiv) <U>Accounting Controls</U>. The Company and its subsidiaries, taken as a whole, maintains a system of internal accounting controls
sufficient to provide reasonable assurance that: (1)&nbsp;transactions are executed in accordance with management&#146;s general or specific authorizations; (2)&nbsp;transactions are recorded as necessary to permit preparation of financial
statements in conformity with GAAP and to maintain asset accountability; (3)&nbsp;access to assets is permitted only in accordance with management&#146;s general or specific authorization; and (4)&nbsp;the recorded accountability for assets is
compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences.&nbsp;&nbsp;&nbsp;&nbsp;The Company&#146;s internal control over financial reporting is effective in all material respects, and
since the date of the latest audited financial statements included in the Registration Statement, the Prospectus and the Disclosure Package, (x)&nbsp;the Company is not aware of any material weaknesses in its internal controls, and (y)&nbsp;there
has been no change in the Company&#146;s internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company&#146;s internal control over financial reporting. The Company maintains
disclosure controls and procedures (as such term is defined in Rule <FONT STYLE="white-space:nowrap">13a-15(e)</FONT> of the 1934 Act Regulations); and such disclosure controls and procedures have been designed to ensure that material information
relating to the Company and its subsidiaries is made known to the Company&#146;s principal executive officer and principal financial officer by others within those entities; and such disclosure controls and procedures are effective. The Company has
not become aware of any fraud, whether or not material, that involves management or other employees who have a significant role in the Company&#146;s internal control over financial reporting. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xxxv) <U>Foreign Corrupt Practices Act</U>. None of the Company or its subsidiaries or, to the knowledge of the Company, any director,
officer, employee or any agent or other person acting on behalf of the Company or any of its subsidiaries has, in the course of its actions for, or on behalf of, the Company or any of its subsidiaries (1)&nbsp;used any corporate funds for any
unlawful contribution, gift, entertainment or other unlawful expenses relating to political activity in violation of the U.S. Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder (collectively, the
&#147;FCPA&#148;); (2) made any direct or indirect unlawful payment to any domestic government official, &#147;foreign official&#148; (as defined in the FCPA) or employee from corporate funds; (3)&nbsp;violated or is in violation of any provision of
the FCPA or any applicable <FONT STYLE="white-space:nowrap">non-U.S.</FONT> anti-bribery statute or regulation; or (4)&nbsp;made any unlawful bribe, rebate, payoff, influence payment, kickback or other unlawful payment to any domestic government
official, such foreign official or employee. The Company has instituted and maintains procedures designed to ensure, and which are reasonably expected to continue to ensure, continued compliance with the FCPA and similar laws, rules and regulations
based on the business of the Company as conducted on the date hereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xxxvi) <U>Compliance with Money Laundering Laws</U>. Except as otherwise disclosed in the
Registration Statement, the Prospectus and the Disclosure Package, the operations of the Company and its subsidiaries are and, to the knowledge of the Company and its subsidiaries, have been conducted at all times in compliance in all material
respects with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering statutes of all applicable jurisdictions, the rules and regulations
thereunder and any related or similar rules, regulations or guidelines issued, administered or enforced by any governmental agency (collectively, the &#147;Money Laundering Laws&#148;), and no action, suit or proceeding by or before any court or
governmental agency, authority or body or any arbitrator involving the Company or its subsidiaries with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or its subsidiaries, threatened. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xxxvii) <U>Compliance with OFAC</U>. Neither the Company nor any of its subsidiaries nor, to the Company&#146;s knowledge, any director,
officer, agent, employee or other person acting on behalf of the Company or any of its subsidiaries is currently subject to any U.S. sanctions administered by the Office of Foreign Assets Control of the U.S. Treasury Department (&#147;OFAC&#148;);
and the Company will not directly or indirectly use the proceeds of the Offering, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture partner or other person or entity, for the purpose of financing the
activities of or business with any person, or in any country or territory, that currently is the subject to any U.S. sanctions administered by OFAC. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xxxviii) <U>IT Systems</U>. The Company and its subsidiaries&#146; information technology assets and equipment, computers, systems, networks,
hardware, software, websites, applications, and databases (collectively, &#147;IT Systems&#148;) are adequate for, and operate and perform as required in connection with, the operation of the business of the Company and its subsidiaries as currently
conducted, and free and clear of all bugs, errors, defects, Trojan horses, time bombs, malware and other corruptants, except where failure in the adequacy, operation or performance of such IT Systems would not, individually or in the aggregate,
result in a Material Adverse Effect. The Company and its subsidiaries have implemented and maintained controls, policies, procedures, and safeguards designed to maintain and protect their confidential information and the integrity, continuous
operation, redundancy and security of all IT Systems and data (including all personal, personally identifiable, sensitive, confidential or regulated data (&#147;Personal Data&#148;)) used in connection with their businesses consistent with industry
standards and practices, and, to the knowledge of the Company, there have been no breaches, violations, outages or unauthorized uses of or accesses to same, nor any incidents under internal review or investigations relating to the same, except where
failure to implement or maintain such controls, policies, procedures and safeguards or the occurrence of breaches, violations, outages or unauthorized uses or access would not, individually or in the aggregate, result in a Material Adverse Effect.
The Company and its subsidiaries are presently in compliance with all applicable laws or statutes and all applicable judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority, internal policies and
contractual obligations relating to the privacy and security of IT Systems and Personal Data and to the protection of such IT Systems and Personal Data from unauthorized use, access, misappropriation or modification, except where failure in
compliance would not, individually or in the aggregate, result in a Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xxxix) <U>No Brokers</U>. Other than the Underwriters, there is no broker, finder or other
party that is entitled to receive from the Company or any subsidiary any brokerage or finder&#146;s fee or other fee or commission as a result of any transactions contemplated by this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xl) <U>Stabilization</U>. Neither the Company nor any of its subsidiaries has taken or will take, directly or indirectly, any action designed
to, or that might be reasonably expected to, cause or result in stabilization or manipulation of the price of the Securities. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xli)
<U>Pending Proceedings and Examinations</U>. The Registration Statement is not the subject of a pending proceeding or examination under Section&nbsp;8(d) or 8(e) of the 1933 Act, and the Company is not the subject of a pending proceeding under
Section&nbsp;8A of the 1933 Act in connection with the offering of the Securities. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xlii) <U>Registration Rights</U>. There are no persons
with registration rights or other similar rights to have any securities of the Company or its subsidiaries registered by the Company or any other person under the 1933 Act. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xliii) <U>Statistical and Market Data</U>. Nothing has come to the attention of the Company that has caused the Company to believe that the
statistical and market-related data included in the Registration Statement, the Prospectus or the Disclosure Package is not based on or derived from sources that are reliable or is not accurate in all material respects. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xliv) <U>Forward-Looking Statements</U>. No forward-looking statement (within the meaning of Section&nbsp;27A of the 1933 Act and
Section&nbsp;21E of the 1934 Act) contained in the Registration Statement, the Prospectus or the Disclosure Package has been made or reaffirmed without a reasonable basis or has been disclosed other than in good faith. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xlv) <U>Investment Securities</U>. Each of the Company and its subsidiaries has good and marketable title to all securities held by it (except
securities sold under repurchase agreements or held in any fiduciary or agency capacity) free and clear of any security interest, mortgage, pledge, lien, charge, encumbrance, claim or equitable right or other restriction of any kind, except to the
extent such securities are pledged in the ordinary course of business consistent with past business practices to secure obligations of the Company or any of its subsidiaries and except for such defects in title or security interest, mortgage,
pledge, lien, charge, encumbrance, claim or equitable right or other restrictions of any kind that would not, individually or in the aggregate, result in a Material Adverse Effect. Such securities are valued on the books of the Company and its
subsidiaries in accordance with GAAP. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xlvi) <U>Derivative Securities</U>. Any and all material swaps, caps, floors, futures, forward
contracts, option agreements (other than employee stock options) and other derivative financial instruments, contracts or arrangements, whether entered into for the account of the Company or one of its subsidiaries or for the account of a customer
of the Company or one of its subsidiaries, were entered into in the ordinary course of business and in accordance with </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
applicable laws, rules, regulations and policies of all applicable regulatory agencies and with counterparties believed to be financially responsible at the time. The Company and each of its
subsidiaries have duly performed in all material respects all of their obligations thereunder to the extent that such obligations to perform have accrued. Neither the Company nor any of its subsidiaries, nor, to the knowledge of the Company, any
other party thereto, is in breach of its material obligations under any such agreement or arrangement.<B> </B> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(xlvii) <U>Deposit
Insurance/Bank Subsidiary Capitalization</U>. The deposit accounts of the Bank Subsidiary are insured up to the applicable limit by the Federal Deposit Insurance Corporation, all premiums and assessments required to be paid in connection therewith
have been paid when due, and no proceedings for the revocation or termination of such insurance is pending or, to the knowledge of the Company, threatened. The Bank Subsidiary is &#147;well capitalized&#148; as that term is defined at 12 CFR part 6.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Any certificate signed by any duly authorized officer of the Company or any of its subsidiaries and delivered to the Representative or to
counsel for the Underwriters shall be deemed a representation and warranty by the Company or the applicable subsidiary, as the case may be, to the Representative as to the matters covered thereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;2. <U>Sale and Delivery to Underwriters; Closing</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On the basis of the representations and warranties herein contained and subject to the terms and conditions herein set forth, the Company
agrees to sell to each Underwriter, severally and not jointly, and each Underwriter, severally and not jointly, agrees to purchase from the Company, the aggregate principal amount of the Securities set forth opposite the name of such Underwriter on
Schedule I hereto, at a purchase price equal to 98.75% of the aggregate principal amount thereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Delivery of the Securities shall be
made at the offices of Covington&nbsp;&amp; Burling LLP, The New York Times Building, 620 Eighth Avenue, 42nd Floor, New York, New York 10018, or such other place as may be agreed to by the Representative and the Company, and payment of the purchase
price for the Securities shall be made by the Representative to the Company by wire transfer of immediately available funds contemporaneous with closing at such place as shall be agreed upon by the Representative and the Company, no later than 10:00
a.m. (New York City time) on November&nbsp;23, 2021 or such other time not later than ten (10)&nbsp;business days after such date as shall be agreed upon by the Representative and the Company (such time and date of payment and delivery being herein
called the &#147;Closing Time&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">It is understood that each Underwriter has authorized the Representative, for its account, to
accept delivery of, receipt for, and make payment of the purchase price for, the Securities which it has agreed to purchase. KBW, individually and not as Representative of the Underwriters, may (but shall not be obligated to) make payment of the
purchase price for the Securities to be purchased by any Underwriter whose funds have not been received by the Closing Time, but such payment shall not relieve such Underwriter from its obligations hereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Payment for the Securities purchased by the Underwriters shall be made to the Company by
wire transfer of immediately available funds to a bank designated by the Company, against delivery to the Representative for the respective accounts of the Underwriters of one or more global notes representing the Securities (collectively, the
&#147;Global Note&#148;) to be purchased by the Underwriters. The Securities represented by the Global Note shall be in such denominations and registered in such names as the Representative may request in writing at least one full business day prior
to the Closing Time. The Global Note shall be made available for examination by the Representative not later than 10:00 a.m. (New York City time) on the business day prior to the Closing Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In performing its duties under this Agreement, the Underwriters shall be entitled to rely upon any notice, signature or writing that the
Underwriters shall in good faith believe to be genuine and to be signed or presented by a proper party or parties. The Underwriters may rely upon any opinions or certificates or other documents delivered by the Company or its counsel or designees to
them. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;3. <U>Covenants of the Company</U>. The Company covenants with the Underwriters as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <I>Compliance with Securities Regulations and Commission Requests</I>. Prior to the completion of the distribution of the Securities as
contemplated in this Agreement (which the Representative will promptly confirm orally to the Company), the Company will notify the Representative promptly, and confirm the notice in writing, (i)&nbsp;when any post-effective amendment to the
Registration Statement or a new registration statement relating to the Securities shall become effective, or any amendment or supplement to the Disclosure Package or the Prospectus or any amended Prospectus shall have been used or filed,
(ii)&nbsp;of the receipt of any comments with respect to the Registration Statement from the Commission, (iii)&nbsp;of any request by the Commission for any amendment to the Registration Statement or the filing of a new registration statement or any
amendment or supplement to the Disclosure Package or the Prospectus or any document incorporated therein by reference or otherwise deemed to be a part thereof or for additional information, (iv)&nbsp;of the issuance by the Commission of any stop
order suspending the effectiveness of the Registration Statement or such new registration statement or of any order preventing or suspending the use of any preliminary prospectus or the Prospectus, or of the suspension of the qualification of the
Securities for offering or sale in any jurisdiction, or of the initiation or threatening of any proceedings for any of such purposes or of any examination pursuant to Section&nbsp;8(e) of the 1933 Act concerning the Registration Statement and
(v)&nbsp;if the Company becomes the subject of a proceeding under Section&nbsp;8A of the 1933 Act. With respect to the Securities, subject to Section&nbsp;3(e), the Company will comply with the requirements of Rule 430B, will prepare the Prospectus
in the form approved by the Representative, will effect the filings required under Rule 424(b) in the manner and within the time period specified therein (without reliance on Rule 424(b)(8)) and will take such steps as it deems necessary to
ascertain promptly whether the Prospectus transmitted for filing under Rule 424(b) under the 1933 Act Regulations was received for filing by the Commission and, in the event that it was not, it will promptly file such Prospectus. The Company will
use its commercially reasonable efforts to prevent the issuance of any stop order or other order and, if any stop order or other order is issued, to obtain the lifting thereof as soon as possible. The Company shall pay the required filing fees of
the Commission relating to the Securities within the time required by Rule 456(b)(1)(i) of the 1933 Act Regulations without regard to the proviso therein and otherwise in accordance with Rules 456(b) and 457(r) of the 1933 Act Regulations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <I>Delivery of Registration Statements</I>. The Company will furnish to each Underwriter
and counsel for the Underwriters, on request without charge, signed or conformed copies of the Registration Statement and of each amendment thereto (including exhibits filed therewith or incorporated by reference therein and documents incorporated
or deemed to be incorporated by reference therein or otherwise deemed to be a part thereof) and signed or conformed copies of all consents and certificates of experts. The copies of the Registration Statement and each amendment thereto furnished to
the Representative will be identical to the electronically transmitted copies thereof filed with the Commission pursuant to EDGAR, except to the extent permitted by Regulation <FONT STYLE="white-space:nowrap">S-T.</FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <I>Delivery of Prospectuses. </I>The Company has delivered to each Underwriter, without charge, as many copies of each preliminary
prospectus as such Underwriter reasonably requested, and the Company hereby consents to the use of such copies for purposes permitted by the 1933 Act. The Company will furnish to each Underwriter, without charge, during the period when a prospectus
is required to be delivered under the 1933 Act, such number of copies of the Prospectus (as amended or supplemented) as such Underwriter may reasonably request, unless, with the prior consent of the Representative, such delivery requirement can be
satisfied by the provisions of Rule 172 of the 1933 Act Regulations. The Prospectus and any amendments or supplements thereto furnished to the Underwriters will be identical to the electronically transmitted copies thereof filed with the Commission
pursuant to EDGAR, except to the extent permitted by Regulation <FONT STYLE="white-space:nowrap">S-T.</FONT> </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <I>Notice and Effect of
Material Events</I>. The Company will comply with the 1933 Act, the 1933 Act Regulations, the 1934 Act, the 1934 Act Regulations, the 1939 Act and the 1939 Act Regulations, as applicable, so as to permit the completion of the distribution of the
Securities as contemplated in this Agreement and in the Registration Statement, the Disclosure Package and the Prospectus. Prior to the completion of the distribution of the Securities by the Underwriters, the Company will immediately notify the
Representative, and confirm such notice in writing, of (x)&nbsp;any filing made by the Company of information relating to the offering of the Securities with any securities exchange or any other regulatory body in the United States, and (y)&nbsp;any
event or condition that results or is reasonably likely to result in a Material Adverse Change, which (i)&nbsp;makes any statement in the Registration Statement, the Disclosure Package or the Prospectus false or misleading or (ii)&nbsp;which is not
disclosed in the Registration Statement, the Disclosure Package or the Prospectus. If, at any time when a prospectus is required by the 1933 Act to be delivered in connection with sales of the Securities, any event shall occur or condition shall
exist as a result of which it is necessary, in the reasonable opinion of the Company, its counsel, the Representative or counsel to the Underwriters, to amend or supplement the Registration Statement or the Prospectus in order that the Prospectus
not include any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein in the light of the circumstances existing at the time it is delivered to purchasers not misleading, or if for any
other reason it shall be necessary, in the reasonable opinion of the Company, its counsel, the Representative or counsel to the Underwriters, during such period to amend the Registration Statement or to file a new registration statement or to amend
or supplement any preliminary prospectus or the Prospectus to comply with the 1933 Act </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
or the 1933 Act Regulations, the Company will forthwith amend the Registration Statement, file such registration statement and/or amend or supplement such preliminary prospectus or the
Prospectus, subject to Section&nbsp;3(e), so as to correct such untrue statement or omission or effect such compliance, and the Company will furnish to each Underwriter such number of written and electronic copies of such amendment or supplement as
such Underwriter may reasonably request. If at any time following the Applicable Time or at any time following the issuance of an Issuer Free Writing Prospectus, any event shall occur or condition shall exist as a result of which the Disclosure
Package or such Issuer Free Writing Prospectus, individually or together with other information that is part of the Disclosure Package, as the case may be, conflicted or would conflict with the information contained in the Registration Statement or
any other registration statement relating to the Securities or included or would include an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order to make the statements therein, in the light of the
circumstances prevailing at that subsequent time, not misleading, the Company will promptly notify the Representative and will promptly amend or supplement, at the Company&#146;s own expense, the Disclosure Package or such Issuer Free Writing
Prospectus, as the case may be, to eliminate or correct such conflict, untrue statement or omission. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <I>Amendment to Prospectus or
Registration Statement</I>. The Company will advise the Representative promptly of any notice of its intention to file or prepare any amendment to the Registration Statement or a new registration statement relating to the Securities or any amendment
or supplement to any preliminary prospectus or the Prospectus or supplement to the Disclosure Package, and will furnish the Representative with copies thereof a reasonable amount of time prior to such proposed filing or use, as the case may be, and
will not file or use any such document with respect to the Securities without the consent of the Representative, which consent shall not be unreasonably withheld. Neither the consent of the Representative, nor the Representative&#146;s delivery of
any such amendment or supplement, shall constitute a waiver of any of the conditions set forth in Section&nbsp;5 hereof. For purposes of clarity, this Section&nbsp;3(e) shall not apply to any filings required in order for the Company to comply with
its reporting obligations under the 1934 Act or the 1934 Act Regulations. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <I>No Stabilization</I>. The Company will not take, directly
or indirectly, any action designed to, or that would reasonably be expected to, cause or result in any stabilization or manipulation of the price of the Securities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <I>DTC</I>. The Company will cooperate with the Underwriters and use its commercially reasonable efforts to permit the Securities to be
eligible for clearance, settlement and trading through the facilities of DTC. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <I>Blue Sky Compliance</I>. The Company will qualify the
Securities for offer and sale under the state securities, or blue sky, laws of such jurisdictions as the Representative shall reasonably request and will continue such qualifications in effect so long as required for the offering and resale of the
Securities; provided that the Company shall not be required to (i)&nbsp;qualify as a foreign corporation or other entity or as a dealer in securities in any such jurisdiction where they would not otherwise be required to so qualify, (ii)&nbsp;file
any general consent to service of process in any such jurisdiction or (iii)&nbsp;subject themselves to taxation in any such jurisdiction if they are not otherwise so subject. The Company will also supply the Underwriters with such information as is
necessary for the determination of the legality of the Securities for investment under the laws of such jurisdiction as the Underwriters may request. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <I>Further Obligations</I>. In the event the Company, at any time, or from time to time,
shall not have sufficient funds to promptly pay in full any amount then due and payable pursuant to Section&nbsp;6 of this Agreement to any indemnified person, the Company shall promptly take such commercially reasonable actions that do not require
prior regulatory approval to obtain sufficient funds to pay such amount. If the funds obtained from such actions shall not be sufficient to pay such amount in full (a &#147;Deficiency&#148;), the Company shall promptly take all such further
commercially reasonable actions, including obtaining all required regulatory approvals for the Bank Subsidiary to pay a dividend to the Company in the amount of the Deficiency. The Company shall pay the Deficiency to the extent that regulatory
authorities approve a dividend from the Bank Subsidiary to the Company, provided that if the dividends from the Bank Subsidiary to the Company are insufficient to pay the Deficiency to any indemnified person, the Company shall remain obligated to
(i)&nbsp;pay such Deficiency and (ii)&nbsp;use its commercially reasonable efforts to obtain such additional regulatory approvals for the Bank Subsidiary to pay additional dividends to the Company until the Company has paid the Deficiency in full to
any indemnified person. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) <I>Earnings Statement</I>. The Company shall timely file such reports pursuant to the 1934 Act as are
necessary in order to make generally available to its securityholders as soon as practicable an earnings statement for the purposes of, and to provide the benefits contemplated by, the last paragraph of Section&nbsp;11(a) of the 1933 Act. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) <I>Reporting Requirements</I>. The Company, during the period when a prospectus is required to be delivered under the 1933 Act (including
in circumstances where such requirement may be satisfied, with the prior consent of the Representative, by Rule 172 under the 1933 Act Regulations), will file all documents required to be filed with the Commission by the Company pursuant to the 1934
Act within the time periods required by the 1934 Act and the 1934 Act Regulations. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) <I>Use of Proceeds</I>. The Company will use the
net proceeds received by it from the sale of the Securities as described in the Registration Statement, the Prospectus and the Disclosure Package under &#147;Use of Proceeds.&#148; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) <I>Stand Off Agreement</I>. Between the date of this Agreement and the Closing Time, the Company and its subsidiaries will not, without the
prior consent of the Representative, directly or indirectly, issue, offer or sell, or enter into any agreement to sell, any debt securities (excluding deposit obligations) of the Company or its subsidiaries, other than the Securities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) <I>Issuer Free Writing Prospectuses</I>. The Company represents and agrees that, unless it obtains the prior written consent of the
Representative, and each Underwriter represents and agrees that, unless it obtains the prior written consent of the Company and the Representative, it has not made and will not make any offer relating to the Securities that would constitute an
&#147;issuer free writing prospectus&#148; (as defined in Rule 433) or that would otherwise constitute a &#147;free writing prospectus&#148; (as defined in Rule 405) required to be filed with the Commission. Any such free writing prospectus
consented to by the Company and the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Representative is referred to herein as a &#147;Permitted Free Writing Prospectus.&#148; The Company represents that it has treated, and agrees that it will treat, each Permitted Free Writing
Prospectus as an &#147;issuer free writing prospectus&#148; (as defined in Rule 433(h)(i)) and has complied and will comply with the requirements of Rule 433 applicable to any Permitted Free Writing Prospectus, including timely filing with the
Commission where required, legending and record keeping. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Subject to the consent of the Representative required in the immediately
preceding paragraph, the Company will prepare a final term sheet relating solely to the final pricing terms of the Securities and will file such final term sheet within the period required by Rule 433(d)(5)(ii) following the date such final terms
have been established for such Securities. Any such final term sheet is an Issuer General Use Free Writing Prospectus and a Permitted Free Writing Prospectus for purposes of this Agreement. Notwithstanding anything to the contrary contained herein,
the Company consents to the use by any Underwriter of a free writing prospectus that contains only (a)&nbsp;(i) information describing the preliminary terms of the Securities generally or the Securities specifically or their offering or
(ii)&nbsp;information that describes the final terms of the Securities or their offering and that is or is to be included in the final term sheet of the Company contemplated in the first sentence of this paragraph or (b)&nbsp;other customary
information that is not &#147;issuer information,&#148; as defined in Rule 433. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o) <I>NRSRO Rating</I>. The Company will use commercially
reasonable efforts to maintain a rating by a &#147;nationally recognized statistical rating organization&#148; as defined in Section&nbsp;3(a)(62) of the 1934 Act (&#147;NRSRO&#148;) while any Securities remain outstanding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;4. <U>Payment of Expenses</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <I>Expenses</I>. The Company will pay all expenses incident to the performance of its obligations under this Agreement, including
(i)&nbsp;the preparation, printing and filing of the Registration Statement (including financial statements and exhibits) and of each amendment thereto and the cost of obtaining all securities and bank regulatory approvals; (ii)&nbsp;the printing
and delivery to the Underwriters of copies of each preliminary prospectus, any Permitted Free Writing Prospectus and the Prospectus and any amendments or supplements thereto and any reasonable and documented costs associated with electronic delivery
of any of the foregoing by the Underwriters to investors; (iii)&nbsp;the costs of blue sky qualification (including fees and expenses of Covington&nbsp;&amp; Burling LLP, blue sky counsel to the Underwriters, relating thereto) of the Securities in
the various jurisdictions; (iv)&nbsp;the costs, fees and expenses incurred by the Underwriters in connection with determining their compliance with the rules and regulations of FINRA related to the Underwriters&#146; participation in the offering
and distribution of the Securities, including any related filing fees and reasonable legal fees of, and disbursements by, counsel to the Underwriters; (v)&nbsp;all fees and disbursements of the Company&#146;s counsel, accountants, agents and other
advisors; (vi)&nbsp;the preparation, issuance and delivery of the certificates for the Securities, including filing fees and the fees and expenses of making the Securities eligible for clearance, settlement and trading through the facilities of DTC;
(vii)&nbsp;the fees and disbursements of the Trustee and its counsel; (viii)&nbsp;the costs and expenses of the Company relating to investor presentations on any &#147;road show&#148; undertaken in connection with the marketing of the Securities;
(ix)&nbsp;any fees payable in connection with the rating of the Securities; (x)&nbsp;all fees and expenses incurred by the Underwriters in connection with their services to be rendered hereunder including, without limitation, road show or investor
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
presentation expenses, word processing charges, the costs of printing or producing any investor presentation materials, messenger and duplicating service expenses, facsimile expenses and other
customary expenditures (including the reasonable fees and expenses of counsel to the Underwriters). In the event any Underwriter incurs any such fees and expenses on behalf of the Company, the Company will reimburse such Underwriter for such
reasonable and documented fees and expenses whether or not the transactions contemplated hereby are consummated. It is understood, however, that, except as provided in this Section, Sections 6, 9 and 10(c) hereof, the Underwriters will pay all of
their own costs and expenses, including transfer taxes on resale of any of the Securities by them and the cost of preparing and distributing any term sheet prepared by any Underwriter. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <I>Termination</I>. If this Agreement is terminated by the Representative in accordance with the provisions of Section&nbsp;5(o),
Section&nbsp;9(a)(i) or Section&nbsp;10(c) hereof, the Company shall reimburse the Underwriters for all of their <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses, including the reasonable and
documented fees and disbursements of counsel for the Underwriters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;5. <U>Conditions of Underwriters&#146; Obligations</U>.
The obligations of the several Underwriters hereunder are subject to the accuracy of the representations and warranties of the Company contained in Section&nbsp;1 hereof or in certificates of any officer of the Company or any of its subsidiaries
delivered pursuant to the provisions hereof, to the performance by the Company of its obligations hereunder required to be performed prior to Closing Time, and to the following further conditions: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <I>Filing of Prospectus</I>. The Prospectus containing the Rule 430B Information shall have been filed with the Commission in the manner
and within the time period required by Rule 424(b) (without reliance on Rule 424(b)(8)) (or a post-effective amendment providing such information shall have been filed and become effective in accordance with the requirements of Rule 430B); all
materials required to be filed by the Company pursuant to Rule 433(d) under the 1933 Act shall have been filed with the Commission within the applicable time period prescribed for such filing by Rule 433 under the 1933 Act. The Registration
Statement is effective and no stop order or other order referred to in Section&nbsp;3(a)(iv) hereof shall have been issued and no proceeding for that purpose shall have been initiated or are pending or threatened; and all requests for additional
information on the part of the Commission shall have been complied with to the Representative&#146;s satisfaction. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <I>Opinion of
Counsel for Company</I>. At the Closing Time, the Representative shall have received the favorable opinions in substantially the form annexed hereto as Annex A of Phelps Dunbar LLP, counsel for the Company, in form and substance reasonably
satisfactory to counsel for the Underwriters. Such counsel may state that, insofar as its opinion involves factual matters, it has relied, to the extent it deems proper, upon certificates of officers of the Company or the Bank Subsidiary and public
officials. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <I>Opinion of Counsel for the Underwriters</I>. At the Closing Time, the Representative shall have received the favorable
opinion, dated the Closing Time, of Covington&nbsp;&amp; Burling LLP, counsel for the Underwriters, with respect to such matters as the Representative may reasonably require. Such counsel may also state that, insofar as such opinion involves factual
matters, they have relied, to the extent they deem proper, upon certificates of officers of the Company or the Bank Subsidiary and public officials. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <I>Certificates</I>. At the Closing Time, there shall not have been, since the date
hereof or since the respective dates as of which information is given in the Registration Statement, the Prospectus or the Disclosure Package, any Material Adverse Effect, and the Representative shall have received a certificate of the Chief
Executive Officer or the President of the Company and of the Chief Financial Officer of the Company, dated the Closing Time, to the effect that (i)&nbsp;there has been no such Material Adverse Effect, (ii)&nbsp;the representations and warranties in
Section&nbsp;1 hereof were true and correct when made and are true and correct with the same force and effect as though expressly made at and as of the Closing Time, and (iii)&nbsp;the Company has complied with all agreements and satisfied all
conditions on their part to be performed or satisfied at or prior to the Closing Time. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) <I>Independent Auditors&#146; Comfort
Letter</I>. At the time of the execution of this Agreement, the Representative shall have received a letter from HORNE LLP, dated such date, in form and substance reasonably satisfactory to the Underwriters, containing statements and information of
the type ordinarily included in accountants&#146; &#147;comfort letters&#148; to underwriters with respect to the financial statements and financial and accounting information included in the Registration Statement, the Prospectus and the Disclosure
Package. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f) <I>Bring-down Comfort Letter</I>. At the Closing Time, the Representative shall have received from HORNE LLP a letter, dated
the Closing Time, to the effect that they reaffirm the statements made in the letter furnished pursuant to subsection (e)&nbsp;of this Section, except that the specified date referred to shall be a date not more than three business days prior to the
Closing Time. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g) <I>Certificate of Chief Financial Officer</I>. At the time of execution of this Agreement and at the Closing Time, the
Representative shall have received a certificate, dated, respectively, the date hereof and such Closing Time, executed by the Chief Financial Officer of the Company, in form and substance satisfactory to the Representative. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h) <I>Ratings</I>. At the Closing Time, the Securities will be rated at least BBB by Kroll Bond Rating Agency, Inc. Subsequent to the
execution of this Agreement, there shall not have occurred a downgrading in or withdrawal of the rating assigned to the Securities or any other securities of the Company by any NRSRO, and no such organization shall have publicly announced that it
has under surveillance or review, or has changed its outlook with respect to, its rating of the Securities or any other securities of the Company (other than an announcement with positive implications of a possible upgrading). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i) <I>DTC</I>. At the Closing Time, the Securities shall be eligible for clearance, settlement and trading through the facilities of DTC. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j) <I>No Objection</I>. If applicable, FINRA shall have raised no objection with respect to the fairness and reasonableness of the
underwriting terms and arrangements, which objection has not been withdrawn or otherwise satisfied. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k) <I>Delivery of Prospectus</I>. The Company shall have complied with the provisions
hereof with respect to the furnishing of prospectuses, in electronic or printed format, on the New York business day next succeeding the date of this Agreement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l) <I>No Legal Impediment to Issuance</I>. No action shall have been taken and no statute, rule, regulation or order shall have been enacted,
adopted or issued by any Governmental Entity that would, as of the Closing Time, prevent the offer, issuance or sale of the Securities; and no injunction or order of any federal, state or foreign court shall have been issued that would, as of the
Closing Time, prevent the issuance or sale of the Securities. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m) <I>Termination Event</I>. On or after the date hereof, there shall not
have occurred any of the events, circumstances or occurrences set forth in Section&nbsp;9(a). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n) <I>Additional Documents</I>. At the
Closing Time, counsel for the Underwriters shall have been furnished with such documents and opinions as they may require for the purpose of enabling them to pass upon the issuance and sale of the Securities as herein contemplated, or in order to
evidence the accuracy of any of the representations or warranties of the Company or the fulfillment of any of the conditions herein contained; and all proceedings taken by the Company in connection with the issuance and sale of the Securities as
herein contemplated shall be satisfactory in form and substance to the Representative and counsel for the Underwriters. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o) <I>Termination
of Agreement</I>. If any condition specified in this Section shall not have been fulfilled when and as required to be fulfilled, this Agreement may be terminated by the Representative by notice to the Company at any time at or prior to the Closing
Time, and such termination shall be without liability of any party to any other party except as provided in Section&nbsp;4 hereof and except that Sections 1, 6, 7, 8 and 15 hereof shall survive any such termination and remain in full force and
effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;6. <U>Indemnification</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <I>Indemnification of Underwriters</I>. The Company agrees to indemnify and hold harmless each Underwriter, their respective affiliates (as
such term is defined in Rule 405 of the 1933 Act Regulations), partners, directors, officers, employees and agents and each person, if any, who controls (within the meaning of Section&nbsp;15 of the 1933 Act or Section&nbsp;20 of the 1934 Act) any
Underwriter (each such person, a &#147;controlling person&#148;): </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) against any and all loss, liability, claim, damage and expense
whatsoever, as incurred, arising out of (A)&nbsp;any untrue statement or alleged untrue statement of a material fact included in the Registration Statement (or any amendment thereto) or the omission or alleged omission therefrom of a material fact
required to be stated therein or necessary to make the statements therein not misleading or (B)&nbsp;any untrue statement or alleged untrue statement of a material fact included in any preliminary prospectus, the Disclosure Package, the Prospectus
or any Issuer Free Writing Prospectus, or any amendment or supplement thereto, or the omission or alleged omission therefrom of a material fact necessary in order to make the statements therein, in the light of the circumstances under which they
were made, not misleading; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) against any and all loss, liability, claim, damage and expense whatsoever, as incurred,
to the extent of the aggregate amount paid in settlement of any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or of any claim whatsoever based upon any such untrue statement or omission,
or any such alleged untrue statement or omission; provided that (subject to Section&nbsp;6(d) hereof) any such settlement is effected with the written consent of the Company; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) against any and all expense whatsoever, as incurred (including the fees and disbursements of counsel chosen by the Representative),
reasonably incurred in investigating, preparing or defending against any litigation, or any investigation or proceeding by or before any governmental agency or body, commenced or threatened, or any claim whatsoever based upon any such untrue
statement or omission, or any such alleged untrue statement or omission, to the extent that any such expense is not paid under (i)&nbsp;or (ii) above; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><U>provided</U>, <U>however</U>, that this indemnity agreement shall not apply to any loss, liability, claim, damage or expense to the extent
arising out of any untrue statement or omission or alleged untrue statement or omission made in reliance upon and in conformity with written information furnished to the Company by the Underwriters through the Representative expressly for inclusion
in any preliminary prospectus, any Issuer Free Writing Prospectus or the Prospectus (or any amendment or supplement thereto) and the parties hereto agree that such information consists only of the following: the discount information appearing in the
Prospectus under the heading &#147; Underwriting&#148; and the information relating to stabilizing transactions, syndicate covering transactions and penalty bids in the first paragraph under the caption &#147;Underwriting&#151;Price Stabilization;
Short Positions&#148; in each of the preliminary prospectus and the Prospectus (collectively, the &#147;Underwriters&#146; Information&#148;).<B> </B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <I>Indemnification of Company, Directors and Officers</I>. Each Underwriter, severally and not jointly, agrees to indemnify and hold
harmless the Company, its directors, each of its officers who signed the Registration Statement and each person, if any, who controls the Company within the meaning of Section&nbsp;15 of the 1933 Act or Section&nbsp;20 of the 1934 Act against any
and all loss, liability, claim, damage and expense described in the indemnity contained in Section&nbsp;6(a) above, as incurred, but only with respect to, arising out of or based on untrue statements or omissions, or alleged untrue statements or
omissions, made in the Registration Statement, any preliminary prospectus, any Issuer Free Writing Prospectus or the Prospectus in conformity with the Underwriters&#146; Information provided by such Underwriter. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) <I>Actions against Parties; Notification</I>. Each indemnified party shall give notice as promptly as reasonably practicable to each
indemnifying party of any action commenced against it in respect of which indemnity may be sought hereunder, but failure to so notify an indemnifying party shall not relieve such indemnifying party from any liability hereunder to the extent it is
not materially prejudiced as a result thereof, and in any event shall not relieve it from any liability which it may have otherwise than on account of this indemnity agreement. An indemnifying party may participate at its own expense in the defense
of any such action or, if it so elects within a reasonable time after receipt of such notice, to assume the defense of any suit brought to enforce any such claim; but if it so elects to assume the defense, such defense shall be conducted by counsel
chosen by it and approved by the indemnified parties, which approval shall not be unreasonably withheld. In the event that an indemnifying party elects to assume the defense of any such suit and retain such counsel, the indemnified party or parties
shall bear the fees and expenses of any additional counsel thereafter retained by such indemnified party or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
parties; <U>provided</U>, <U>however</U>, that the indemnified party or parties shall have the right to employ counsel (in addition to local counsel) to represent the indemnified party or parties
who may be subject to liability arising out of any action in respect of which indemnity may be sought against the indemnifying party if, (i)&nbsp;the employment of such counsel shall have been authorized in writing by one of the indemnifying parties
in connection with the defense of such action, (ii)&nbsp;the indemnifying parties shall not have employed counsel to have charge of the defense of such action within a reasonable time after notice of commencement of the action, or (iii)&nbsp;in the
reasonable judgment of counsel for the indemnified party or parties, there may be legal defenses available to such indemnified person which are different from or in addition to those available to such indemnifying person, in which event the
reasonable fees and expenses of appropriate separate counsel shall be borne by the indemnifying party. In no event shall the indemnifying parties be liable for fees and expenses of more than one counsel (in addition to any local counsel) separate
from their own counsel for all indemnified parties in connection with any one action or separate but similar or related actions in the same jurisdiction arising out of the same general allegations or circumstances. No indemnifying party shall,
without the prior written consent of the indemnified parties, settle or compromise or consent to the entry of any judgment with respect to any litigation, or any investigation or proceeding by or before any governmental agency or body, commenced or
threatened, or any claim whatsoever in respect of which indemnification or contribution could be sought under this Section&nbsp;6 or Section&nbsp;7 hereof (whether or not the indemnified parties are actual or potential parties thereto), unless such
settlement, compromise or consent (i)&nbsp;includes an unconditional release of each indemnified party from all liability arising out of such litigation, investigation, proceeding or claim and (ii)&nbsp;does not include a statement as to or an
admission of fault, culpability or a failure to act by or on behalf of any indemnified party. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) <I>Settlement without Consent if Failure
to Reimburse.</I> If at any time an indemnified party shall have validly requested an indemnifying party to reimburse the indemnified party for fees and expenses of counsel, such indemnifying party agrees that it shall be liable for any settlement
of the nature contemplated by Section&nbsp;6(a)(ii) effected without its written consent if (i)&nbsp;such settlement is entered into more than 60 days after receipt by such indemnifying party of the aforesaid request, (ii)&nbsp;such indemnifying
party shall have received notice of the terms of such settlement at least 45 days prior to such settlement being entered into and (iii)&nbsp;such indemnifying party shall not have reimbursed such indemnified party in accordance with such request
prior to the date of such settlement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;7. <U>Contribution</U>. In order to provide for just and equitable contribution in
circumstances under which the indemnification provided for in Section&nbsp;6 hereof is for any reason held to be unavailable to an indemnified party or insufficient in respect of any losses, liabilities, claims, damages or expenses referred to
therein, then each indemnifying party shall contribute to the aggregate amount of such losses, liabilities, claims, damages and expenses incurred by such indemnified party, as incurred, (i)&nbsp;in such proportion as is appropriate to reflect the
relative benefits received by the Company, on the one hand, and the Underwriters, on the other hand, from the offering of the Securities pursuant to this Agreement or (ii)&nbsp;if the allocation provided by clause (i)&nbsp;is not permitted by
applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i)&nbsp;above but also the relative fault of the Company, on the one hand, and the Underwriters, on the other hand, in connection
with the statements or omissions which resulted in such losses, liabilities, claims, damages or expenses, as well as any other relevant equitable considerations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The relative benefits received by the Company, on the one hand, and the Underwriters, on the
other hand, in connection with the offering of the Securities pursuant to this Agreement shall be deemed to be in the same respective proportions as the total net proceeds from the offering of the Securities pursuant to this Agreement (before
deducting expenses) received by the Company and the total underwriting discounts and commissions received by the Underwriters, in each case as set forth on the cover of the Prospectus, bears to the aggregate initial offering price of the Securities
as set forth on the cover of the Prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The relative fault of the Company, on the one hand, and the Underwriters, on the other hand,
shall be determined by reference to, among other things, whether any such untrue or alleged untrue statements of a material fact or omission or alleged omission to state a material fact relates to information supplied by the Company or by the
Underwriters and the parties&#146; relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company and the Underwriters agree that it would not be just and equitable if contribution pursuant to this Section&nbsp;7 were determined
by pro rata allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method of allocation which does not take account of the equitable considerations referred to above in this Section&nbsp;7. The aggregate
amount of losses, liabilities, claims, damages and expenses incurred by an indemnified party and referred to above in this Section&nbsp;7 shall be deemed to include any legal or other expenses reasonably incurred by such indemnified party in
investigating, preparing or defending against any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever based upon any such untrue or alleged untrue statement or omission
or alleged omission. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the provisions of this Section&nbsp;7, no Underwriter shall be required to contribute any amount in
excess of the amount by which the total underwriting discounts and commissions received by it exceeds the amount of any damages which such Underwriter has otherwise been required to pay by reason of such untrue or alleged untrue statement or
omission or alleged omission. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No person guilty of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f) of the 1933 Act)
shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this
Section&nbsp;7, each person, if any, who controls an Underwriter within the meaning of Section&nbsp;15 of the 1933 Act or Section&nbsp;20 of the 1934 Act and the respective partners, directors, officers, employees and agents of such Underwriter or
any such controlling person shall have the same rights to contribution as such Underwriter, while each director of the Company, each officer of the Company who signed the Registration Statement, and each person, if any, who controls the Company
within the meaning of Section&nbsp;15 of the 1933 Act or Section&nbsp;20 of the 1934 Act shall have the same rights to contribution as the Company. The obligations of the Underwriters in this Section&nbsp;7 to contribute are several in proportion to
their respective underwriting obligations and not joint. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;8. <U>Representations, Warranties and Agreements to Survive Delivery</U>. All
representations, warranties and agreements contained in this Agreement or in certificates of officers of the Company or its subsidiaries submitted pursuant hereto shall remain operative and in full force and effect, regardless of any investigation
made by or on behalf of any Underwriter or controlling person, or by or on behalf of the Company, and shall survive delivery of the Securities to the Underwriters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;9. <U>Termination of Agreement</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) <I>Termination; General</I>. The Representative may terminate this Agreement, by notice to the Company, at any time at or prior to the
Closing Time if, in the reasonable judgement of the Representative, since the time of execution of this Agreement or since the respective dates as of which information is given in the Registration Statement, Disclosure Package or the Prospectus,
(i)&nbsp;there has occurred any Material Adverse Effect, (ii)&nbsp;there has occurred any material adverse change in the financial markets in the United States, any outbreak of hostilities or escalation thereof or any other calamity or crisis,
including a widespread outbreak of epidemic illnesses (including the novel coronavirus <FONT STYLE="white-space:nowrap">COVID-19</FONT> to the extent that there is a material worsening of such outbreak that actually occurs after the date hereof in
the markets in which the Company operates) or any change or development involving a prospective change in national political, financial or economic conditions, in each case the effect of which is such as to make it, in the judgment of the
Representative, impracticable or inadvisable to proceed with the completion of the offering of the Securities on the terms and in the manner contemplated in the Registration Statement, the Prospectus and the Disclosure Package or to enforce
contracts for the sale of the Securities, (iii)&nbsp;trading or quotation in any securities of the Company has been suspended or limited by the Commission or by the Nasdaq Global Select Market, or if trading generally on the New York Stock Exchange
or the Nasdaq Global Select Market has been suspended or limited, or minimum or maximum prices for trading have been fixed, or maximum ranges for prices have been required, by any of said exchanges or by such system or by order of the Commission,
FINRA or any other governmental authority, (iv)&nbsp;there has occurred a downgrading in or withdrawal of the rating assigned to the Securities or any other securities of the Company by any NRSRO, or such organization has publicly announced that it
has under surveillance or review, or has changed its outlook with respect to, its rating of the Securities or any other securities of the Company, or (v)&nbsp;a banking moratorium has been declared by the United States, New York or Mississippi
authorities or a material restriction on banking activities or operations by such regulatory authorities or a material disruption has occurred in commercial banking or securities settlement and clearances services in the United States. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) <I>Liabilities</I>. If this Agreement is terminated pursuant to this Section, such termination shall be without liability of any party to
any other party except as provided in Section&nbsp;4 hereof, and provided further that Sections 1, 6, 7, 8 and 15 hereof shall survive such termination and remain in full force and effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;10. <U>Defaulting Underwriter</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) If, at the Closing Time, any Underwriter defaults on its obligation to purchase the Securities that it has agreed to purchase hereunder,
the Representative may in its discretion but in any event within 36 hours after such default, arrange for the purchase of such Securities by other persons satisfactory to the Company on the terms contained in this Agreement. If other persons become
obligated or agree to purchase the Securities of a defaulting Underwriter within such <FONT STYLE="white-space:nowrap">36-hour</FONT> period, either the Representative or the Company may postpone the Closing Time for up to five (5)&nbsp;full
business days in order to effect any changes that in the opinion of counsel for the Company or counsel for the Underwriters may be necessary in Registration Statement, the Prospectus, Disclosure Package or in any other document or arrangement, and
the Company agrees to promptly prepare any amendment or supplement to the Registration Statement, the Prospectus or Disclosure Package that effects any such changes. As used in this Agreement, the term &#147;Underwriter&#148; includes, for all
purposes of this Agreement unless the context otherwise requires, any person not listed in Schedule I hereto that, pursuant to this Section&nbsp;10, purchases Securities that a defaulting Underwriter agreed but failed to purchase. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) If, after giving effect to any arrangement for the purchase of the Securities of a defaulting Underwriter or Underwriters by the
Representative and the Company as provided in paragraph (a)&nbsp;above, the aggregate principal amount of such Securities that remains unpurchased does not exceed 10% of the aggregate principal amount of all of the Securities, then the Company shall
have the right to require each <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriter to purchase the aggregate principal amount of Securities that such Underwriter agreed to purchase hereunder plus such Underwriter&#146;s pro rata share
(based on the aggregate principal amount of Securities that such Underwriter agreed to purchase hereunder) of the Securities of such defaulting Underwriter or Underwriters for which such arrangement has not been made. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) If, after giving effect to any arrangements for the purchase of the Securities of a defaulting Underwriter or Underwriters by the <FONT
STYLE="white-space:nowrap">non-defaulting</FONT> Underwriter and the Company as provided in paragraph (a)&nbsp;above, the aggregate principal amount of such Securities that remains unpurchased exceeds 10% of the aggregate principal amount of all of
the Securities, or if the Company shall not exercise the right described in paragraph (b)&nbsp;above, then this Agreement shall terminate without liability on the part of the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters. Any
termination of this Agreement pursuant to this Section&nbsp;10 shall be without liability on the part of the Company, except that the Company will continue to be liable for the payment of expenses as set forth in Section&nbsp;4 hereof and except
that the provisions of Sections 1, 6, 7, 8 and 15 hereof shall not terminate and shall remain in effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) Nothing contained herein
shall relieve a defaulting Underwriter of any liability it may have to the Company or any <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriter for damages caused by its default. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;11. <U>Notices</U>. All notices and other communications hereunder shall be in writing and shall be deemed to have been duly
given if mailed or transmitted by any standard form of telecommunication. Notices to the Underwriters shall be directed to Keefe, Bruyette&nbsp;&amp; Woods, Inc., 787 Seventh Avenue, 4th Floor, New York, New York 10019, Attention: Christopher T.
Mihok, with a copy to Covington&nbsp;&amp; Burling LLP, The New York Times Building, 620 Eighth Avenue, 42nd Floor, New York, New York 10018, Attention: Christopher DeCresce; and notices to the Company shall be directed to it at 209 Troy Street,
Tupelo, Mississippi 38804, Attention: James C. Mabry IV and General Counsel, with a copy to Phelps Dunbar LLP, 365 Canal Street, Suite 2000, New Orleans, Louisiana 70130, Attention: Mark Fullmer. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;12. <U>Parties</U>. This Agreement shall inure to the benefit of and be binding
upon each Underwriter, the Company and their respective successors. Nothing expressed or mentioned in this Agreement is intended or shall be construed to give any person, firm or corporation, other than the Underwriters, the Company and their
respective successors and the controlling persons and other persons referred to in Sections 1, 6 and 7 hereof and their heirs and legal representatives, any legal or equitable right, remedy or claim under or in respect of this Agreement or any
provision herein contained. This Agreement and all conditions and provisions hereof are intended to be for the sole and exclusive benefit of the Underwriters, the Company and their respective successors, and said controlling persons and other
persons and their heirs and legal representatives, and for the benefit of no other person, firm or corporation. No purchaser of Securities from any Underwriter shall be deemed to be a successor by reason merely of such purchase. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;13. <U>Entire Agreement; Counterparts; Facsimile</U>. This Agreement constitutes the entire agreement of the parties to this
Agreement and supersedes all prior written or oral and all contemporaneous oral agreements, understandings and negotiations with respect to the subject matter hereof. This Underwriting Agreement may be executed in any number of counterparts and by
the parties hereto in separate counterparts, and signature pages may be delivered by facsimile or other electronic means, each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the
same agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;14. <U>Recognition of the U.S. Special Resolution Regimes</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) In the event that any Underwriter that is a Covered Entity becomes subject to a proceeding under a U.S. Special Resolution Regime, the
transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if this Agreement, and any
such interest and obligation, were governed by the laws of the United States or a state of the United States. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) In the event that any
Underwriter that is a Covered Entity or a BHC Act Affiliate of such Underwriter becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted
to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this Agreement, (A) &#147;BHC Act Affiliate&#148; has the meaning assigned to the term &#147;affiliate&#148; in, and shall be
interpreted in accordance with, 12 U.S.C. &#167; 1841(k); (B) &#147;Covered Entity&#148; means any of the following: (i)&nbsp;a &#147;covered entity&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 252.82(b);
(ii) a &#147;covered bank&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 47.3(b); or (iii)&nbsp;a &#147;covered FSI&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167;
382.2(b); (C) &#147;Default Right&#148; has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable; and (D) &#147;U.S. Special Resolution Regime&#148; means each
of (i)&nbsp;the Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii)&nbsp;Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;15. <U>GOVERNING LAW; JURISDICTION</U>. THIS AGREEMENT AND ANY CLAIM,
CONTROVERSY OR DISPUTE ARISING UNDER OR RELATED TO THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO CONFLICT OF LAW PRINCIPLES OF SAID STATE OTHER THAN SECTION 5&#150;1401 OF
THE NEW YORK GENERAL OBLIGATIONS LAW. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">THE COMPANY ON BEHALF OF ITSELF AND ITS SUBSIDIARIES HEREBY IRREVOCABLY SUBMITS TO THE EXCLUSIVE
JURISDICTION OF THE FEDERAL AND NEW YORK STATE COURTS LOCATED IN THE CITY OF NEW YORK IN CONNECTION WITH ANY SUIT, ACTION OR PROCEEDING RELATED TO THIS AGREEMENT OR ANY OF THE MATTERS CONTEMPLATED HEREBY, IRREVOCABLY WAIVES ANY DEFENSE OF LACK OF
PERSONAL JURISDICTION AND IRREVOCABLY AGREES THAT ALL CLAIMS IN RESPECT OF ANY SUIT, ACTION OR PROCEEDING MAY BE HEARD AND DETERMINED IN ANY SUCH COURT. THE COMPANY ON BEHALF OF ITSELF AND ITS SUBSIDIARIES IRREVOCABLY WAIVES, TO THE FULLEST EXTENT
IT MAY EFFECTIVELY DO SO UNDER APPLICABLE LAW, ANY OBJECTION WHICH IT MAY NOW OR HEREAFTER HAVE TO THE LAYING OF VENUE OF ANY SUCH SUIT, ACTION OR PROCEEDING BROUGHT IN ANY SUCH COURT AND ANY CLAIM THAT ANY SUCH SUIT, ACTION OR PROCEEDING BROUGHT IN
ANY SUCH COURT HAS BEEN BROUGHT IN AN INCONVENIENT FORUM. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;16. <U>Amendment; Waiver; Effect of Headings</U>. This Agreement
may not be amended or modified unless in writing by all of the parties hereto, and no condition herein (express or implied) may be waived unless waived in writing by each party whom the condition is meant to benefit. The Article and Section headings
herein are for convenience only and shall not affect the construction hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;17. <U>Trial by Jury</U>. Each of the Company
(on its behalf and, to the extent permitted by applicable law, on behalf of its stockholders and affiliates) and the Underwriters hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any
legal proceeding arising out of or relating to this Agreement or the transactions contemplated hereby </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION&nbsp;18. <U>Nature of
Relationship</U>. The Company acknowledges and agrees that (a)&nbsp;the offering or purchase and sale of the Securities pursuant to this Agreement, including the determination of the terms of the Securities and the offering price thereof and any
related discounts and commissions, is an <FONT STYLE="white-space:nowrap">arm&#146;s-length</FONT> commercial transaction between the Company, on the one hand, and the several Underwriters, on the other hand, (b)&nbsp;in connection with the offering
pursuant to this Agreement and the process leading to such offering each Underwriter is and has been acting solely as a principal and is not the agent or fiduciary of the Company or its </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
stockholders, creditors, employees or any other party, (c)&nbsp;no Underwriter has assumed or will assume an advisory or fiduciary responsibility in favor of the Company with respect to the
offering pursuant to this Agreement or the process leading thereto (irrespective of whether such Underwriter has advised or is currently advising the Company on other matters) and no Underwriter has any obligation to the Company with respect to the
offering pursuant to this Agreement except the obligations expressly set forth in this Agreement, (d)&nbsp;the Underwriters and their respective affiliates may be engaged in a broad range of transactions that involve interests that differ from those
of the Company and (e)&nbsp;the Underwriters have not provided any legal, accounting, regulatory or tax advice with respect to the offering contemplated hereby and the Company has consulted its own legal, financial, accounting, regulatory and tax
advisors to the extent it deemed appropriate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the foregoing is in accordance with your understanding, please indicate your acceptance
of this Agreement by signing in the space below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[<I>Signature pages follow</I>] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">RENASANT CORPORATION</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ C. Mitchell Waycaster</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">C. Mitchell Waycaster</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">President and Chief Executive Officer</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="13%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="86%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">CONFIRMED AND ACCEPTED,</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">as of the date first above written:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">KEEFE, BRUYETTE&nbsp;&amp; WOODS, INC.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Scott R. Anderson</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Scott R. Anderson</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Head of Investment Banking</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For itself and as Representative of the other Underwriters named in Schedule I hereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SCHEDULE I </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; ">Name of Underwriter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Aggregate&nbsp;Principal&nbsp;Amount&nbsp;of<BR>Securities to be Purchased</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Keefe, Bruyette&nbsp;&amp; Woods, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">100,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Piper Sandler&nbsp;&amp; Co.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stephens Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">40,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Raymond James&nbsp;&amp; Associates, Inc.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">20,000,000.00</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom"><B>$</B></TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"><B></B>200,000,000.00</TD>
<TD NOWRAP VALIGN="bottom"><B></B>&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SCHEDULE II </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Pricing Term Sheet for Securities, dated November&nbsp;17, 2021 </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Investor Presentation, filed with the Commission on November&nbsp;17, 2021 </P></TD></TR></TABLE>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ANNEX A </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Form of Opinion Paragraphs of Phelps Dunbar LLP </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Opinion paragraph omitted. </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>3
<FILENAME>d242176dex42.htm
<DESCRIPTION>EX-4.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-4.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 4.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B><I>Execution Copy </I></B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RENASANT CORPORATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOURTH SUPPLEMENTAL INDENTURE </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>dated as of November 23, 2021 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>to the Subordinated Indenture </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>dated as of August&nbsp;22, 2016 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>3.00% <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Fixed-to-Floating</FONT></FONT> Rate Subordinated Notes due 2031
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Wilmington Trust, National Association, as Trustee </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FOURTH SUPPLEMENTAL INDENTURE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">THIS FOURTH SUPPLEMENTAL INDENTURE (&#147;<B>Fourth Supplemental Indenture</B>&#148;), dated as of November&nbsp;23, 2021, is made by and
between Renasant Corporation, a Mississippi corporation (the &#147;<B>Company</B>&#148;), and Wilmington Trust, National Association, a national banking association, not in its individual capacity but solely as trustee (&#147;<B>Trustee</B>&#148;).
</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RECITALS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, the Company and the Trustee have executed and delivered a Subordinated Indenture, dated as of August&nbsp;22, 2016 (the
&#147;<B>Base Indenture</B>&#148; and as supplemented by the First Supplemental Indenture, dated as of August&nbsp;22, 2016 between the Company and the Trustee, by the Second Supplemental Indenture, dated as of August&nbsp;22, 2016 between the
Company and the Trustee, by the Third Supplemental Indenture, dated as of September&nbsp;3, 2020 between the Company and the Trustee and by this Fourth Supplemental Indenture, and as further supplemented from time to time, the
&#147;<B>Indenture</B>&#148;), to provide for the issuance from time to time by the Company of its unsecured subordinated indebtedness to be issued in one or more series as provided in the Indenture; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS,</B> Section&nbsp;9.1(j) of the Base Indenture provides that the Company and the Trustee may, without the consent of any Holder,
enter into a supplemental indenture to<B> </B>provide for the issuance of and establish the form or terms of Securities of any Series as permitted by Sections 2.1 and 2.2 thereof; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, the issuance and sale of Two Hundred Million Dollars ($200,000,000) aggregate principal amount of a new series of Securities
of the Company designated as its 3.00% <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Fixed-to-Floating</FONT></FONT> Rate Subordinated Notes due 2031 (the &#147;<B>2031 Notes</B>&#148;) have been authorized by resolutions adopted
by the Board of Directors of the Company; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, the Company desires to issue and sell Two Hundred Million Dollars
($200,000,000) aggregate principal amount of the 2031 Notes as of the date hereof; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, the Company desires to establish the
terms of the 2031 Notes; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, all things necessary to make this Fourth Supplemental Indenture a legal and binding supplement
to the Base Indenture in accordance with its terms and the terms of the Base Indenture have been done; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, the Company has
complied with all conditions precedent provided for in the Base Indenture relating to this Fourth Supplemental Indenture; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>WHEREAS</B>, the Company has requested that the Trustee execute and deliver this Fourth Supplemental Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>NOW, THEREFORE</B>, for and in consideration of the premises stated herein and the purchase of the 2031 Notes by the Holders thereof, the
Company and the Trustee covenant and agree, for the equal and proportionate benefit of the Holders of the 2031 Notes, as follows: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE I </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SCOPE OF FOURTH SUPPLEMENTAL INDENTURE </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;1.01. <I>Scope</I>. This Fourth Supplemental Indenture constitutes a supplement to the Base Indenture and an integral part of the
Indenture and shall be read together with the Base Indenture as though all the provisions thereof are contained in one instrument. Except as expressly amended by the Fourth Supplemental Indenture, the terms and provisions of the Base Indenture shall
remain in full force and effect. Notwithstanding the foregoing, this Fourth Supplemental Indenture shall only apply to the 2031 Notes. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE II </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">DEFINITIONS </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;2.01. <I>Definitions and Other Provisions of General Application</I>. For all purposes of this Fourth Supplemental Indenture
unless otherwise specified herein: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) all terms used in this Fourth Supplemental Indenture which are not otherwise defined herein shall
have the meanings they are given in the Base Indenture and include the plural as well as the singular; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) the provisions of general
application stated in Sections 10.1 through 10.14 of the Base Indenture shall apply to this Fourth Supplemental Indenture, except that the words &#147;<B>herein</B>,&#148; &#147;<B>hereof</B>,&#148; &#147;<B>hereto</B>&#148; and
&#147;<B>hereunder</B>&#148; and other words of similar import refer to this Fourth Supplemental Indenture as a whole and not to the Base Indenture or any particular Article, Section or other subdivision of the Base Indenture or this Fourth
Supplemental Indenture; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) Section&nbsp;1.1 of the Base Indenture is amended and supplemented, solely with respect to the 2031 Notes, by
inserting the following additional defined terms in their appropriate alphabetical positions: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Act</B>&#148; means any request,
demand, authorization, direction, notice, consent, waiver or other action provided or permitted by the Indenture to be given, made or taken by Holders, which may be embodied in and evidenced by one or more instruments of substantially similar tenor
signed by such Holders in person or by agent duly appointed in writing; such action shall become effective when such instrument or instruments are delivered to the Trustee and, where it is hereby expressly required, to the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Administrative or Judicial Action</B>&#148; has the meaning provided in the definition of &#147;<B>Tax Event</B>.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Benchmark</B>&#148; means, initially, Three-Month Term SOFR; provided that if the Calculation Agent determines on or prior to the
Reference Time that a Benchmark Transition Event and its related Benchmark Replacement Date have occurred with respect to Three-Month Term SOFR or the then-current Benchmark, then &#147;<B>Benchmark</B>&#148; means the applicable Benchmark
Replacement. All percentages used in or resulting from any calculation of the then-current Benchmark shall be rounded, if necessary, to the nearest <FONT STYLE="white-space:nowrap">one-hundred-thousandth</FONT> of a percentage point, with 0.000005%
rounded up to 0.00001%. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Benchmark Replacement</B>&#148; means the Interpolated Benchmark with respect to the then-current
Benchmark, plus the Benchmark Replacement Adjustment for such Benchmark; provided that if (a)&nbsp;the Calculation Agent cannot determine the Interpolated Benchmark as of the Benchmark Replacement Date or (b)&nbsp;the then-current Benchmark is
Three-Month Term SOFR and a Benchmark Transition Event and its related Benchmark Replacement Date have occurred with respect to Three-Month Term SOFR (in which event no Interpolated Benchmark with respect to Three-Month Term SOFR shall be
determined), then &#147;Benchmark Replacement&#148; means the first alternative set forth in the order below that can be determined by the Calculation Agent as of the Benchmark Replacement Date: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) Compounded SOFR; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) the sum of: (a)&nbsp;the alternate rate that has been selected or recommended by the Relevant Governmental Body as the replacement for the
then-current Benchmark for the applicable Corresponding Tenor and (b)&nbsp;the Benchmark Replacement Adjustment; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) the sum of:
(a)&nbsp;the ISDA Fallback Rate, and (b)&nbsp;the Benchmark Replacement Adjustment; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) the sum of: (a)&nbsp;the alternate rate that
has been selected by the Calculation Agent as the replacement for the then-current Benchmark for the applicable Corresponding Tenor, giving due consideration to any industry-accepted rate as a replacement for the then-current Benchmark for U.S.
Dollar-denominated floating rate securities at such time, and (b)&nbsp;the Benchmark Replacement Adjustment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Benchmark
Replacement Adjustment</B>&#148; means the first alternative set forth in the order below that can be determined by the Calculation Agent as of the Benchmark Replacement Date: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) the spread adjustment, or method for calculating or determining such spread adjustment (which may be a positive or negative value or zero),
that has been selected or recommended by the Relevant Governmental Body for the applicable Unadjusted Benchmark Replacement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) if the
applicable Unadjusted Benchmark Replacement is equivalent to the ISDA Fallback Rate, then the ISDA Fallback Adjustment; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) the spread
adjustment (which may be a positive or negative value or zero) that has been selected by the Calculation Agent giving due consideration to any industry-accepted spread adjustment or method for calculating or determining such spread adjustment, for
the replacement of the then-current Benchmark with the applicable Unadjusted Benchmark Replacement for U.S. Dollar-denominated floating rate securities at such time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Benchmark Replacement Conforming Changes</B>&#148; means, with respect to any Benchmark Replacement, any technical, administrative or
operational changes (including changes to the definition of &#147;interest period,&#148; timing and frequency of determining rates with respect to each interest period and making payments of interest, rounding of amounts or tenors, and other
administrative matters) that the Calculation Agent decides may be appropriate to reflect the adoption of such Benchmark Replacement in a manner substantially consistent with market practice (or, if the Calculation Agent decides that adoption of any
portion of such market practice is not administratively feasible or if the Calculation Agent determines that no market practice for use of the Benchmark Replacement exists, in such other manner as the Calculation Agent determines is reasonably
necessary). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Benchmark Replacement Date</B>&#148; means the earliest to occur of the following events with respect to the
then-current Benchmark: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) in the case of clause (1)&nbsp;of the definition of &#147;<B>Benchmark Transition Event</B>,&#148;<B> </B>the
relevant Reference Time in respect of any determination; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) in the case of clause (2)&nbsp;or (3) of the definition of &#147;<B>Benchmark
Transition Event</B>,&#148; the later of (a)&nbsp;the date of the public statement or publication of information referenced therein and (b)&nbsp;the date on which the administrator of the Benchmark permanently or indefinitely ceases to provide the
Benchmark; or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) in the case of clause (4)&nbsp;of the definition of &#147;<B>Benchmark Transition
Event</B>,&#148;<B> </B>the date of the public statement or publication of information referenced therein. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the avoidance of doubt,
for purposes of the definitions of Benchmark Replacement Date and Benchmark Transition Event, references to the Benchmark also include any reference rate underlying the Benchmark (for example, if the Benchmark becomes Compounded SOFR, references to
the Benchmark would include SOFR). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the avoidance of doubt, if the event giving rise to the Benchmark Replacement Date occurs on the
same day as, but earlier than, the Reference Time in respect of any determination, the Benchmark Replacement Date will be deemed to have occurred prior to the Reference Time for such determination. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Benchmark Transition Event</B>&#148; means the occurrence of one or more of the following events with respect to the then-current
Benchmark: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) if the Benchmark is Three-Month Term SOFR, (a)&nbsp;the Relevant Governmental Body has not selected or recommended a
forward-looking term rate for a tenor of three months based on SOFR, (b)&nbsp;the development of a forward-looking term rate for a tenor of three months based on SOFR that has been recommended or selected by the Relevant Governmental Body is not
complete or (c)&nbsp;the Company determines that the use of a forward-looking rate for a tenor of three months based on SOFR is not administratively feasible; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) a public statement or publication of information by or on behalf of the administrator of the Benchmark announcing that such administrator
has ceased or will cease to provide the Benchmark, permanently or indefinitely, provided that, at the time of such statement or publication, there is no successor administrator that will continue to provide the Benchmark; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(3) a public statement or publication of information by the regulatory supervisor for the administrator of the Benchmark, the central bank for
the currency of the Benchmark, an insolvency official with jurisdiction over the administrator for the Benchmark, a resolution authority with jurisdiction over the administrator for the Benchmark or a court or an entity with similar insolvency or
resolution authority over the administrator for the Benchmark, which states that the administrator of the Benchmark has ceased or will cease to provide the Benchmark permanently or indefinitely, provided that, at the time of such statement or
publication, there is no successor administrator that will continue to provide the Benchmark; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(4) a public statement or publication of
information by the regulatory supervisor for the administrator of the Benchmark announcing that the Benchmark is no longer representative. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Calculation Agent</B>&#148; has the meaning ascribed in Section&nbsp;3.02(e)(iv) of the Fourth Supplemental Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Compounded SOFR</B>&#148; means the compounded average of SOFRs for the applicable Corresponding Tenor, with the rate, or methodology
for this rate, and conventions for this rate being established by the Calculation Agent in accordance with: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(1) the rate, or methodology
for this rate, and conventions for this rate selected or recommended by the Relevant Governmental Body for determining Compounded SOFR; provided that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(2) if, and to the extent that, the Calculation Agent determines that Compounded SOFR cannot be determined in accordance with clause
(1)&nbsp;above, then the rate, or methodology for this rate, and conventions for this rate that have been selected by the Calculation Agent giving due consideration to any industry-accepted market practice for U.S. Dollar-denominated floating rate
securities at such time. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For the avoidance of doubt, the calculation of Compounded SOFR shall exclude the Benchmark
Replacement Adjustment (if applicable) and the spread of 191 basis points per annum. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Corresponding Tenor</B>&#148; with respect
to a Benchmark Replacement means a tenor (including overnight) having approximately the same length (disregarding business day adjustment) as the applicable tenor for the then-current Benchmark. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>DTC</B>&#148; has the meaning provided in Section&nbsp;3.02(h) of the Fourth Supplemental Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Federal Reserve</B>&#148; has the meaning provided in the definition of &#147;<B>Tier 2 Capital Event.</B>&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Federal Reserve Bank of New York&#146;s Website</B>&#148; means the website of the Federal Reserve Bank of New York at
<U>http://www.newyorkfed.org</U>, or any successor source. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Fixed Rate Interest Payment Date</B>&#148; has the meaning provided
in Section&nbsp;3.02(e)(i) of the Fourth Supplemental Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Fixed Rate Period</B>&#148; has the meaning provided in
Section&nbsp;3.02(e)(i) of the Fourth Supplemental Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Fixed Rate Regular Record Date</B>&#148; has the meaning provided
in Section&nbsp;3.02(e)(i) of the Fourth Supplemental Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Floating Rate Interest Payment Date</B>&#148; has the meaning
provided in Section&nbsp;3.02(e)(ii) of the Fourth Supplemental Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Floating Rate Period</B>&#148; has the meaning
provided in Section&nbsp;3.02(e)(ii) of the Fourth Supplemental Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Floating Rate Regular Record Date</B>&#148; has the
meaning provided in Section&nbsp;3.02(e)(ii) of the Fourth Supplemental Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Interest Payment Date</B>&#148; has the
meaning provided in Section&nbsp;3.02(e)(ii) of the Fourth Supplemental Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>interest period</B>&#148; means the period
from and including the immediately preceding Interest Payment Date in respect of which interest has been paid or duly provided for or, if no interest has been paid or duly provided for, from and including the Issue Date to, but excluding, the
applicable Interest Payment Date or the Maturity Date or date of earlier redemption, if applicable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Interpolated
Benchmark</B>&#148; with respect to the Benchmark means the rate determined for the Corresponding Tenor by interpolating on a linear basis between: (1)&nbsp;the Benchmark for the longest period (for which the Benchmark is available) that is shorter
than the Corresponding Tenor, and (2)&nbsp;the Benchmark for the shortest period (for which the Benchmark is available) that is longer than the Corresponding Tenor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>ISDA</B>&#148; means the International Swaps and Derivatives Association, Inc. or any successor. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>ISDA Definitions</B>&#148; means the 2006 ISDA Definitions published by the ISDA or
any successor thereto, as amended or supplemented from time to time, or any successor definitional booklet for interest rate derivatives published from time to time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>ISDA Fallback Adjustment</B>&#148; means the spread adjustment (which may be a positive or negative value or zero) that would apply
for derivatives transactions referencing the ISDA Definitions to be determined upon the occurrence of an index cessation event with respect to the Benchmark for the applicable tenor. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>ISDA Fallback Rate</B>&#148; means the rate that would apply for derivatives transactions referencing the ISDA Definitions to be
effective upon the occurrence of an index cessation date with respect to the Benchmark for the applicable tenor excluding the applicable ISDA Fallback Adjustment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Issue Date</B>&#148; means November&nbsp;23, 2021. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Major Constituent Bank</B>&#148; means any Subsidiary which is organized as a banking organization under federal or state law and
which represents 50% or more of the consolidated assets of the Company determined as of the date of the most recent audited financial statements of the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Maturity Date</B>&#148; has the meaning provided in Section&nbsp;3.02(d) of the Fourth Supplemental Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Redemption Date</B>&#148; has the meaning provided in Section&nbsp;3.02(h) of the Fourth Supplemental Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Reference Time</B>&#148; with respect to any determination of the Benchmark means (1)&nbsp;if the Benchmark is Three-Month Term SOFR,
the time determined by the Calculation Agent after giving effect to the Three-Month Term SOFR Conventions, and (2)&nbsp;if the Benchmark is not Three-Month Term SOFR, the time determined by the Calculation Agent after giving effect to the Benchmark
Replacement Conforming Changes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Relevant Governmental Body</B>&#148; means the Federal Reserve and/or the Federal Reserve Bank
of New York, or a committee officially endorsed or convened by the Federal Reserve and/or the Federal Reserve Bank of New York or any successor thereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>SOFR</B>&#148; means the secured overnight financing rate published by the Federal Reserve Bank of New York, as the administrator of
the Benchmark (or a successor administrator), on the Federal Reserve Bank of New York&#146;s website. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Tax Event</B>&#148; means
the receipt by the Company of an opinion of independent tax counsel to the effect that as a result of (a)&nbsp;an amendment to, or change (including any announced prospective amendment or change) in, any law or treaty, or any regulation thereunder,
of the United States or any political subdivision or taxing authority thereof or therein; (b)&nbsp;a judicial decision, administrative action, official administrative pronouncement, ruling, regulatory procedure, regulation, notice or announcement,
including any notice or announcement of intent to adopt or promulgate any ruling, regulatory procedure or regulation (any of the foregoing, an &#147;<B>Administrative or Judicial Action</B>&#148;); or (c)&nbsp;an amendment to or change in any
official position with respect to, or any interpretation of, an Administrative or Judicial Action or a law or regulation of the United States that differs from the previously generally accepted position or interpretation, in each case, which change
or amendment or challenge becomes effective or which pronouncement, decision or challenge is announced on or after the original issue date of the 2031 Notes, there is more than an insubstantial risk that interest payable by the Company on the 2031
Notes is not, or, within 90 days of the date of such opinion, will not be, deductible by the Company, in whole or in part, for United States federal income tax purposes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Term SOFR</B>&#148; means the forward-looking term rate based on SOFR that has been
selected or recommended by the Relevant Governmental Body. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Term SOFR Administrator</B>&#148; means any entity designated by the
Relevant Governmental Body as the administrator of Term SOFR (or a successor administrator). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Three-Month Term SOFR</B>&#148;
means the rate for Term SOFR for a tenor of three months that is published by the Term SOFR Administrator at the Reference Time for any interest period, as determined by the Calculation Agent after giving effect to the Three-Month Term SOFR
Conventions. All percentages used in or resulting from any calculation of Three-Month Term SOFR shall be rounded, if necessary, to the nearest <FONT STYLE="white-space:nowrap">one-hundred-thousandth</FONT> of a percentage point, with 0.000005%
rounded up to 0.00001%. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Three-Month Term SOFR Conventions</B>&#148; means any determination, decision or election with respect
to any technical, administrative or operational matter (including with respect to the manner and timing of the publication of Three-Month Term SOFR, or changes to the definition of &#147;<B>interest period</B>,&#148; timing and frequency of
determining Three-Month Term SOFR with respect to each interest period and making payments of interest, rounding of amounts or tenors, and other administrative matters) that the Calculation Agent decides may be appropriate to reflect the use of
Three-Month Term SOFR as the Benchmark in a manner substantially consistent with market practice (or, if the Calculation Agent decides that adoption of any portion of such market practice is not administratively feasible or if the Calculation Agent
determines that no market practice for the use of Three-Month Term SOFR exists, in such other manner as the Calculation Agent determines is reasonably necessary). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Tier 2 Capital Event</B>&#148; means the Company&#146;s good faith determination that, as a result of (a)&nbsp;any amendment to, or
change in, the laws, rules or regulations of the United States (including, for the avoidance of doubt, any agency or instrumentality of the United States, including the Federal Reserve and other federal bank regulatory agencies) or any political
subdivision of or in the United States that is enacted or becomes effective after the original issue date of the 2031 Notes; (b)&nbsp;any proposed change in those laws, rules or regulations that is announced or becomes effective after the original
issue date of the 2031 Notes; or (c)&nbsp;any official administrative decision or judicial decision or administrative action or other official pronouncement interpreting or applying those laws, rules, regulations, policies or guidelines with respect
thereto that is announced after the original issue date of the 2031 Notes, there is more than an insubstantial risk that the Company will not be entitled to treat the 2031 Notes then outstanding as &#147;Tier 2 Capital&#148; (or its equivalent) for
purposes of the capital adequacy rules or regulations of the Board of Governors of the Federal Reserve System (the &#147;<B>Federal Reserve</B>&#148;) (or, as and if applicable, the capital adequacy rules or regulations of any successor appropriate
federal banking agency) as then in effect and applicable to the Company, for so long as any 2031 Notes are outstanding. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Unadjusted Benchmark Replacement</B>&#148; means the Benchmark Replacement excluding the Benchmark Replacement Adjustment. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) Section&nbsp;1.1 of the Base Indenture is amended and supplemented, solely with respect to the 2031 Notes, by replacing the corresponding
defined term in the Base Indenture with the following defined terms: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Business Day</B>&#148; means (a)&nbsp;each Monday, Tuesday, Wednesday, Thursday and
Friday which is not a day on which banking institutions in New York are authorized or obligated by law or executive order to close, or (b)&nbsp;a day on which the Corporate Trust Office of the Trustee is not closed for business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Indenture</B>&#148; has the meaning set forth in the Recitals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;<B>Senior Indebtedness</B>&#148; means any obligation of the Company to its creditors, whether now outstanding or subsequently incurred,
other than any obligation where, in the instrument creating or evidencing the obligation or pursuant to which the obligation is outstanding, it is provided that the obligation is not Senior Indebtedness. Senior Indebtedness includes, without
limitation: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a. the principal (and premium, if any) of and interest in respect of indebtedness of the Company for purchased or borrowed
money, whether or not evidenced by securities, notes, debentures, bonds or other similar instruments issued by the Company, including obligations incurred in connection with the acquisition of property, assets or businesses; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b. all capital lease obligations of the Company; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">c. all obligations of the Company issued or assumed as the deferred purchase price of property, all conditional sale obligations of the Company
and all obligations of the Company under any conditional sale or title retention agreement, but excluding trade accounts payable in the ordinary course of business; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">d. all obligations of the Company arising from <FONT STYLE="white-space:nowrap">off-balance</FONT> sheet guarantees and direct credit
substitutes, including obligations in respect of any letters of credit, bankers&#146; acceptance, security purchase facilities and similar credit transactions; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">e. all obligations of the Company associated with derivative products, including obligations in respect of interest rate swap, cap or other
agreements, interest rate future or options contracts, currency swap agreements, currency future or option contracts and other similar agreements; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">f. all obligations of the type referred to in clauses (a)&nbsp;through (e) of other persons for the payment of which the Company is responsible
or liable as obligor, guarantor or otherwise; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">g. all obligations of the type referred to in clauses (a)&nbsp;through (f) of other persons
secured by any lien on any property or asset of the Company whether or not such obligation is assumed by the Company; and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">h. any
deferrals, renewals or extensions of any obligations of the type referred to in clauses (a)&nbsp;through (g) above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the
foregoing, Senior Indebtedness does not include: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">a. the 2031 Notes; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">b. trade accounts payable arising in the ordinary course of business; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">c. any indebtedness that by its terms is subordinated to, or ranks on an equal basis with, the 2031 Notes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE III </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">FORM AND TERMS OF THE 2031 Notes </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.01. <I>Form and Dating</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) The 2031 Notes shall be substantially in the form of <U>Exhibit A</U> attached hereto. The 2031 Notes shall be executed in the name and on
behalf of the Company by the manual, electronic signature or facsimile signature of its Chairman of the Board of Directors, its Chief Executive Officer, its President or one of its Executive Vice Presidents. Unless otherwise provided herein or in
the 2031 Notes, the words &#147;execute,&#148; &#147;execution,&#148; &#147;signed,&#148; and &#147;signature&#148; and words of similar import used in or related to any document to be signed in connection with this Indenture, any 2031 Notes or any
of the transactions contemplated hereby (including amendments, waivers, consents and other modifications) shall be deemed to include electronic signatures and the keeping of records in electronic form, each of which shall be of the same legal
effect, validity or enforceability as a manually executed signature in ink or the use of a paper-based recordkeeping system, as applicable, to the fullest extent and as provided for in any Applicable Law, including the Federal Electronic Signatures
in Global and National Commerce Act, the New York State Electronic Signatures and Records Act, and any other similar state laws based on the Uniform Electronic Transactions Act, provided that, notwithstanding anything herein to the contrary, the
Trustee is not under any obligation to agree to accept electronic signatures in any form or in any format unless expressly agreed to by such Trustee pursuant to procedures approved by such Trustee. If the person whose signature is on any 2031 Notes
no longer holds that office at the time the 2031 Notes are authenticated and delivered, the 2031 Notes shall nevertheless be valid. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b)
The 2031 Notes may have a legend or legends or endorsements as may be required to comply with any law or with any rules of any securities exchange or usage. The 2031 Notes shall be dated the date of their authentication. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) The terms contained in the 2031 Notes shall constitute, and are hereby expressly made, a part of the Indenture as supplemented by this
Fourth Supplemental Indenture, and the Company and the Trustee, by their execution and delivery of this Fourth Supplemental Indenture, expressly agree to such terms and provisions and to be bound thereby. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;3.02. <I>Terms of the 2031 Notes</I>. The following terms relating to the 2031 Notes are hereby established: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(a) <I>Title</I>. The 2031 Notes shall constitute a series of Securities having the title &#147;Renasant Corporation 3.00% <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Fixed-to-Floating</FONT></FONT> Rate Subordinated Notes due 2031&#148; and the CUSIP number 75970E AE7. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(b) <I>Principal Amount</I>. The aggregate principal amount of the 2031 Notes that may be authenticated and delivered under the Indenture, as
amended hereby, shall be Two Hundred Million Dollars ($200,000,000) on the Issue Date. Provided that no Event of Default has occurred and is continuing with respect to the 2031 Notes, the Company may, without notice to or the consent of the Holders,
create and issue additional Securities having the same terms as, and ranking equally and ratably with, the 2031 Notes in all respects and so that such additional 2031 Notes will be consolidated and form a single series with, and have the same terms
as to status, redemption or otherwise as, the 2031 Notes initially issued (except for any differences in the issue price and interest accrued prior to the date of issuance of the additional 2031 Notes), and with the same CUSIP number as the 2031
Notes, provided that such additional 2031 Notes are fungible for U.S. federal income tax purposes with the 2031 Notes. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(c) <I>Person to Whom Interest is Payable</I>. Interest payable, and punctually paid or duly
provided for, on any Interest Payment Date will be paid to the person in whose name the 2031 Notes are registered for such interest at the close of business on the fifteenth calendar day of the month immediately preceding the applicable Interest
Payment Date, whether or not such day is a Business Day. Any such interest which is payable, but not so punctually paid or duly provided for on any Interest Payment Date shall cease to be payable to the Holder on such relevant record date by virtue
of having been a Holder on such date, and such defaulted interest may be paid by the Company to the person in whose name the 2031 Note is registered at the close of business on a special record date for the payment of such defaulted interest to be
fixed by the Company, notice whereof shall be given to Holders of 2031 Notes of this series not less than 10 days prior to such special record date that complies with Section&nbsp;2.13 of the Base Indenture, or be paid at any time in any other
lawful manner not inconsistent with the requirements of any securities exchange on which the 2031 Notes may be listed and upon such notice as may be required by such exchange and in compliance with the Base Indenture. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(d) <I>Maturity Date</I>. The entire outstanding Principal of the 2031 Notes shall be payable on December&nbsp;1, 2031 (the &#147;<B>Maturity
Date</B>&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(e) <I>Interest</I>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) The 2031 Notes will bear interest at a fixed rate of 3.00% per annum from and including the Issue Date to, but excluding, December&nbsp;1,
2026 or the date of earlier redemption (the &#147;<B>Fixed Rate Period</B>&#148;). Interest accrued on the 2031 Notes during the Fixed Rate Period will be payable semi-annually in arrears on June&nbsp;1 and December&nbsp;1 of each year (each such
date a &#147;<B>Fixed Rate Interest Payment Date</B>&#148;), commencing on June&nbsp;1, 2022. The last Fixed Rate Interest Payment Date shall be December&nbsp;1, 2026, unless the 2031 Notes are earlier redeemed. The interest payable during the Fixed
Rate Period will be paid to each holder in whose name a 2031 Note is registered at the close of business on the fifteenth day (whether or not a Business Day) of the month immediately preceding the applicable Fixed Rate Interest Payment Date (each
such date, a &#147;<B>Fixed Rate Regular Record Date</B>&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) The 2031 Notes will bear a floating interest rate from and
including December&nbsp;1, 2026 to, but excluding, the Maturity Date or earlier Redemption Date (the &#147;<B>Floating Rate Period</B>&#148;). The floating interest rate will be reset quarterly, and the interest rate for any Floating Rate Period
shall be equal to the Benchmark, which is expected to be the then-current Three-Month Term SOFR, plus 191 basis points for each quarterly interest period during the Floating Rate Period. During the Floating Rate Period, interest on the 2031 Notes
will be payable quarterly in arrears on March&nbsp;1, June&nbsp;1, September&nbsp;1, and December&nbsp;1 of each year (each such date, a &#147;<B>Floating Rate Interest Payment Date</B>&#148;, together with a Fixed Rate Interest Payment Date, an
&#147;<B>Interest Payment Date</B>&#148;), commencing on March&nbsp;1, 2027 through the Maturity Date or Redemption Date. The interest payable during the Floating Rate Period will be paid to each holder in whose name a 2031 Note is registered at the
close of business on the fifteenth day (whether or not a Business Day) of the month immediately preceding the applicable Floating Rate Interest Payment Date (each such date, a &#147;<B>Floating Rate Regular Record Date</B>&#148;). Notwithstanding
the foregoing, if Three-Month Term SOFR (or other applicable Benchmark) is less than zero, then Three-Month Term SOFR (or other such Benchmark) shall be deemed to be zero. The Calculation Agent (as defined below) will provide the Company and the
Trustee with the interest rate in effect on the 2031 Notes promptly after the Reference Time (or such other date of determination for the applicable Benchmark). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) The amount of interest payable on any Fixed Rate Interest Payment Date during the
Fixed Rate Period will be computed on the basis of a <FONT STYLE="white-space:nowrap">360-day</FONT> year consisting of twelve <FONT STYLE="white-space:nowrap">30-day</FONT> months up to, but excluding December&nbsp;1, 2026, and the amount of
interest payable on any Floating Rate Interest Payment Date during the Floating Rate Period will be computed on the basis of a <FONT STYLE="white-space:nowrap">360-day</FONT> year and the number of days actually elapsed. The Company or the
Calculation Agent, as applicable, shall calculate the amount of interest payable on any Interest Payment Date and the Trustee shall have no duty to confirm or verify any such calculation. In the event that any scheduled Interest Payment Date or the
Maturity Date for the 2031 Notes falls on a day that is not a Business Day, then payment of interest payable on such Interest Payment Date or of principal and interest payable on the Maturity Date will be paid on the next succeeding day which is a
Business Day (any payment made on such date will be treated as being made on the date that the payment was first due and no interest on such payment will accrue for the period from and after such scheduled Interest Payment Date); provided, that in
the event that any scheduled Floating Rate Interest Payment Date falls on a day that is not a Business Day and the next succeeding Business Day falls in the next succeeding calendar month, such Floating Rate Interest Payment Date will be accelerated
to the immediately preceding Business Day, and, in each such case, the amounts payable on such Business Day will include interest accrued to but excluding such Business Day. Dollar amounts resulting from interest calculations will be rounded to the
nearest cent, with <FONT STYLE="white-space:nowrap">one-half</FONT> cent being rounded upward. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) The Company shall take such actions
as are necessary to ensure that, from the commencement of the Floating Rate Period, for so long as any of the 2031 Notes are outstanding, there will at all times be a calculation agent appointed by the Company to calculate Three-Month Term SOFR in
respect of each Floating Rate Period (the &#147;<B>Calculation Agent</B>&#148;). The calculation of Three-Month Term SOFR for each applicable Floating Rate Period by the Calculation Agent will (in the absence of manifest error) be final and binding.
The Calculation Agent&#146;s determination of any interest rate and its calculation of interest payments for any period will be maintained on file at the Calculation Agent&#146;s principal offices, will be made available to any Holder of the Notes
upon request and will be provided to the Trustee. The Calculation Agent shall have all the rights, protections and indemnities afforded to the Trustee under the Base Indenture and hereunder. The Company will act as the initial Calculation Agent. The
Calculation Agent may be removed by the Company at any time. If the Calculation Agent is unable or unwilling to act as Calculation Agent or is removed by the Company, the Company will promptly appoint a replacement Calculation Agent. The Calculation
Agent may not resign its duties without a successor having been duly appointed; provided, that if a successor Calculation Agent has not been appointed by the Company and such successor accepted such position within 30 days after the giving of notice
of resignation by the Calculation Agent, the resigning Calculation Agent may petition, at the expense of the Company, any court of competent jurisdiction for the appointment of a successor Calculation Agent with respect to such series. The Trustee
will not be under any duty to succeed to, assume or otherwise perform any of the duties of the Calculation Agent, or to appoint a successor or replacement in the event of the Calculation Agent&#146;s resignation or removal or to replace the
Calculation Agent in the event of a default, breach or failure of performance on the part of the Calculation Agent with respect to the Calculation Agent&#146;s duties and obligations hereunder. For the avoidance of doubt, if at any time there is no
Calculation Agent appointed by the Company, then the Company shall be the Calculation Agent. The Company may appoint itself or any of its Affiliates to be the Calculation Agent. The Calculation Agent&#146;s calculation of the amount of any interest
payable on any Interest Payment Date will be maintained on file at the Calculation Agent&#146;s principal offices, and will be made available to any Holder of the 2031 Notes upon request and will be provided to the Trustee. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(f) <I>Effect of Benchmark Transition Event.</I> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) If the Calculation Agent determines that a Benchmark Transition Event and its related Benchmark Replacement Date have occurred on or prior
to the Reference Time in respect of any determination of the Benchmark on any date, then the Benchmark Replacement will replace the then-current Benchmark for all purposes relating to the 2031 Notes during the Floating Rate Period in respect of such
determination on such date and all determinations on all subsequent dates. In connection with the implementation of a Benchmark Replacement, the Calculation Agent will have the right to make Benchmark Replacement Conforming Changes from time to
time. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) Notwithstanding anything set forth in Section&nbsp;3.02(e)(ii) above, if the
Calculation Agent determines on or prior to the relevant Reference Time that a Benchmark Transition Event and its related Benchmark Replacement Date have occurred with respect to Three-Month Term SOFR, then the provisions set forth in this
Section&nbsp;3.02(f) will thereafter apply to all subsequent determinations of the interest rate on the 2031 Notes during the Floating Rate Period. After a Benchmark Transition Event and its related Benchmark Replacement Date have occurred, the
interest rate on the 2031 Notes for each interest period during the Floating Rate Period will subsequently be an annual rate equal to the Benchmark Replacement plus 191 basis points. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) The Calculation Agent is expressly authorized to make certain determinations, decisions and elections under the terms of the 2031 Notes,
including with respect to the use of Three-Month Term SOFR as the Benchmark and under this Section&nbsp;3.02(f). Any determination, decision or election that may be made by the Calculation Agent under the terms of the 2031 Notes, including any
determination with respect to a tenor, rate or adjustment or of the occurrence or <FONT STYLE="white-space:nowrap">non-occurrence</FONT> of an event, circumstance or date and any decision to take or refrain from taking any action or selection
(A)&nbsp;will be conclusive and binding on the Holders of the 2031 Notes and the Trustee absent manifest error, (B)&nbsp;if made by the Company as Calculation Agent, will be made in the Company&#146;s sole discretion, (C)&nbsp;if made by a
Calculation Agent other than the Company, will be made after consultation with the Company, and the Calculation Agent will not make any such determination, decision or election to which the Company reasonably objects and (D)&nbsp;notwithstanding
anything to the contrary herein or in the Base Indenture, shall become effective without consent from the Holders of the 2031 Notes, the Trustee or any other party. If the Calculation Agent fails to make any determination, decision or election that
it is required to make under the terms of the 2031 Notes, then the Company will make such determination, decision or election on the same basis as described above. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iv) The Company (or its Calculation Agent) shall notify the Trustee in writing (i)&nbsp;upon the occurrence of the Benchmark Transition Event
or the Benchmark Replacement Date, and (ii)&nbsp;of any Benchmark Replacements, Benchmark Replacement Conforming Changes and other items affecting the interest rate on the 2031 Notes after a Benchmark Transition Event. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(v) The Trustee (including in its capacity as Paying Agent) shall have no (A)&nbsp;responsibility or liability for the (w)&nbsp;Three-Month
Term SOFR Conventions, (x)&nbsp;selection of an alternative reference rate to Three-Month Term SOFR (including, without limitation, whether the conditions for the designation of such rate have been satisfied or whether such rate is a Benchmark
Replacement or an Unadjusted Benchmark Replacement), (y) determination or calculation of a Benchmark Replacement, or (z)&nbsp;determination of whether a Benchmark Transition Event or Benchmark Replacement Date has occurred, and in each such case
under clauses (w)&nbsp;through (z) above shall be entitled to conclusively rely upon the selection, determination, and/or calculation thereof as provided by the Company or its Calculation Agent, as applicable, and (B)&nbsp;liability for any failure
or delay in performing its duties hereunder as a result of the unavailability of a Benchmark rate as described in the definition thereof, including, without limitation, as a result of the Company&#146;s or Calculation Agent&#146;s failure to select
a Benchmark Replacement or the Calculation Agent&#146;s failure to calculate a Benchmark. The Trustee shall be entitled to rely conclusively on all notices from the Company or its Calculation Agent regarding any Benchmark or Benchmark Replacement,
including, without limitation, in regards to Three-Month Term SOFR Conventions, a Benchmark Transition Event, Benchmark Replacement Date, and Benchmark Replacement Conforming Changes. The Trustee shall not be responsible or liable for the actions or
omissions of the Calculation Agent, or any failure or delay in the performance of the Calculation Agent&#146;s duties or obligations, nor shall it be under any obligation to monitor or oversee the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
performance of the Calculation Agent. The Trustee shall be entitled to conclusively rely on any determination made, and any instruction, notice, Officers&#146; Certificate or other instruction or
information provided by the Calculation Agent without independent verification, investigation or inquiry of any kind. The Trustee shall not be obligated to enter into any amendment or supplement hereto that adversely impacts its rights, duties,
obligations, immunities or liabilities (including, without limitation, in connection with the adoption of any Benchmark Replacement Conforming Changes). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(vi) If the then-current Benchmark is Three-Month Term SOFR, the Calculation Agent will have the right to establish the Three-Month Term SOFR
Conventions, and if any of the foregoing provisions concerning the calculation of the interest rate and the payment of interest during the Floating Rate Period are inconsistent with any of the Three-Month Term SOFR Conventions determined by the
Calculation Agent, then the relevant Three-Month Term SOFR Conventions will apply. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(g) <I>Place of Payment of Principal and Interest</I>.
So long as the 2031 Notes shall be issued in global form, the Company shall make, or cause the Paying Agent to make, all payments of principal and interest on the 2031 Notes by wire transfer in immediately available funds to the Depository or its
nominee, in accordance with applicable procedures of the Depository. If the 2031 Notes are not in global form, the Company, may, at its option, make, or cause the Paying Agent to make, payments of principal and interest on the 2031 Notes by check
mailed to the address of the person specified for payment in accordance with Section&nbsp;3.02(e)(i) and (e)(ii) above. A global security with respect to the 2031 Notes shall be exchangeable for physical securities of such series only if: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Depository is at any time unwilling or unable or ineligible to continue as a depository or ceases to be a
clearing agency registered under the Exchange Act and a successor depository is not appointed by the Company within 90 days of the date the Company is so notified in writing; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The Company executes and delivers to the Trustee a Company Order to the effect that such global securities
shall be so exchangeable (and the Trustee consents thereto); or </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">An Event of Default has occurred and is continuing with respect to the global securities and a Holder requests
such exchange. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(h) <I>Redemption</I>. The 2031 Notes shall be redeemable, in each case, in whole or in part from time
to time, at the option of the Company prior to the Maturity Date beginning with the Interest Payment Date on December&nbsp;1, 2026, and on any Interest Payment Date thereafter (each, a &#147;<B>Redemption Date</B>&#148;) subject to obtaining the
prior approval of the Federal Reserve to the extent such approval is required under the rules of the Federal Reserve (or, as and if applicable, the rules of any appropriate successor bank regulatory agency). The 2031 Notes may not otherwise be
redeemed prior to the Maturity Date, except that the Company may, at its option, redeem the 2031 Notes before the Maturity Date in whole but not in part from time to time, subject to obtaining the prior approval of the Federal Reserve to the extent
such approval is then required under the rules of the Federal Reserve (or, as and if applicable, the rules of any appropriate successor bank regulatory agency), upon the occurrence of a Tier 2 Capital Event or a Tax Event, or if the Company is
required to register as an investment company pursuant to the Investment Company Act of 1940, as amended (15 U.S.C. <FONT STYLE="white-space:nowrap">80a-1</FONT> et seq.). Any such redemption will be at a Redemption Price equal to 100% of the
principal amount of the 2031 Notes to be redeemed, plus accrued and unpaid interest to, but excluding, the Redemption Date fixed by the Company. The provisions of Article III of the Base Indenture shall apply to any redemption of the 2031 Notes
pursuant to this Article 3, provided that a notice of redemption shall be delivered to holders of the 2031 Notes (with a copy to the Trustee) not less than 30 nor more than 60 days prior to the Redemption
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Date. Any partial redemption will be made in accordance with The Depository Trust Company&#146;s (&#147;<B>DTC</B>&#148;) applicable procedures among all of the Holders of the 2031 Notes. If any
2031 Note is to be redeemed in part only, the notice of redemption relating to such 2031 Note shall state that it is a partial redemption and the portion of the principal amount thereof to be redeemed, and a replacement 2031 Note in principal amount
equal to the unredeemed portion thereof will be issued in the name of the Holder thereof upon cancellation of the original 2031 Note. Any notice of redemption may be conditional in the Company&#146;s discretion on one or more conditions precedent,
and the Redemption Date may be delayed until such time as any or all of such conditions have been satisfied or revoked by the Company if it determines that such conditions will not be satisfied. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) <I>No Repayment or Sinking Fund</I>. The 2031 Notes will not be subject to redemption or repayment at the option of any Holder at any time
prior to the Maturity Date. There shall be no sinking fund for the 2031 Notes. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(j) <I>Notes Not Convertible or Exchangeable.</I> The 2031
Notes will not be convertible into or exchangeable for equity securities, other securities, or assets or property of the Company or its subsidiaries. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(k) <I>Denomination</I>. The 2031 Notes and any beneficial interest in the 2031 Notes shall be in minimum denominations of $1,000 and integral
multiples of $1,000 in excess thereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(l) <I>Currency of the 2031 Notes</I>. The 2031 Notes shall be denominated, and payment of
principal and interest of the 2031 Notes shall be payable in, the currency of the United States of America. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(m) <I>No Additional
Amounts</I>.<I> </I>In the event that any payment on the 2031 Notes is subject to withholding of any U.S. federal income tax or other tax or assessment (as a result of a change in law or otherwise), the Company will not pay additional amounts with
respect to such tax or assessment. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(n) <I>Acceleration</I>. Neither the Trustee nor the Holders of the 2031 Notes shall have the right to
accelerate the maturity of the 2031 Notes unless there is an Event of Default specified under clause (e), (f) or (g)&nbsp;of Section&nbsp;6.1 (as amended herein) of the Base Indenture. If an Event of Default specified in clause (e), (f) or
(g)&nbsp;of Section&nbsp;6.1 (as amended herein) of the Base Indenture occurs, then the principal amount of all of the outstanding 2031 Notes, including any accrued and unpaid interest on the 2031 Notes and premium, if any, shall automatically
become and be immediately due and payable without any declaration or other act on the part of the Trustee or the Holders of the 2031 Notes in accordance with the provisions of Section&nbsp;6.2 of the Base Indenture. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(o) <I>Registered Form</I>. The 2031 Notes shall be issuable as registered global Securities, and the Depository for the 2031 Notes shall be
the DTC or any successor Depository appointed by the Company within 90 days of the termination of services of DTC (or any successor to DTC). Sections 2.11 and 2.13 of the Base Indenture shall apply to the 2031 Notes. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(p) <I>Events of Default</I>. The Events of Default provided for in Section&nbsp;6.1 of the Base Indenture shall apply to the 2031 Notes,
provided that: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(i) the text of clause (c)&nbsp;of Section&nbsp;6.1 of the Base Indenture is deleted and replaced with the word
&#147;Reserved&#148;; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(ii) the text of clause (g)&nbsp;of Section&nbsp;6.1 of the Base Indenture shall be
substituted with the following: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&#147;(g) the appointment by a competent government agency having primary regulatory authority over any
Major Constituent Bank under any applicable federal or state banking, insolvency or similar law now or hereafter in effect of a Custodian of any such Major Constituent Bank or (ii)&nbsp;the entry of a decree or order in any case or proceeding under
any applicable federal or state banking, insolvency or other similar law now or hereafter in effect appointing any receiver of any Major Constituent Bank;&#148; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:13%; font-size:10pt; font-family:Times New Roman">(iii) a new clause (h), reading in its entirety as follows, shall be inserted: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&#147;(h) any other Event of Default provided with respect to the Securities of that Series, which is specified in a Board Resolution, a
supplemental indenture hereto or an Officers&#146; Certificate, in accordance with Section&nbsp;2.2(n).&#148; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(q) <I>Acceleration of
Maturity, Rescission and Annulment</I>. Solely with respect to the 2031 Notes, the text of Section&nbsp;6.2 of the Base Indenture shall be substituted with the following: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&#147;If an Event of Default specified in Sections 6.1(e), 6.1(f) or 6.1(g) occurs, the principal amount of all the 2031 Notes, together with
accrued and unpaid interest, if any, thereon, shall automatically, and without any declaration or other action on the part of the Trustee or any Holder, become immediately due and payable. The Maturity Date of the 2031 Notes shall not otherwise be
accelerated as a result of an Event of Default. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">At any time after the acceleration of the 2031 Notes and before a judgment or decree for
payment of the money due has been obtained by the Trustee as hereinafter in this Article provided, the Holders of a majority in principal amount of the outstanding 2031 Notes, by written notice to the Company and the Trustee, may rescind and annul
such acceleration and its consequences if (a)&nbsp;the Company has paid or deposited with the Trustee a sum sufficient to pay (i)&nbsp;all overdue interest on the 2031 Notes, (ii)&nbsp;the principal of (and premium, if any, on) the 2031 Notes which
have become due otherwise than by such acceleration and, to the extent permitted by applicable law, interest thereon at the rate or rates prescribed therefor in the 2031 Notes, (iii)&nbsp;to the extent that payment of such interest is lawful,
interest upon overdue interest at the rate or rates prescribed therefor in the 2031 Notes, and (iv)&nbsp;all sums paid or advanced by the Trustee hereunder and the compensation, reasonable expenses, disbursements and advances of the Trustee, its
agents and counsel; and (b)&nbsp;all Events of Default with respect to the 2031 Notes, other than the <FONT STYLE="white-space:nowrap">non-payment</FONT> of the principal of the Notes which has become due solely by such declaration of acceleration,
have been cured or waived as provided in Section&nbsp;6.13. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">No such rescission shall affect any subsequent Default or impair any right
consequent thereon.&#148; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(r) <I>Collection of Indebtedness And Suits For Enforcement By Trustee</I>. Solely with respect to the 2031
Notes, the first paragraph of Section&nbsp;6.3 of the Base Indenture shall be substituted with the following: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;The
Company covenants that if: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(a) default is made in the payment of any interest on the 2031 Notes when such interest becomes due and payable
and such default continues for a period of 30 days, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(b) default is made in the payment of the principal of (or premium, if any, on) any 2031
Note at the Maturity Date, or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(c) the failure of the Company, subject to the provisions of Section&nbsp;6.13 of the Base Indenture, to
perform any covenants or agreements contained in the Indenture, which failure shall not have been remedied, or without provision deemed to be adequate for the remedying thereof having been made, for a period of 90 days after written notice shall
have been given to the Company by the Trustee or shall have been given to the Company and the Trustee by Holders of 25% or more in aggregate principal amount of the 2031 Notes then outstanding, specifying such failure, requiring the Company to
remedy the same and stating that such notice is a notice of default under the Indenture, </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">the Company will, upon demand of the Trustee, pay
to the Trustee, for the benefit of the Holders of the 2031 Notes, the whole amount then due and payable on the 2031 Notes for principal, and any premium and interest and, to the extent that payment of such interest shall be legally enforceable,
interest on any overdue principal and premium and on any overdue interest, at the rate or rates prescribed in the 2031 Notes, and, in addition thereto, such further amount as shall be sufficient to cover the costs and expenses of collection,
including the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel.&#148; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(s)
<I>Ranking</I>. The 2031 Notes shall rank junior to and shall be subordinated to all Senior Indebtedness of the Company, whether existing as of the date of this Fourth Supplemental Indenture, or hereafter issued or incurred, including all
indebtedness relating to money owed to general creditors and trade creditors. The 2031 Notes shall rank senior to the Company&#146;s Floating Rate Junior Subordinated Debentures due 2033, 2035, 2036, 2037 and 2038, and rank equally with all of the
Company&#146;s other unsecured, subordinated obligations from time to time outstanding, including the Company&#146;s existing 5.00% <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Fixed-to-Floating</FONT></FONT> Rate Subordinated
Notes due 2026, 5.50% <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Fixed-to-Floating</FONT></FONT> Rate Subordinated Notes due 2031 and 4.50%
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Fixed-to-Floating</FONT></FONT> Rate Subordinated Notes due 2035. Subject to the terms of the Base Indenture, if the Trustee or any holder of any of the 2031 Notes receives any
payment or distribution of the Company&#146;s assets in contravention of the subordination provisions applicable to the 2031 Notes before all Senior Indebtedness is paid in full in cash, property or securities, including by way of <FONT
STYLE="white-space:nowrap">set-off</FONT> or any such payment or distribution that may be payable or deliverable by reason of the payment of any other indebtedness of the Company being subordinated to the payment of the 2031 Notes, then such payment
or distribution will be held in trust for the benefit of holders of Senior Indebtedness or their representatives to the extent necessary to make payment in full in cash or payment satisfactory to the holders of Senior Indebtedness of all unpaid
Senior Indebtedness. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(t) <I>No Collateral</I>. The 2031 Notes shall not be entitled to the benefit of any security interest in, or
collateralization by, any rights, property or interest of the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(u) <I>Additional Terms</I>. Other terms applicable to the 2031
Notes are as otherwise provided for in the Base Indenture, as supplemented by this Fourth Supplemental Indenture. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE IV </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SATISFACTION AND DISCHARGE; DEFEASANCE </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.01. <I>Legal Defeasance</I>. Solely with respect to the 2031 Notes, the text of Section&nbsp;8.3(c) of the Base Indenture shall
be substituted with the following: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&#147;(c) the rights, powers, trust and immunities of the Trustee hereunder; provided that, the
following conditions shall have been satisfied: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">i. the Company shall have deposited or caused to be irrevocably deposited (except as
provided in Section&nbsp;8.2(c)) with the Trustee as trust funds in trust for the purpose of making the following payments, specifically pledged as security for and dedicated solely to the benefit of the Holders of such Securities, cash in Dollars
and/or U.S. Government Obligations, which through the payment of interest and principal in respect thereof in accordance with their terms, will provide (and without reinvestment and assuming no tax liability will be imposed on such Trustee), not
later than one day before the due date of any payment of money, an amount in cash, sufficient, in the opinion of a regionally recognized firm of independent public accountants expressed in a written certification thereof delivered to the Trustee, to
pay and discharge each installment of principal of and interest, if any, on and any mandatory sinking fund payments in respect of all the Securities of such Series on the dates such installments of interest or principal and such sinking fund
payments are due; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">ii. such deposit will not result in a breach or violation of, or constitute a default under, this Indenture or any other
agreement or instrument to which the Company is a party or by which it is bound; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">iii. no Default or Event of Default with respect to the
Securities of such Series shall have occurred and be continuing on the date of such deposit or during the period ending on the 120th day after such date; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">iv. the Company shall have delivered to the Trustee an Officers&#146; Certificate and an Opinion of Counsel to the effect that (A)&nbsp;the
Company has received from, or there has been published by, the Internal Revenue Service a ruling, or (B)&nbsp;since the date of execution of this Indenture, there has been a change in the applicable Federal income tax law, in either case to the
effect that, and based thereon such Opinion of Counsel shall confirm that, the Holders of the Securities of such Series will not recognize income, gain or loss for Federal income tax purposes as a result of such deposit, defeasance and discharge and
will be subject to Federal income tax on the same amounts and in the same manner and at the same times as would have been the case if such deposit, defeasance and discharge had not occurred; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">v. the Company shall have delivered to the Trustee an Officers&#146; Certificate to the effect that the Securities, if then listed on any
securities exchange, will be delisted as a result of such deposit; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">vi. the Company shall have delivered to the Trustee an Officers&#146;
Certificate stating that the deposit was not made by the Company with the intent of preferring the Holders of the Securities of such Series over any other creditors of the Company or with the intent of defeating, hindering, delaying or defrauding
any other creditors of the Company; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">vii. the defeasance shall not cause the Trustee to have a conflicting interest within the meaning of
the Trust Indenture Act (assuming all of the Securities are in default within the meaning of the Trust Indenture Act); </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">viii. such defeasance shall not result in the trust arising from such deposit constituting
an investment company within the meaning of the Investment Company Act unless such trust shall be registered under the Investment Company Act or exempt from registration thereunder; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">vi. the Company shall have delivered to the Trustee an Officers&#146; Certificate and an Opinion of Counsel, each stating that all conditions
precedent provided for relating to the defeasance contemplated by this Section have been complied with.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.02.
<I>Covenant Defeasance</I>. Solely with respect to the 2031 Notes, the text of Section&nbsp;8.4 of the Base Indenture shall be substituted with the following: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&#147;Unless this Section&nbsp;8.4 is otherwise specified pursuant to Section&nbsp;2.2(p) to be inapplicable to Securities of any Series, on
and after the 91st day after the date of the deposit referred to in subparagraph (a)&nbsp;hereof, the Company may omit to comply with respect to the Securities of any Series with any term, provision or condition set forth under Sections 4.2, 4.3,
4.4, 4.6, and 5.1 as well as any additional covenants specified in a supplemental indenture for such Series of Securities or a Board Resolution or an Officers&#146; Certificate delivered pursuant to Section&nbsp;2.2(p) (and the failure to comply
with any such covenants shall not constitute a Default or Event of Default with respect to such Series under Section&nbsp;6.1) and the occurrence of any event specified in a supplemental indenture for such Series of Securities or a Board Resolution
or an Officers&#146; Certificate delivered pursuant to Section&nbsp;2.2(n) and designated as an Event of Default shall not constitute a Default or Event of Default hereunder, with respect to the Securities of such Series, provided that the following
conditions shall have been satisfied: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(a) With reference to this Section&nbsp;8.4, the Company has deposited or caused to be irrevocably
deposited (except as provided in Section&nbsp;8.2(c)) with the Trustee as trust funds in trust for the purpose of making the following payments specifically pledged as security for, and dedicated solely to, the benefit of the Holders of such
Securities, cash in Dollars and/or U.S. Government Obligations, which through the payment of interest and principal in respect thereof in accordance with their terms, will provide (and without reinvestment and assuming no tax liability will be
imposed on such Trustee), not later than one day before the due date of any payment of money, an amount in cash, sufficient, in the opinion of a regionally recognized firm of independent certified public accountants expressed in a written
certification thereof delivered to the Trustee, to pay and discharge each installment of principal of and interest, if any, on and any mandatory sinking fund payments in respect of the Securities of such Series on the dates such installments of
interest or principal and such sinking fund payments are due; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(b) Such deposit will not result in a breach or violation of, or constitute
a default under, this Indenture or any other agreement or instrument to which the Company is a party or by which it is bound; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(c) No
Default or Event of Default with respect to the Securities of such Series shall have occurred and be continuing on the date of such deposit or during the period ending on the 120th day after such date; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(d) The Company shall have delivered to the Trustee an Opinion of Counsel to the effect that Holders of the Securities of such Series will not
recognize income, gain or loss for federal income tax purposes as a result of such deposit and covenant defeasance and will be subject to federal income tax on the same amounts, in the same manner and at the same times as would have been the case if
such deposit and covenant defeasance had not occurred; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(e) The Company shall have delivered to the Trustee an Officers&#146; Certificate to the
effect that the Securities, if then listed on any securities exchange, will be delisted as a result of such deposit; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(f) The defeasance
shall not cause the Trustee to have a conflicting interest within the meaning of the Trust Indenture Act (assuming all of the Securities are in default within the meaning of the Trust Indenture Act); </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(g) Such defeasance shall not result in the trust arising from such deposit constituting an investment company within the meaning of the
Investment Company Act unless such trust shall be registered under the Investment Company Act or exempt from registration thereunder; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(h) The Company shall have delivered to the Trustee an Officers&#146; Certificate and an Opinion of Counsel, each stating that all conditions
precedent herein provided for relating to the covenant defeasance contemplated by this Section have been complied with.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;4.03. <I>Repayment to Company</I>. Solely with respect to the 2031 Notes, the text of Section&nbsp;8.5 of the Base Indenture
shall be substituted with the following: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&#147;Subject to applicable law, any money deposited with the Trustee or any Paying Agent, or
then held by the Company, in trust for the payment of the principal of and premium, if any, or interest on the 2031 Notes and remaining unclaimed for two years after such principal and premium, if any, or interest has become due and payable shall be
paid to the Company upon request by the Company or (if then held by the Company) shall be discharged from such trust, and the Holder of such 2031 Notes shall thereafter, as an unsecured general creditor, look only to the Company for payment of such
amounts without interest thereon, and all liability of the Trustee or such Paying Agent with respect to such trust money, and all liability of the Company as trustee thereof, shall thereupon cease; provided, however, that the Company may publish or
cause to be published once, in a newspaper published in the English language, customarily published on each Business Day and of general circulation in The City of New York, notice that such money remains unclaimed and that, after a date specified
therein, which shall not be less than 30 days from the date of such publication, any unclaimed balance of such money then remaining will be repaid to the Company.&#148; </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE V </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">AMENDMENT, MODIFICATION
AND WAIVER </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.01. <I>Modification of Supplemental Indentures Without Consent of Holders</I>. Solely with respect to the 2031
Notes, the text of Section&nbsp;9.1 of the Base Indenture shall be substituted with the following: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&#147;Without the consent of any
Holders, the Company, when authorized by a resolution of the Board of Directors of the Company, and the Trustee, at any time and from time to time, may amend the Indenture by entering into an indenture or indentures supplemental hereto, for any of
the following purposes: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(a) to evidence the succession of another Person to the Company and the assumption by any
such successor of the covenants of the Company in the Indenture and in the 2031 Notes; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(b) to add to the covenants of the Company for the
benefit of the Holders of the 2031 Notes or to surrender any right or power herein conferred upon the Company; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(c) to add any additional
Events of Default for the benefit of the Holders of the 2031 Notes; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(d) to add to or change any of the provisions of the Indenture to such
extent as shall be necessary to permit or facilitate the issuance of 2031 Notes in certificated form; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(e) to add to, change or eliminate
any of the provisions of the Indenture,<I> </I>provided that any such addition, change or elimination (A)&nbsp;shall neither (i)&nbsp;apply to any 2031 Note created prior to the execution of such supplemental indenture and entitled to the benefit of
such provision nor (ii)&nbsp;modify the rights of the Holder of any such 2031 Note with respect to such provision or (B)&nbsp;shall become effective only when there is no such 2031 Note outstanding; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(f) to secure the 2031 Notes; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(g) to establish the form or terms of 2031 Notes of any series as permitted by Sections 2.1 and 2.2 hereof; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(h) to evidence and provide for the acceptance of appointment hereunder by a successor Trustee with respect to the 2031 Notes and to add to or
change any of the provisions of the Indenture as shall be necessary to provide for or facilitate the administration of the trusts under the Indenture by more than one Trustee, pursuant to the requirements of Section&nbsp;7.8; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(i) to cure any ambiguity, to correct or supplement any provision herein which may be defective or inconsistent with any other provision
herein, or to make any other provisions with respect to matters or questions arising under the Indenture,<I> </I>provided that such action pursuant to this Clause (i)&nbsp;shall not adversely affect the interests of the Holders of the Notes as
determined, in good faith, by the Company; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(j) to provide for the issuance of and establish the form and terms and conditions of
Securities of any Series as permitted by this Indenture. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Subject to the provisions of Section&nbsp;9.7 of the Base Indenture, the Trustee
is authorized to join with the Company in the execution of any such supplemental indenture, to make the further agreements and stipulations which may be therein contained and to accept the conveyance, transfer, assignment, mortgage or pledge of any
property or assets thereunder.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;5.02. <I>Limitations</I>. Solely with respect to the 2031 Notes, the text of
Section&nbsp;9.3 of the Base Indenture shall be substituted with the following: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&#147;No supplemental indenture shall, without the consent
of the Holder of each outstanding 2031 Note affected thereby, </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(a) change the Maturity Date of the principal of, or any installment of
principal of or interest on, any 2031 Note, or change the timing of an interest payment on any 2031 Note, or reduce the principal amount thereof or the rate of interest thereon or any premium payable upon the redemption thereof, or reduce the amount
of the principal of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">
any 2031 Note which would be due and payable upon an acceleration of the Maturity Date thereof pursuant to Section&nbsp;6.2 hereof, or change any Place of Payment where, or the coin or currency
in which, any 2031 Note or any premium or interest thereon is payable, or impair the right to institute suit for the enforcement of any such payment on or after the Maturity Date thereof (or, in the case of redemption, on or after the Redemption
Date) or modify the provisions of the Indenture with respect to the subordination of the 2031 Notes in a manner adverse to Holders; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(b)
reduce the percentage in principal amount of the outstanding 2031 Notes, the consent of whose Holders is required for any such supplemental indenture, or the consent of whose Holders is required for any waiver (of compliance with certain provisions
of the Indenture or certain defaults hereunder and their consequences) provided for in the Indenture; or </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">(c) modify any of the provisions
of this Section or Section&nbsp;6.13 of the Base Indenture, except to increase any such percentage or to provide that certain other provisions of the Indenture cannot be modified or waived without the consent of the Holder of each outstanding 2031
Note affected thereby; provided, however, that this clause shall not be deemed to require the consent of any Holder with respect to changes in the references to &#147;the Trustee&#148; and concomitant changes in this Section and clause (b)&nbsp;of
Section&nbsp;6.13, or the deletion of this proviso, in accordance with the requirements of Sections 7.8 and Section&nbsp;9.1(h). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">A
supplemental indenture which changes or eliminates any covenant or other provision of the Indenture which has expressly been included solely for the benefit of the 2031 Notes, or which modifies the rights of the Holders of the 2031 Notes with
respect to such covenant or other provision, shall be deemed not to affect the rights under the Indenture of the Holders of Securities of any other series. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">It shall not be necessary for any Act of Holders under this Section to approve the particular form of any proposed supplemental indenture, but
it shall be sufficient if such Act shall approve the substance thereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">The Company may set a record date for purposes of determining the
identity of the Holders of each series of Securities entitled to give a written consent or waive compliance by the Company as authorized or permitted by this Section. Such record date shall not be more than 30 days prior to the first solicitation of
such consent or waiver or the date of the most recent list of Holders furnished to the Trustee prior to such solicitation pursuant to Section&nbsp;312 of the Trust Indenture Act. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">Promptly after the execution by the Company and the Trustee of any supplemental indenture pursuant to the provisions of this Section, the
Company shall mail a notice, setting forth in general terms the substance of such supplemental indenture, to the Holders of 2031 Notes at their addresses as the same shall then appear in the Register of the Company. Any failure of the Company to
mail such notice, or any defect therein, shall not, however, in any way impair or affect the validity of any such supplemental indenture. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE VI </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SUPPLEMENTAL INDENTURES </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;6.01. <I>Supplemental Indentures</I>. The following paragraph shall be added to the end of Section&nbsp;9.2 of the Base Indenture
and shall only apply to the 2031 Notes: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:9%; font-size:10pt; font-family:Times New Roman">&#147;Not in limitation of the foregoing, without the consent of any Holder of 2031 Notes, the
Company and the Trustee may amend or supplement the Indenture or the 2031 Notes to conform the terms of the Indenture and the 2031 Notes to the description of the 2031 Notes in the prospectus supplement dated November&nbsp;17, 2021 relating to the
offering of the 2031 Notes, as certified by the Company to the Trustee in an Officers&#146; Certificate.&#148; </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">ARTICLE VII </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">MISCELLANEOUS </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.01.
<I>Trust Indenture Act</I>. This Fourth Supplemental Indenture is subject to the provisions of the Trust Indenture Act that are required to be part of the Indenture and shall, to the extent applicable, be governed by such provisions. If any
provision of this Fourth Supplemental Indenture limits, qualifies, or conflicts with a provision of the Trust Indenture Act that is required under such act to be a part of and govern this Fourth Supplemental Indenture, the latter provision shall
control. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.02. <I>GOVERNING LAW</I>. THE LAWS OF THE STATE OF NEW YORK SHALL GOVERN THIS FOURTH SUPPLEMENTAL INDENTURE AND
THE 2031 NOTES. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.03. <I>JURISDICTION.</I> THE PARTIES HEREBY (I)&nbsp;IRREVOCABLY SUBMIT TO THE <FONT
STYLE="white-space:nowrap">NON-EXCLUSIVE</FONT> JURISDICTION OF ANY FEDERAL OR STATE COURT SITTING IN THE BOROUGH OF MANHATTAN, THE CITY OF NEW YORK, (II)&nbsp;WAIVE ANY OBJECTION TO LAYING OF VENUE IN ANY SUCH ACTION OR PROCEEDING IN SUCH COURTS,
AND (III)&nbsp;WAIVE ANY OBJECTION THAT SUCH COURTS ARE AN INCONVENIENT FORUM OR DO NOT HAVE JURISDICTION OVER ANY PARTY </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.04. <I>WAIVER OF TRIAL BY JURY. </I>EACH OF THE PARTIES HERETO, AND EACH HOLDER OF A NOTE BY ITS ACCEPTANCE THEREOF, HEREBY
WAIVES TO THE FULLEST EXTENT PERMITTED BY LAW THE RIGHT TO TRIAL BY JURY WITH RESPECT TO ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH THIS INDENTURE. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.05. <I>Duplicate Originals</I>. The parties may sign any number of copies of this Fourth Supplemental Indenture. Each signed
copy shall be an original, but all of them together represent the same agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.06. <I>Severability; Entire
Agreement</I>. In case any provision in this Fourth Supplemental Indenture or the 2031 Notes shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or
impaired thereby. The Base Indenture and this Fourth Supplemental Indenture and the exhibits thereto and hereto set forth the entire agreement and understanding of the parties related to this transaction and supersedes all prior agreements and
understandings, oral or written. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.07. <I>Ratification</I>. The Base Indenture, as supplemented and amended by this Fourth
Supplemental Indenture, is in all respects ratified and confirmed. The Base Indenture and this Fourth Supplemental Indenture shall be read, taken and construed as one and the same instrument. All provisions included in this Fourth Supplemental
Indenture supersede any conflicting provisions included in the Base Indenture unless not permitted by law. The Trustee accepts the trusts created by the Base Indenture, as supplemented by this Fourth Supplemental Indenture, and agrees to perform the
same upon the terms and conditions of the Base Indenture, as supplemented by this Fourth Supplemental Indenture. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.08. <I>Effectiveness</I>. The provisions of this Fourth Supplemental
Indenture shall become effective as of the date hereof. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.09. <I>Successors</I>. All agreements of the Company in this
Fourth Supplemental Indenture shall bind its successors. All agreements of the Trustee in this Fourth Supplemental Indenture shall bind its successors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.10. <I>Rights of Trustee</I>. Solely with respect to the 2031 Notes, the text of Section&nbsp;7.2(m) of the Base Indenture
shall be substituted with the following: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">&#147;The Trustee shall not be responsible or liable for any failure or delay in the performance
of its obligations under this Indenture arising out of or caused, directly or indirectly, by circumstances beyond its reasonable control, including, without limitation, any act or provision of any present or future law or regulation or governmental
authority; acts of God; earthquakes; fire; flood; terrorism; wars and other military disturbances; sabotage; epidemics; riots; interruptions; loss or malfunction of utilities, computer (hardware or software) or communication services; accidents;
labor disputes; and acts of civil or military authorities and governmental action; or the unavailability of the Federal Reserve Bank wire or telex or other wire or communication facility.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.11. <I>Indenture and Notes Solely Corporate Obligations</I>. No recourse for the payment of the principal of or interest on any
2031 Note, or for any claim based thereon or otherwise in respect thereof, shall be had against any shareholder, employee, agent, officer or director, as such, past, present or future, of the Company or of any successor Person; it being expressly
understood that all such liability is hereby expressly waived and released as a condition of, and as a consideration for, the execution of this Fourth Supplemental Indenture and the issue of the 2031 Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.12. <I>Trustee&#146;s Disclaimer</I>. The recitals contained herein shall be taken as the statements of the Company and the
Trustee assumes no responsibility for their correctness. The Trustee shall not be responsible in any manner whatsoever for or in respect of the validity or sufficiency of this Fourth Supplemental Indenture, the 2031 Notes, or for or in respect of
the recitals contained herein, all of which recitals are made solely by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Section&nbsp;7.13. <I>USA PATRIOT Act</I>. The
parties hereto acknowledge that in accordance with Section&nbsp;326 of the USA PATRIOT Act the Trustee, like all financial institutions and in order to help fight the funding of terrorism and money laundering, is required to obtain, verify, and
record information that identifies each person or legal entity that establishes a relationship or opens an account. The parties to this agreement agree that they shall provide the Trustee with such information as it may request in order to satisfy
the requirements of the USA PATRIOT Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Remainder of page intentionally left blank.] </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the parties hereto have caused this Fourth Supplemental Indenture to be
duly executed as of the date first above written. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">RENASANT CORPORATION</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ C. Mitchell Waycaster</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">C. Mitchell Waycaster</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">President and Principal Executive Officer</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to Fourth Supplemental Indenture] </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="12%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="87%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Wilmington Trust, National Association,</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">as Trustee</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Michael H. Wass</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Name:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Michael H. Wass</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Title:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Vice President</TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature Page to Fourth Supplemental Indenture] </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT A </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FORM OF NOTE </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">See
attached. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-26 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THIS SECURITY AND THE OBLIGATIONS OF THE COMPANY (AS DEFINED HEREIN) AS EVIDENCED HEREBY (1)&nbsp;ARE NOT
DEPOSITS WITH OR HELD BY THE COMPANY AND ARE NOT INSURED OR GUARANTEED BY ANY FEDERAL AGENCY OR INSTRUMENTALITY, INCLUDING, WITHOUT LIMITATION, THE FEDERAL DEPOSIT INSURANCE CORPORATION, AND (2)&nbsp;ARE SUBORDINATE IN THE RIGHT OF PAYMENT TO THE
SENIOR INDEBTEDNESS (AS DEFINED IN THE INDENTURE IDENTIFIED HEREIN). </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>GLOBAL NOTE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">THIS SECURITY IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF THE DEPOSITARY OR A NOMINEE OF
THE DEPOSITARY, WHICH MAY BE TREATED BY THE COMPANY, THE TRUSTEE AND ANY AGENT THEREOF AS OWNER AND HOLDER OF THIS SECURITY FOR ALL PURPOSES. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">UNLESS AND
UNTIL IT IS EXCHANGED IN WHOLE OR IN PART FOR THE INDIVIDUAL SECURITIES REPRESENTED HEREBY, THIS GLOBAL SECURITY MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE (I)&nbsp;BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY OR (II)&nbsp;BY A NOMINEE OF THE
DEPOSITARY OR THE DEPOSITARY TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH SUCCESSOR DEPOSITARY. UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY TO THE ISSUER OR ITS AGENT FOR REGISTRATION OF
TRANSFER, EXCHANGE OR PAYMENT AND ANY CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE&nbsp;&amp; CO. OR SUCH OTHER NAME AS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY AND ANY PAYMENT IS MADE TO CEDE&nbsp;&amp; CO.,
ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL SINCE THE REGISTERED OWNER HEREOF, CEDE&nbsp;&amp; CO., HAS AN INTEREST HEREIN. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">TRANSFERS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS IN WHOLE, BUT NOT IN PART, BY THE DEPOSITARY TO A NOMINEE OF THE DEPOSITARY, OR BY A NOMINEE
OF THE DEPOSITARY TO THE DEPOSITARY OR ANOTHER NOMINEE OF THE DEPOSITARY, OR BY THE DEPOSITARY OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH SUCCESSOR DEPOSITARY. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RENASANT CORPORATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3.00% <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Fixed-to-Floating</FONT></FONT> Rate Subordinated Notes due 2031 </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">No.&nbsp;1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">CUSIP: 75970E AE7</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">ISIN: US75970EAE77</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">$200,000,000</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Renasant Corporation, a Mississippi corporation (hereinafter called the &#147;<U>Company</U>,&#148; which term
includes any successor corporation under the Indenture hereinafter referred to), for value received, hereby promises to pay to CEDE&nbsp;&amp; CO., or its registered assigns, the principal sum of $200,000,000 (or such other amount as set forth in
the Schedule of Increases or Decreases in Global Note attached hereto) on December&nbsp;1, 2031 (such date is hereinafter referred to as the &#147;<U>Stated Maturity Date</U>&#148;), unless redeemed prior to such date, and to pay interest thereon
(i)&nbsp;from, and including, November&nbsp;23, 2021, to, but excluding, December&nbsp;1, 2026, unless redeemed prior to such date, at a rate of 3.00% per annum, semi-annually in arrears on June&nbsp;1 and December&nbsp;1 of each year, commencing
June&nbsp;1, 2022 (each such date, a &#147;<U>Fixed Rate Interest Payment Date</U>,&#148; with the period from, and including, November&nbsp;23, 2021 to, but excluding, the first Fixed Rate Interest Payment Date and each successive period from, and
including, a Fixed Rate Interest Payment Date to, but excluding, the next Fixed Rate Interest Payment Date being a &#147;<U>Fixed Rate</U> <U>Period</U>&#148;) and (ii)&nbsp;from, and including, December&nbsp;1, 2026 to, but excluding, the Stated
Maturity Date, unless redeemed subsequent to December&nbsp;1, 2026 but prior to the Stated Maturity Date, at a rate equal to Three-Month Term SOFR, reset quarterly, plus 191 basis points (1.91%), or such other rate as determined pursuant to the
Fourth Supplemental Indenture, payable quarterly in arrears on March&nbsp;1, June&nbsp;1, September&nbsp;1 and December&nbsp;1 of each year (each, a &#147;<U>Floating Rate Interest Payment Date</U>,&#148; and together with the Fixed Rate Interest
Payment Dates, the &#147;<U>Interest Payment Dates</U>,&#148; with the period from, and including, December&nbsp;1, 2026 to, but excluding, the first Floating Rate Interest Payment Date and each successive period from, and including a Floating Rate
Interest Payment Date to, but excluding, the next Floating Rate Interest Payment Date being a &#147;<U>Floating Rate Period</U>&#148;), commencing on March&nbsp;1, 2027 through the Stated Maturity Date or earlier redemption date. The amount of
interest payable on any Fixed Rate Interest Payment Date during the Fixed Rate Period will be computed on the basis of a <FONT STYLE="white-space:nowrap">360-day</FONT> year consisting of twelve <FONT STYLE="white-space:nowrap">30-day</FONT> months
up to, but excluding December&nbsp;1, 2026, and, the amount of interest payable on any Floating Rate Interest Payment Date during the Floating Rate Period will be computed on the basis of a <FONT STYLE="white-space:nowrap">360-day</FONT> year and
the number of days actually elapsed. In the event that any scheduled Interest Payment Date or the Stated Maturity Date for the Notes falls on a day that is not a Business Day, then payment of interest payable on such Interest Payment Date or of
principal and interest payable on the Stated Maturity Date will be paid on the next succeeding day which is a Business Day (any payment made on such date will be treated as being made on the date that the payment was first due and no interest on
such payment will accrue for the period from and after such scheduled Interest Payment Date); provided, that in the event that any scheduled Floating Rate Interest Payment Date falls on a day that is not a Business Day and the next succeeding
Business Day falls in the next succeeding calendar month, such Floating Rate Interest Payment Date will be accelerated to the immediately preceding Business Day, and, in each such case, the amounts payable on such Business Day will include interest
accrued to but excluding such Business Day. All percentages used in or resulting from any calculation of Three-Month Term SOFR (or, if different, the then-current Benchmark) shall be rounded, if necessary, to the nearest one hundred-thousandth of a
percentage point, with 0.000005% rounded up to 0.00001%. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The interest so payable, and punctually paid or duly provided for, on any Interest Payment
Date will, as provided in the Indenture, be paid to the Person in whose name this Note is registered at the close of business on the 15<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> day of the month (whether or not a Business Day)
immediately preceding such Interest Payment Date. Any such interest not so punctually paid or duly provided for will forthwith cease to be payable to the Holder on such relevant record date and may either be paid to the person in whose name this
Note is registered at the close of business on a special record date for the payment of such defaulted interest to be fixed by the Company, notice whereof shall be given to Holders of the Notes not less than 10 days prior to such special record
date, or be paid at any time in any other lawful manner not inconsistent with the requirements of any securities exchange on which the Notes may be listed, and upon such notice as may be required by such exchange, all as more fully provided in said
Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Payment of the principal of (and premium, if any) and interest on this Note will be made at the office or agency of the
Company maintained for that purpose, which shall initially be the Corporate Trust Office of the Trustee, in such currency of the United States of America as at the time of payment is legal tender for payment of public and private debts. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Reference is hereby made to the further provisions of this Note set forth on the reverse hereof, which further provisions shall for all
purposes have the same effect as if set forth at this place. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Unless the certificate of authentication hereon has been executed by the
Trustee referred to on the reverse hereof by manual signature, this Note shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Remainder of this page intentionally left blank. Signature page follows.] </I></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Company has caused this Note to be signed manually or by facsimile
by its duly authorized officer. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>RENASANT CORPORATION</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Name:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Title:</TD></TR>
</TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>TRUSTEE&#146;S CERTIFICATE OF AUTHENTICATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This is one of the Notes of the series designated therein referred to in the within-mentioned Indenture. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date of authentication:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>WILMINGTON TRUST, NATIONAL</B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>ASSOCIATION</B>, as Trustee</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">Authorized Signatory</P></TD></TR>
</TABLE></DIV>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">REVERSE OF NOTE </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RENASANT CORPORATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3.00% <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Fixed-to-Floating</FONT></FONT> Rate Subordinated Notes due 2031 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Note is one of a duly authorized issue of Securities of the Company of a series designated as the &#147;3.00% <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Fixed-to-Floating</FONT></FONT> Rate Subordinated Notes due 2031&#148; (herein called the &#147;<U>Notes</U>&#148;) initially issued in an aggregate principal amount of $200,000,000 on
November&nbsp;23, 2021. Such series of Notes has been established pursuant to, and is one of an indefinite number of series of subordinated debt securities of the Company issued or issuable under and pursuant to the Indenture, dated as of
August&nbsp;22, 2016 (the &#147;<U>Base Indenture</U>&#148;), between the Company and Wilmington Trust, National Association, as Trustee (herein called the &#147;<U>Trustee</U>,&#148; which term includes any successor trustee), as supplemented and
amended by the First Supplemental Indenture between the Company and the Trustee, dated as of August&nbsp;22, 2016 (the &#147;<U>First Supplemental Indenture</U>,&#148;), the Second Supplemental Indenture between the Company and the Trustee, dated as
of August&nbsp;22, 2016 (the &#147;<U>Second Supplemental Indenture</U>&#148;), the Third Supplemental Indenture between the Company and the Trustee, dated as of September&nbsp;3, 2020 (the &#147;<U>Third Supplemental Indenture</U>,&#148;), and the
Fourth Supplemental Indenture between the Company and the Trustee, dated as of November&nbsp;23, 2021 (the &#147;<U>Fourth Supplemental Indenture</U>,&#148; and the Base Indenture as supplemented and amended by the First Supplemental Indenture, the
Second Supplemental Indenture, the Third Supplemental Indenture and the Fourth Supplemental Indenture, the &#147;<U>Indenture</U>&#148;), to which Indenture and any other indentures supplemental thereto reference is hereby made for a statement of
the respective rights, limitations of rights, duties and immunities thereunder of the Company, the Trustee and the Persons in whose names Notes are registered from time to time and of the terms upon which the Notes are, and are to be, authenticated
and delivered. The terms, conditions and provisions of the Notes are those stated in the Indenture, those made part of the Indenture by reference to the Trust Indenture Act of 1939, as amended (the &#147;<U>Trust Indenture Act</U>&#148;), and those
set forth in this Note. To the extent that the terms, conditions and provisions of this Note modify, supplement or are inconsistent with those of the Indenture, then the terms, conditions and other provisions of this Note shall govern to the extent
that such terms, conditions and other provisions of this Note are not inconsistent with the terms, conditions and provisions made part of the Indenture by reference to the Trust Indenture Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">All capitalized terms used in this Note and not defined herein that are defined in the Indenture shall have the meanings assigned to them in
the Indenture. To the extent that any capitalized term used in this Note and defined herein is also defined in the Indenture but conflicts with the definition provided in the Indenture, the definition of the capitalized term in this Note shall
control. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The indebtedness of the Company evidenced by the Notes, including the principal thereof, premium, if any, Additional Amounts, if
any, and interest thereon, is, to the extent and in the manner set forth in the Indenture, subordinate and subject in right of payment to the prior payment in full of all Senior Indebtedness, whether outstanding at the date hereof or hereafter
incurred, and on the terms and subject to the terms and conditions set forth in the Indenture, and shall rank <I>pari passu </I>in right of payment with all other Securities and with all other unsecured subordinated indebtedness of the Company and
not by its terms subordinate and subject in right of payment to </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the prior payment in full of debentures, notes, bonds or other evidences of indebtedness of types that include the Notes. Each Holder of this Note, by the acceptance hereof, (a)&nbsp;agrees to
and shall be bound by such provisions of the Indenture, (b)&nbsp;authorizes and directs the Trustee on his or her behalf to take such actions as may be necessary or appropriate to effectuate the subordination so provided, and (c)&nbsp;appoints the
Trustee his or her <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">attorney-in-fact</FONT></FONT> for any and all such purposes. Each Holder hereof, by his or her acceptance hereof, waives all notice of the acceptance of the
subordination provisions contained herein and in the Indenture by each holder of Senior Indebtedness, whether now outstanding or hereafter created, incurred, assumed or guaranteed, and waives reliance by each such holder upon said provisions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Indenture contains provisions for defeasance at any time of certain restrictive covenants and Events of Default with respect to this Note,
in each case upon compliance with certain conditions set forth in the Indenture. If certain Events of Default with respect to the Notes shall occur and be continuing, the principal of the Notes shall be immediately accelerated in the manner and with
the effect provided in the Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are intended to be treated as Tier 2 capital (or its then-equivalent if the Company were
subject to such capital requirement) for purposes of capital adequacy guidelines of the Board of Governors of the Federal Reserve System (or, as and if applicable, the capital adequacy rules or regulations of any appropriate successor federal
banking agency) (the &#147;<U>Federal Reserve Board</U>&#148;) as then in effect and applicable to the Company. If an Event of Default with respect to Notes shall occur and be continuing, the principal and interest owed on the Notes shall only
become due and payable in accordance with the terms and conditions set forth in Article VI of the Base Indenture and Section&nbsp;3.02(n) and (p)&nbsp;of the Fourth Supplemental Indenture. <B>Accordingly, the Holder of this Note has no right to
accelerate the maturity of this Note in the event that the Company fails to pay interest on any of the Notes, or fails to perform any other obligations under the Notes or in the Indenture that are applicable to the Notes.</B> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company may, at its option, redeem the Notes, in whole or in part, at a redemption price equal to 100% of the principal amount of the
Notes to be redeemed, plus accrued and unpaid interest (the &#147;<U>Redemption Price</U>&#148;) to but excluding, the date of redemption (the &#147;<U>Redemption Date</U>&#148;), on any Interest Payment Date on or after December&nbsp;1, 2026. The
Company may also, at its option, redeem the Notes before the Stated Maturity Date, in whole, but not in part, at any time, upon the occurrence of a Tier 2 Capital Event, a Tax Event or if the Company is required to register as an investment company
pursuant to the Investment Company Act of 1940, as amended. Any such redemption will be at a redemption price equal to the Redemption Price to, but excluding, the Redemption Date fixed by the Company. No redemption of the Notes by the Company prior
to the Stated Maturity Date shall be made without the prior approval of the Federal Reserve Board if such prior approval is or will be required at the scheduled Redemption Date. The provisions of Article III of the Base Indenture and
Section&nbsp;3.02(h) of the Fourth Supplemental Indenture shall apply to the redemption of any Notes by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event that
any payment on the Notes is subject to withholding of any U.S. federal income tax or other tax or assessment (as a result of a change in law or otherwise), the Company will not pay Additional Amounts with respect to such tax or assessment. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are not entitled to the benefit of any sinking fund. The Notes are not convertible
into or exchangeable for any other securities or property of the Company or any Subsidiary of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Indenture permits, with
certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of the Company and the rights of the Holders of the Notes at any time by the Company and the Trustee with the consent of the Holders of
at least a majority in principal amount of the Notes at the time outstanding. The Indenture also contains provisions permitting the Holders of specified percentages in principal amount of the Notes at the time outstanding, on behalf of the Holders
of all Notes, to waive compliance by the Company with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences. Any such consent or waiver by the Holder of this Note shall be conclusive and binding
upon such Holder and upon all future Holders of this Note and of any Note issued upon the registration of transfer hereof or in exchange therefor or in lieu hereof, whether or not notation of such consent or waiver is made upon this Note. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As provided in and subject to the provisions of the Indenture, the Holder of this Note shall not have the right to institute any proceeding
with respect to the Indenture or for the appointment of a receiver or trustee or for any other remedy thereunder, unless such Holder shall have previously given the Trustee written notice of a continuing Event of Default with respect to the Notes,
the Holders of not less than 25% in principal amount of the Notes at the time outstanding shall have made written request to the Trustee to institute proceedings in respect of such Event of Default and offered the Trustee indemnity satisfactory to
it, and the Trustee shall not have received from the Holders of a majority in principal amount of Notes at the time outstanding a direction inconsistent with such request, and shall have failed to institute any such proceeding, for 60 days after
receipt of such notice, request and offer of indemnity. The foregoing shall not apply to any suit instituted by the Holder of this Note for the enforcement of any payment of principal hereof or any premium or interest hereon on or after the
respective due dates expressed herein. No reference herein to the Indenture and no provision of this Note or of the Indenture shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay the principal of and any
premium and interest on this Note at the times, place and rate, and in the coin or currency, herein prescribed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As provided in the
Indenture and subject to certain limitations therein set forth, the transfer of this Note is registrable in the Register described in Section&nbsp;2.7 of the Base Indenture, upon surrender of this Note for registration of transfer at the office or
agency of the Company in any place where the principal of and interest on this Note are payable, duly endorsed by, or accompanied by a written instrument of transfer in form satisfactory to the Company and the Registrar duly executed by the Holder
hereof or his attorney duly authorized in writing, and thereupon one or more new Notes, of authorized denominations and for the same aggregate principal amount, will be issued to the designated transferee or transferees. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Notes are issuable only in registered form without coupons in minimum denominations of $1,000 and any integral multiples of $1,000 in
excess thereof. No service charge shall be made for any such registration of transfer or exchange, but the Company may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection therewith. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company and the Trustee and any agent of the Company or the Trustee may treat the Person
in whose name this Note is registered as the owner hereof for all purposes, whether or not this Note is overdue, and neither the Company, the Trustee nor any such agent shall be affected by notice to the contrary. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>This Note is a global note, represented by one or more permanent global certificates registered in the name of the nominee of The
Depository Trust Company (each a &#147;<U>Global Note</U>&#148; and collectively, the &#147;<U>Global Notes</U>&#148;). Accordingly, unless and until it is exchanged for individual certificates, this Note may not be transferred except as a whole by
The Depository Trust Company (the &#147;<U>Depositary</U>&#148;) to a nominee of such Depositary or by a nominee of such Depositary or by the Depositary or any nominee to a successor Depositary or any nominee of such successor. Ownership of
beneficial interests in this Note will be shown on, and the transfer of that ownership will be effected only through, records maintained by the applicable Depositary or its nominee (with respect to interest of persons that have accounts with the
Depositary (&#147;<U>Participants</U>&#148;)) and the records of Participants (with respect to interests of persons other than Participants). Beneficial interests in Notes owned by persons that hold through Participants will be evidenced only by,
and transfers of such beneficial interests with such Participants will be effected only through, records maintained by such Participants. Except as provided below, owners of beneficial interests in this Note will not be entitled to have any
individual certificates and will not be considered the owners or Holders thereof under the Indenture. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Except in the limited
circumstances set forth in the Base Indenture, Participants and owners of beneficial interests in the Global Notes will not be entitled to receive Notes in the form of individual Securities and will not be considered Holders of Notes. None of the
Company, the Trustee, the Registrar, the Paying Agent or any of their respective agents will be liable for any delay by the Depositary, its nominee or any direct or indirect Participant in identifying the beneficial owners of the related Notes. The
Company, the Trustee, the Registrar, the Paying Agent and each of their respective agents may conclusively rely on, and will be protected in relying on, instructions from the Depositary or its nominee for all purposes, including with respect to the
registration and delivery, and the respective principal amounts, of the Notes to be issued. </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>Except as provided in
Section&nbsp;2.14 of the Base Indenture, beneficial owners of Global Notes will not be entitled to receive physical delivery of Notes in the form of individual Securities, and no Global Note will be exchangeable except for another Global Note of
like denomination and tenor to be registered in the name of the Depositary or its nominee. Accordingly, each person owning a beneficial interest in a Global Note must rely on the procedures of the Depositary and, if such person is not a Participant,
on the procedures of the Participant through which such person owns its interest, to exercise any rights of a Holder under the Notes. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B>The laws of some jurisdictions may require that certain purchasers of securities take physical delivery of those securities in definitive
form. Accordingly, the ability to transfer interests in the Notes represented by a Global Note to those persons may be limited. In addition, because the Depositary can act only on behalf of its Participants, who in turn act on behalf of persons who
hold interests through Participants, the ability of a person having </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>
an interest in Notes represented by a Global Note to pledge or transfer such interest to persons or entities that do not participate in the Depositary&#146;s system, or otherwise to take actions
in respect of such interest, may be affected by the lack of a physical definitive security in respect of such interest. None of the Company, the Trustee, the Paying Agent and the Registrar will have any responsibility or liability for any aspect of
the records relating to or payments made on account of Notes by the Depositary, or for maintaining, supervising or reviewing any records of the Depositary relating to the Notes. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Trustee will act as the Company&#146;s Paying Agent with respect to the Notes through its Corporate Trust Office presently located at 1100
North Market Street, Wilmington, Delaware 19890. The Company may at any time rescind the designation of a Paying Agent, appoint a successor Paying Agent, or approve a change in the office through which any Paying Agent acts. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notices to the Holders of registered Notes in the form of individual Securities will be given to such Holders at their respective addresses in
the Register, or in the case of Global Notes, electronic delivery in accordance with DTC&#146;s applicable procedures. The Indenture contains provisions setting forth certain conditions to the institution of proceedings by the Holders of Notes with
respect to the Indenture or for any remedy under the Indenture. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">THIS NOTE SHALL BE DEEMED TO BE A CONTRACT MADE UNDER THE LAWS OF THE
STATE OF NEW YORK. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>ASSIGNMENT FORM </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">To assign the within Note, fill in the form below: I or we assign and transfer the within Note to: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(Insert assignee&#146;s legal name)</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(Insert assignee&#146;s social security or tax I.D. number)</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">(Print or type assignee&#146;s name, address and zip code)</P></TD></TR>
</TABLE></DIV> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">and irrevocably appoint the Trustee as agent to transfer this Note on the books of Renasant Corporation. The agent may
substitute another to act for it. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Your Signature: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(<I>Sign exactly as your name appears on the other side of this Security</I>) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Your Name: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Date: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Signature Guarantee: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SIGNATURE GUARANTEE </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Signatures must be guaranteed by an &#147;eligible guarantor institution&#148; meeting the requirements of the Registrar, which requirements include
membership or participation in the Security Transfer Agent Medallion Program (&#147;<U>STAMP</U>&#148;) or such other &#147;signature guarantee program&#148; as may be determined by the Registrar in addition to, or in substitution for, STAMP, all in
accordance with the Securities Exchange Act of 1934, as amended. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SCHEDULE OF INCREASES OR DECREASES IN GLOBAL NOTE </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The initial principal amount of this Global Note is $200,000,000. The following increases or decreases in the principal amount of this Global
Note have been made: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="21%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="19%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="18%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Date</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Amount of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>decrease in</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>principal
amount</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of this</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Global Note</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Amount of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>increase in</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>principal
amount</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of this</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Global Note</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Principal</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>amount</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>of this</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Global Note</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>following
such</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>decrease</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>or
increase</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Signature of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>authorized</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>signatory
of</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Trustee</B></P></TD></TR></TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>4
<FILENAME>d242176dex51.htm
<DESCRIPTION>EX-5.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.1 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g242176dsp087.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">November&nbsp;23, 2021 </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Renasant Corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">209 Troy Street </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tupelo, Mississippi 38804-4827 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">Re:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Renasant Corporation </P></TD></TR></TABLE>
<P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><U>Form <FONT STYLE="white-space:nowrap">S-3</FONT> Registration Statement (File
<FONT STYLE="white-space:nowrap">No.&nbsp;333-260188)</FONT></U> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We have acted as counsel to Renasant Corporation, a Mississippi corporation (the &#147;Company&#148;), in connection with the Company&#146;s
issuance and sale of $200,000,000 aggregate principal amount of 3.00% <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Fixed-to-Floating</FONT></FONT> Rate Subordinated Notes due 2031 (the &#147;Notes&#148;), pursuant to the
Company&#146;s prospectus, dated October&nbsp;12, 2021 (the &#147;Base Prospectus&#148;), which was included in the Company&#146;s Registration Statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (File
<FONT STYLE="white-space:nowrap">No.&nbsp;333-260188)</FONT> (the &#147;Registration Statement&#148;) filed with the Securities and Exchange Commission (the &#147;Commission&#148;) on October&nbsp;12, 2021 under the Securities Act of 1933, as
amended (the &#147;Securities Act&#148;), and the related preliminary prospectus supplement dated November&nbsp;17, 2021 and the related final prospectus supplement dated November&nbsp;17, 2021 (collectively, the &#147;Prospectus Supplement&#148;).
The Notes are being issued and sold pursuant to (i)&nbsp;that certain Subordinated Indenture dated as of August&nbsp;22, 2016 (the &#147;Base Indenture&#148;) by and between the Company and Wilmington Trust, National Association, as trustee (the
&#147;Trustee&#148;), as supplemented by that certain Fourth Supplemental Indenture dated as of November&nbsp;23, 2021 between the Company and the Trustee (collectively with the Base Indenture, the &#147;Indenture&#148;), and (ii)&nbsp;that certain
Underwriting Agreement dated as of November&nbsp;17, 2021 (the &#147;Underwriting Agreement&#148;) by and between the Company and Keefe, Bruyette&nbsp;&amp; Woods, Inc., as representative of the several underwriters listed on Schedule I to the
Underwriting Agreement (the &#147;Underwriters&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In rendering this opinion, we have examined and relied upon originals, or
photostatic, scanned/emailed or certified (or otherwise satisfactorily identified) copies, of the Registration Statement (including the exhibits attached thereto), the Base Prospectus, the Prospectus Supplement, the Underwriting Agreement, the
Indenture, the Global Note representing the Notes, the Issuer-Represented Free Writing Prospectuses relating to the Company dated November&nbsp;17, 2021 and filed with the Commission pursuant to Rule 433 of the rules and regulations of the
Commission, used by the Company in connection with the offering, issuance and sale of the Notes and the Articles of Incorporation of the Company, as amended through the date hereof, and the Amended and Restated Bylaws of the Company, as amended
through the date hereof. We have also examined and relied upon originals, or photostatic, scanned/emailed or certified (or otherwise satisfactorily identified) copies, of such other records of the Company, certificates of officers of the Company and
other agreements, documents and instruments and have examined such questions of law as we have deemed relevant and necessary as the basis for the opinions set forth below. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g242176dso087a.jpg" ALT="LOGO">
 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Renasant Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">November&nbsp;23, 2021 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 2 </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In such examination, we have assumed the genuineness of all signatures appearing on all
documents, the legal capacity of all natural persons signing such documents, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as certified, conformed, photostatic
or scanned/emailed copies, the accuracy and completeness of all corporate records made available to us by the Company, and the truth and accuracy of all facts set forth in all certificates provided to or examined by us. Except to the extent
expressly set forth herein, we have made no independent investigations with regard thereto, and, accordingly, we do not express any opinion as to matters that might have been disclosed by independent verification. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Based upon the foregoing and representations made to us by officers of the Company, and subject to the limitations, qualifications, exceptions
and assumptions set forth herein, we are of the opinion that, insofar as the laws of the State of Mississippi are concerned, (i)&nbsp;the Company is duly organized, validly existing and in good standing under the laws of the State of Mississippi and
has all requisite corporate power, authority and legal right to execute, deliver and perform its obligations under the Indenture and the Notes, as applicable, and (ii)&nbsp;the Notes and the Indenture have been duly authorized, executed and
delivered by the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">With respect to all matters of New York law, we note that you are relying on an opinion of Covington&nbsp;&amp;
Burling LLP, dated as of even date herewith, which opinion is filed as Exhibit 5.2 to the Company&#146;s Current Report on Form <FONT STYLE="white-space:nowrap">8-K,</FONT> which is incorporated by reference in the Registration Statement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our opinions are subject to: (i)&nbsp;the effect of bankruptcy, insolvency, reorganization, preference, fraudulent transfer, moratorium or
other similar laws relating to or affecting the rights and remedies of creditors; (ii)&nbsp;the effect of general principles of equity, whether considered in a proceeding in equity or at law (including the possible unavailability of specific
performance or injunctive relief), concepts of materiality, reasonableness, good faith and fair dealing, and the discretion of the court before which a proceeding is brought; and (iii)&nbsp;the invalidity under certain circumstances under law or
court decisions of provisions providing for the indemnification of or contribution to a party with respect to a liability where such indemnification or contribution is contrary to public policy.<B> </B>We express no opinion as to (i)&nbsp;any
provision for liquidated damages, default interest, late charges, monetary penalties, make-whole premiums or other economic remedies to the extent such provisions are deemed to constitute a penalty, (ii)&nbsp;restrictions upon, governing law,
jurisdiction, venue, arbitration, remedies or judicial relief, (iii)&nbsp;advance waivers of claims, defenses, rights or notice, opportunity for hearing, evidentiary requirements, statutes of limitation, trial by jury or other procedural rights,
(iv)&nbsp;provisions for exclusivity, election or cumulation of rights or remedies, (v)&nbsp;provisions authorizing or validating conclusive or discretionary determinations, (vi)&nbsp;grants of setoff rights, (vii)&nbsp;proxies, powers of attorney
and trusts and (viii)&nbsp;the severability, if invalid, of provisions to the foregoing effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The foregoing opinions are limited to the
federal laws of the United States and the laws of the State of Mississippi. We express no opinion as to matters governed by the laws of any other state, including without limitation any state securities or blue sky laws. Furthermore, no opinion is
expressed herein as to the effect of any future acts of the parties or changes in existing law. We undertake no responsibility to advise you of any changes after the date hereof in the law or the facts presently in effect that would alter the scope
or substance of the opinions herein expressed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This opinion is delivered for use solely in connection with the issuance of the Notes, in
the transactions contemplated by the Registration Statement, the Base Prospectus, the Prospectus Supplement and the Underwriting Agreement, and may not be used, circulated, quoted or otherwise relied upon for any other purpose without our express
written consent. This letter expresses our legal opinion as to the foregoing matters based on our professional judgment at this time; it is not, however, to be construed as a guaranty, nor is it a warranty that a court considering such matters would
not rule in a manner contrary to the opinion set forth above. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Renasant Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">November&nbsp;23, 2021 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 3 </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We hereby consent to the filing of this opinion letter as Exhibit 5.1 to the Company&#146;s
Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> dated November&nbsp;23, 2021, which is incorporated by reference in the Registration Statement, and to being named in the Registration Statement under the heading &#147;Legal
Matters&#148; as the law firm which passed on the validity of the Notes. In giving this consent, we do not admit that we are within the category of persons whose consent is required under Section&nbsp;7 of the Securities Act and the rules and
regulations of the Commission promulgated thereunder. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ PHELPS DUNBAR, L.L.P.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">PHELPS DUNBAR, L.L.P.</TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.2
<SEQUENCE>5
<FILENAME>d242176dex52.htm
<DESCRIPTION>EX-5.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-5.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 5.2 </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g242176dsp95.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:60%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">November&nbsp;23, 2021 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Renasant Corporation </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">209 Troy Street </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Tupelo, MS 38804 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and Gentlemen: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">We have acted as counsel to the Underwriters named in the Underwriting Agreement (as defined below) in connection with the registration by
Renasant Corporation, a Mississippi corporation (the &#147;<U>Company</U>&#148;), under the Securities Act of 1933, as amended (the &#147;<U>Act</U>&#148;), of $200,000,000 in aggregate principal amount of the Company&#146;s 3.00% <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Fixed-to-Floating</FONT></FONT> Rate Subordinated Notes due 2031 (the &#147;<U>Notes</U>&#148;) issued pursuant to the Subordinated Indenture, dated as of August&nbsp;22, 2016 (the
&#147;<U>Base Indenture</U>&#148;), between the Company and Wilmington Trust, National Association, as trustee (the &#147;<U>Trustee</U>&#148;), as supplemented by the Fourth Supplemental Indenture, dated as of November&nbsp;23, 2021 (the
&#147;<U>Fourth Supplemental Indenture</U>&#148;) between the Company and the Trustee (the Base Indenture, as supplemented by the Fourth Supplemental Indenture, the &#147;<U>Indenture</U>&#148;), pursuant to the Company&#146;s Registration Statement
on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-260188),</FONT> filed with the Securities and Exchange Commission (the &#147;<U>Commission</U>&#148;) on October&nbsp;12, 2021 (such registration
statement, as amended and supplemented to the date hereof, the &#147;<U>Registration Statement</U>&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">We have reviewed: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(i) the Underwriting Agreement, dated November&nbsp;17, 2021, between the Company and Keefe, Bruyette&nbsp;&amp; Woods, Inc., individually and
as representative of the several underwriters named in Schedule I thereto (the &#147;<U>Underwriting Agreement</U>&#148;); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(ii) the
Registration Statement; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iii) the preliminary prospectus, consisting of the prospectus, dated October&nbsp;12, 2021 (the &#147;<U>Base
Prospectus</U>&#148;), as supplemented by the preliminary prospectus supplement, dated November&nbsp;17, 2021, with respect to the offer and sale of the Notes, filed with the Commission on November&nbsp;17, 2021 pursuant to Rule 424(b) under the
Act; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(iv) the pricing information, comprised of (i) the aggregate principal amount of the Notes sold pursuant to the Underwriting
Agreement, (ii) the public offering price of the Notes, and (iii) the underwriting discounts and commissions, in each case as reflected on the cover page of the Prospectus; </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g242176g1123074951482.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Renasant Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">November&nbsp;23, 2021 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 2 </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(v) the final prospectus, consisting of the Base Prospectus as supplemented by the final
prospectus supplement, dated November&nbsp;17, 2021, with respect to the offer and sale of the Notes, filed with the Commission on November&nbsp;19, 2021 pursuant to Rule 424(b) under the Act; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vi) the Base Indenture and the Fourth Supplemental Indenture; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">(vii) an executed copy of the Global Note representing the Notes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">We also have reviewed such other corporate records, certificates and other documents, and such questions of law, as we have considered
necessary or appropriate for the purposes of this opinion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">We have assumed that all signatures are genuine, that all documents submitted
to us as originals are authentic and that all copies of documents submitted to us conform to the originals. We have assumed further that the Trustee has duly authorized, executed and delivered the Base Indenture and the Fourth Supplemental
Indenture. We have assumed further that the information, representations and warranties contained in the agreements, instruments, records, certificates and other documents we have reviewed were true, accurate and complete as of their stated date and
are true, accurate and complete as of the date of this letter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">We have assumed further that (i)&nbsp;the Company is duly organized,
validly existing and in good standing under the law of the State of Mississippi and has all requisite power, authority and legal right to execute, deliver and perform its obligations under the Indenture and the Notes, as applicable, and
(ii)&nbsp;the Company has duly authorized, executed and delivered the Indenture and the Notes (insofar as the law of the State of Mississippi is applicable to the execution and delivery thereof). We have assumed further that the execution and
delivery of the Indenture and the Notes by the Company and the performance by the Company of its obligations thereunder do not and will not violate or contravene any judgment, order, decree or permit issued by any court, arbitrator or governmental
or regulatory authority, or conflict with or result in the breach of, or constitute a default under, any contract or other instrument binding on or affecting the Company or any subsidiary thereof or any of their respective properties or assets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">With respect to all matters of Mississippi law, we note that you are relying on an opinion of Phelps Dunbar LLP, dated as of even date
herewith, which opinion is filed as Exhibit 5.1 to the Company&#146;s Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> which is incorporated by reference in the Registration Statement. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g242176g1123074951482.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Renasant Corporation </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">November&nbsp;23, 2021 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Page 3 </P>
<p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">We have relied as to certain matters on information obtained from public officials, officers
of the Company and other sources believed by us to be responsible. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">Based upon the foregoing, and subject to the qualifications and
assumptions set forth herein, we are of the opinion that, insofar as the law of the State of New York is concerned, when the Notes have been (a)&nbsp;duly authenticated by the Trustee in accordance with the Indenture and (b)&nbsp;duly issued and
delivered by the Company against payment of the purchase price therefor in accordance with the Underwriting Agreement, the Notes will constitute the valid and binding obligations of the Company, enforceable against the Company in accordance with
their terms, subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and other laws of general applicability relating to or affecting creditors&#146; rights and to general equity principles. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">We express no opinion as to (i)&nbsp;waivers of defenses, subrogation and related rights, rights to trial by jury, rights to object to venue,
or other rights or benefits bestowed by operation of law; (ii)&nbsp;indemnification, contribution, exculpation, or arbitration provisions, or provisions for the <FONT STYLE="white-space:nowrap">non-survival</FONT> of representations, to the extent
they purport to indemnify any party against, or release or limit any party&#146;s liability for, its own breach or failure to comply with statutory obligations, or to the extent such provisions are contrary to public policy; or (iii)&nbsp;provisions
for liquidated damages and penalties, penalty interest and interest on interest. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">We are members of the bar of the District of Columbia
and the State of New York. We do not express any opinion herein on any laws other than the law of the State of New York. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">We hereby
consent to the filing of this opinion as Exhibit 5.2 to the Company&#146;s Current Report on Form <FONT STYLE="white-space:nowrap">8-K</FONT> which is incorporated by reference in the Registration Statement. We also hereby consent to the references
to our firm under the heading &#147;Legal Matters&#148; in the prospectus constituting part of the Registration Statement. In giving such consent, we do not thereby admit that we are in the category of persons whose consent is required under
Section&nbsp;7 of the Act. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Very truly yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">/s/ Covington&nbsp;&amp; Burling LLP</TD></TR>
</TABLE></DIV>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>6
<FILENAME>d242176dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g242176g1123070735341.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="38%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="38%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Contacts:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>For Media</B>:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>For Financials</B>:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">John S. Oxford</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">James C. Mabry IV</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Senior Vice President</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman">Executive Vice President</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Director of Marketing</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Chief Financial Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">(662) <FONT STYLE="white-space:nowrap">680-1219</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">(662) <FONT STYLE="white-space:nowrap">680-1281</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><U>joxford@renasant.com</U></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><U>jim.mabry@renasant.com</U></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RENASANT CORPORATION ANNOUNCES PRICING </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>OF SUBORDINATED NOTES </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>TUPELO,
MISSISSIPPI (November 17, 2021)</B> &#150; Renasant Corporation (Nasdaq: RNST) (the &#147;Company&#148;), the parent company of Renasant Bank, today announced the pricing of its public offering of $200&nbsp;million aggregate principal amount of
3.00% <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Fixed-to-Floating</FONT></FONT> Rate Subordinated Notes due 2031 (the &#147;Notes&#148;). The Notes, which have an initial fixed interest rate of 3.00% until December&nbsp;1,
2026, payable semi-annually in arrears, and a <FONT STYLE="white-space:nowrap">10-year</FONT> term, were offered to the public at par. Commencing December&nbsp;1, 2026, the interest rate on the Notes resets quarterly to a floating rate per annum
equal to a benchmark rate that is expected to be Three-Month Term SOFR (which is defined in the Notes), plus 191<B> </B>basis points, payable quarterly in arrears. The Company may redeem the Notes, in whole or in part, after December&nbsp;1, 2026,
at a price equal to 100% of the principal amount of the Notes being redeemed plus accrued and unpaid interest. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Notes are intended to qualify as Tier
2 capital for regulatory purposes. The Company expects net proceeds from the offering (before expenses) to be $197.5<B></B>&nbsp;million. The Company intends to use the net proceeds from the Notes offering for general corporate purposes, which may
include providing capital to support the Company&#146;s organic growth or growth through strategic acquisitions, redeeming or repaying indebtedness, financing investments, capital expenditures and for investments in Renasant Bank as regulatory
capital. The offering is expected to close on November&nbsp;23, 2021, subject to the satisfaction of customary closing conditions. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Keefe, Bruyette&nbsp;&amp; Woods, <I>A</I> <I>Stifel Company</I>, is acting as lead book-running manager for
the offering, while Piper Sandler&nbsp;&amp; Co. and Stephens Inc. are acting as active book-running managers and Raymond James&nbsp;&amp; Associates, Inc. is serving as a <FONT STYLE="white-space:nowrap">co-manager.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Notes are being offered only by means of a prospectus supplement and accompanying base prospectus. The Company has filed a Registration Statement on Form <FONT
STYLE="white-space:nowrap">S-3</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-260188)</FONT> (including a base prospectus) under the Securities Act of 1933, as amended, and a related preliminary prospectus supplement dated
November&nbsp;17, 2021 to the base prospectus contained in the registration statement with the Securities and Exchange Commission (the &#147;SEC&#148;), and it will file a final prospectus supplement relating to the offering of the Notes with the
SEC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Copies of the preliminary prospectus supplement and accompanying base prospectus relating to the offering of the Notes may be obtained by visiting
EDGAR on the SEC website at <I>www.sec.gov</I>. Alternatively, the Company, the underwriters or any dealer participating in the offering will arrange to send you the base prospectus and the related prospectus supplement if you request it by
contacting Keefe, Bruyette&nbsp;&amp; Woods, <I>A Stifel Company</I>, by telephone at (800) <FONT STYLE="white-space:nowrap">966-1559</FONT> or by email at USCapitalMarkets@kbw.com. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release does not constitute an offer to sell or the solicitation of an offer to buy the Notes, nor shall there be any sale of the Notes, in any
state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Any offering of the Notes is being made only by means of a written
prospectus meeting the requirements of Section&nbsp;10 of the Securities Act of 1933, as amended. The securities being offered have not been approved or disapproved by any regulatory authority, nor has any such authority passed upon the accuracy or
adequacy of either prospectus supplement or the shelf registration statement or prospectus relating thereto. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>ABOUT RENASANT CORPORATION: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Renasant Corporation is the parent of Renasant Bank, a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">117-year-old</FONT></FONT> financial
services institution. Renasant has assets of approximately $16.2&nbsp;billion and operates 200 banking, lending, mortgage, wealth management and insurance offices in Mississippi, Tennessee, Alabama, Florida, Georgia, North Carolina and South
Carolina. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release may contain, or incorporate by reference, statements about Renasant Corporation that constitute &#147;forward-looking statements&#148;
within the meaning of Section&nbsp;27A of the Securities Act of 1933, as amended, and Section&nbsp;21E of the Securities Exchange Act of 1934, as amended. Statements preceded by, followed by or that otherwise include the words &#147;believes,&#148;
&#147;expects,&#148; &#147;projects,&#148; &#147;anticipates,&#148; &#147;intends,&#148; &#147;estimates,&#148; &#147;plans,&#148; &#147;potential,&#148; &#147;possible,&#148; &#147;may increase,&#148; &#147;may fluctuate,&#148; &#147;will likely
result,&#148; and similar expressions, or future or conditional verbs such as &#147;will,&#148; &#147;should,&#148; &#147;would&#148; and &#147;could,&#148; are generally forward-looking in nature and not historical facts. Forward-looking statements
include information about the Company&#146;s future financial performance, business strategy, projected plans and objectives and are based on the current beliefs and expectations of management. The Company&#146;s management believes these
forward-looking statements are reasonable, but they are all inherently subject to significant business, economic and competitive risks and uncertainties, many of which are beyond the Company&#146;s control. In addition, these forward-looking
statements are subject to assumptions with respect to future business strategies and decisions that are subject to change. Actual results may differ from those indicated or implied in the forward-looking statements, and such differences may be
material. Prospective investors are cautioned that any forward-looking statements are not guarantees of future performance and involve risks and uncertainties and, accordingly, investors should not place undue reliance on these forward-looking
statements, which speak only as of the date they are made. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Important factors currently known to management that could cause our actual results to differ
materially from those in forward-looking statements include the following: (i)&nbsp;the continued impact of the <FONT STYLE="white-space:nowrap">COVID-19</FONT> pandemic (and variants thereof) and related governmental response measures on the U.S.
economy and the economies of the markets in which we operate; (ii)&nbsp;the Company&#146;s ability to efficiently integrate acquisitions into its operations, retain the customers of these businesses, grow the acquired operations and realize the cost
savings expected from an acquisition to the extent and in the timeframe anticipated by management; (iii)&nbsp;the effect of economic conditions and interest rates on a national, regional or international basis; (iv)&nbsp;timing and success of the
implementation of changes in operations to achieve enhanced earnings or effect cost savings; (v)&nbsp;competitive pressures in the consumer finance, commercial finance, insurance, financial services, asset management, retail banking, mortgage
lending and auto lending industries; (vi)&nbsp;the financial resources of, and products available from, competitors; (vii)&nbsp;changes in laws and regulations as well as changes in accounting standards; (viii)&nbsp;changes in policy by regulatory
agencies; (ix)&nbsp;changes in the securities and foreign exchange markets; (x)&nbsp;the Company&#146;s potential growth, including its entrance or expansion into new markets, and the need for sufficient capital to support that growth;
(xi)&nbsp;changes in the quality or composition of the Company&#146;s loan or investment portfolios, including adverse developments in borrower industries or in the repayment ability of individual borrowers; (xii)&nbsp;an insufficient allowance for
credit losses as a result of inaccurate assumptions; (xiii)&nbsp;general economic, market or business conditions, including the impact of inflation; (xiv)&nbsp;changes in demand for loan products and financial services; (xv)&nbsp;concentration of
credit exposure; (xvi)&nbsp;changes or the lack of changes in interest rates, yield curves and interest rate spread relationships; (xvii)&nbsp;increased cybersecurity risk, including potential network breaches, business disruptions or financial
losses; (xviii)&nbsp;civil unrest, natural disasters, epidemics and other catastrophic events in the Company&#146;s geographic area; (xix)&nbsp;the impact, extent and timing of technological changes; and (xx)&nbsp;other circumstances, many of which
are beyond management&#146;s control. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Management believes that the assumptions underlying the Company&#146;s forward-looking statements are
reasonable, but any of the assumptions could prove to be inaccurate. Investors are urged to carefully consider the risks described in the Company&#146;s filings with the SEC from time to time, including its most recent Annual Report on Form <FONT
STYLE="white-space:nowrap">10-K</FONT> and subsequent Quarterly Reports on Form <FONT STYLE="white-space:nowrap">10-Q,</FONT> which are available at the SEC&#146;s website at www.sec.gov. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company undertakes no obligation, and specifically disclaims any obligation, to update or revise forward-looking statements, whether as a result of new
information or to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results over time, except as required by federal securities laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">### </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>rnst-20211117.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20210621.2 -->
<!-- Creation date: 11/24/2021 1:50:14 AM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2020-01-31"
  xmlns:rnst="http://www.renasantbank.com/20211117"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"

  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://www.renasantbank.com/20211117"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2020-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />

    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rnst-20211117_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="rnst-20211117_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.renasantbank.com//20211117/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>rnst-20211117_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20210621.2 -->
<!-- Creation date: 11/24/2021 1:50:14 AM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>rnst-20211117_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20210621.2 -->
<!-- Creation date: 11/24/2021 1:50:14 AM Eastern Time -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.renasantbank.com//20211117/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="rnst-20211117.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.renasantbank.com//20211117/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="24.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g242176dso087a.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g242176dso087a.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M9=@YEW#[7;?\_$7_ 'V*.678.9=P^UVW_/Q%_P!]BCEEV#F7</M=M_S\1?\
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M9=@YEW#[7;?\_$7_ 'V*.678.9=P^UVW_/Q%_P!]BCEEV#F7</M=M_S\1?\
M?8HY9=@YEW#[7;?\_$7_ 'V*.678.9=P^UVW_/Q%_P!]BCEEV#F7</M=M_S\
M1?\ ?8HY9=@YEW#[7;?\_$7_ 'V*.678.9=P^UVW_/Q%_P!]BCEEV#F7</M=
MM_S\1?\ ?8HY9=@YEW#[7;?\_$7_ 'V*.678.9=P^UVW_/Q%_P!]BCEEV#F7
M</M=M_S\1?\ ?8HY9=@YEW#[7;?\_$7_ 'V*.678.9=P^UVW_/Q%_P!]BCEE
MV#F7</M=M_S\1?\ ?8HY9=@YEW#[7;?\_$7_ 'V*.678.9=P^UVW_/Q%_P!]
MBCEEV#F7</M=M_S\1?\ ?8HY9=@YEW#[7;?\_$7_ 'V*.678.9=P^UVW_/Q%
M_P!]BCEEV#F7</M=M_S\1?\ ?8HY9=@YEW#[7;?\_$7_ 'V*.678.9=P^UVW
M_/Q%_P!]BCEEV#F7</M=M_S\1?\ ?8HY9=@YEW#[7;?\_$7_ 'V*.678.9=P
M^UVW_/Q%_P!]BCEEV#F7</M=M_S\1?\ ?8HY9=@YEW#[7;?\_$7_ 'V*.678
M.9=Q\<L<H)CD5\==ISBDTUN":>P^D,CFMX;F/RYX4E3.=KJ&'Y&FI.+NF)I/
M1E;^Q],_Z!UK_P!^5_PJ_:U/YG]Y/)'L']CZ9_T#K7_ORO\ A1[6I_,_O#DC
MV#^Q],_Z!UK_ -^5_P */:U/YG]X<D>P?V/IG_0.M?\ ORO^%'M:G\S^\.2/
M8/['TS_H'6O_ 'Y7_"CVM3^9_>')'L']CZ9_T#K7_ORO^%'M:G\S^\.2/8/[
M'TS_ *!UK_WY7_"CVM3^9_>')'L']CZ9_P! ZU_[\K_A1[6I_,_O#DCV#^Q]
M,_Z!UK_WY7_"CVM3^9_>')'L']CZ9_T#K7_ORO\ A1[6I_,_O#DCV#^Q],_Z
M!UK_ -^5_P */:U/YG]X<D>P?V/IG_0.M?\ ORO^%'M:G\S^\.2/8/['TS_H
M'6O_ 'Y7_"CVM3^9_>')'L']CZ9_T#K7_ORO^%'M:G\S^\.2/8/['TS_ *!U
MK_WY7_"CVM3^9_>')'L']CZ9_P! ZU_[\K_A1[6I_,_O#DCV#^Q],_Z!UK_W
MY7_"CVM3^9_>')'L']CZ9_T#K7_ORO\ A1[6I_,_O#DCV#^Q],_Z!UK_ -^5
M_P */:U/YG]X<D>P?V/IG_0.M?\ ORO^%'M:G\S^\.2/8/['TS_H'6O_ 'Y7
M_"CVM3^9_>')'L']CZ9_T#K7_ORO^%'M:G\S^\.2/8/['TS_ *!UK_WY7_"C
MVM3^9_>')'L']CZ9_P! ZU_[\K_A1[6I_,_O#DCV#^Q],_Z!UK_WY7_"CVM3
M^9_>')'L']CZ9_T#K7_ORO\ A1[6I_,_O#DCV#^Q],_Z!UK_ -^5_P */:U/
MYG]X<D>P?V/IG_0.M?\ ORO^%'M:G\S^\.2/8/['TS_H'6O_ 'Y7_"CVM3^9
M_>')'L']CZ9_T#K7_ORO^%'M:G\S^\.2/8/['TS_ *!UK_WY7_"CVM3^9_>'
M)'L']CZ9_P! ZU_[\K_A1[6I_,_O#DCV#^Q],_Z!UK_WY7_"CVM3^9_>')'L
M']CZ9_T#K7_ORO\ A1[6I_,_O#DCV#^Q],_Z!UK_ -^5_P */:U/YG]X<D>P
M?V/IG_0.M?\ ORO^%'M:G\S^\.2/8/['TS_H'6O_ 'Y7_"CVM3^9_>')'L']
MCZ9_T#K7_ORO^%'M:G\S^\.2/8/['TS_ *!UK_WY7_"CVM3^9_>')'L']CZ9
M_P! ZU_[\K_A1[6I_,_O#DCV#^Q],_Z!UK_WY7_"CVM3^9_>')'L']CZ9_T#
MK7_ORO\ A1[6I_,_O#DCV#^Q],_Z!UK_ -^5_P */:U/YG]X<D>P?V/IG_0.
MM?\ ORO^%'M:G\S^\.2/8/['TS_H'6O_ 'Y7_"CVM3^9_>')'L']CZ9_T#K7
M_ORO^%'M:G\S^\.2/8/['TS_ *!UK_WY7_"CVM3^9_>')'L']CZ9_P! ZU_[
M\K_A1[6I_,_O#DCV#^Q],_Z!UK_WY7_"CVM3^9_>')'L']CZ9_T#K7_ORO\
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M](\4*@2-](@LQ<78V_O$4N5\P'T7 )'ID]J ''Q?]GO;RV>%KN=]0^R6,,
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M.<]_:@#:T;5CJL%P9+62TN+:8P30NP;:P ;@C@@A@?QH TJ "@ H * "@ H
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
% 4 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g242176dsp087.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g242176dsp087.jpg
M_]C_X  02D9)1@ !  $ 8 !@  #__@ ?3$5!1"!496-H;F]L;V=I97,@26YC
M+B!6,2XP,0#_VP"$  @&!@<&!0@'!P<*"0@*#18.#0P,#1L3%! 6(!PB(1\<
M'QXC*#,K(R8P)AX?+#TM,#4V.3HY(BL_0SXX0S,X.3<!"0H*#0L-&@X.&C<D
M'R0W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W-S<W
M-S<W-S<W-__$ :(   $% 0$! 0$!           ! @,$!08'" D*"P$  P$!
M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * *6G7$EQ]J\P@^7
M.Z+QC@=*TG%1M;L3%WN<1=^(=5;6-;AAU._1[2X,5O;V^E^?&W[M6 +A>I)/
M\0K,HNQ>+M8M/[2EO](:2*Q\EK@I(JB$-$C.%'5R"2?IWH EO_B!!:ZE?6MK
MITUVE@^RX=6PV[ )"+CYB 1Z>V: !_&-Q:7?V?[#)>R7.HM:6Z(1&5 B#C.?
MQH ?>^.&T^)X[K2FAO8IEBD1YP(DW*65C+C 4@$#CKQ0!K:9KBZQX=DU.",1
M$*^!YBR %<\AE)!'% '.PW?B*V\%Q>)7UP7#+9K=R6TMM&J,-NXJ&7!'< \T
M ;K^)XX],U&]^S-MLITA*[N6W!#GV^_^E %2\\7S6MSJ(31Y9;33IUBN)_-4
M8!53E5/+8W#(X_I0!7B\5:I!%JMS-I+W-A874R23K*JL(T/\*?Q8'7)'0]:
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MCF=Y)'=LLS-]X],?D,4 9D/@B!+"'3KC6M4NM.B54%K+)&$*KT4[4#$<=,T
M37_@ZQO[BY=[N]C@N9$FEMHY (VD7;ANF?X5XSCCI0!<F\/6<]MJ=NS2A-1D
M$DV&&0=JKQQQPHH HR^"[.5KM/[1U!+6]E:6YMDE41RENH/R[@.V 10 R?P1
M8RO.%O[^&"6X%UY$<BA$E#!MPRN>H'!)'M0!NV6GPV#7+1%R;F8S/N.?F( X
M]N!0!E3^%RVIWM]:ZYJ5BUXZO+' 8MA8($!^:-CT4=Z &0^%&MKR>XMM>U2
M7$WG2Q*82C/@ GF,GG:.] &MI^FP:;]J\@N?M,[W#[CG#-UQ[<4 7* "@ H
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MHK:8NGOIEJ+)&WB+RP%4^OL?>@"Y8VMI96B6]C#%%;I]U(@ H_*@"Q0 4 %
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M%TL7+FY*B/6*\,](* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MDU[]#K^O4O,X>W74/B/\0X=6M;!H+.*2,NYZ*BGN>[''2O1DX8'#.G)W;O\
MB<BYL36YTM#WNOF#V0H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * ,W1_\ E_\ ^ON2
MM:OV?0B'4=9ZWIU_J=[IUM<A[NR($\>""N1D=>H^E9%D]I?VU];?:+>4-%O9
M-Q&.58J1S[@T 6-P'&1TS0 ;AP 1ZT 9-_XGTK3KM[6::5YXP#(D$#R^6#T+
M; =OXT 7[2^M+^TCNK2YCFMY!E)$8$$?6@ M;ZVO8'F@D#1I(\3$C&&5BK#G
MW!H G+*HR6 'J30 %E7JP'U-  650"6 STR: %H K0WUO<7MS:129GMMOFK@
M_+N&1^E $&I:WIVCR6D=_=+"]W*(80<G<Q^G;WZ4 377V>TWZC+&[-#&5RBL
M[;<@D!1DGH.@[4 9<7C'1I))D>2XMS#"9W-S:RP@("!GYE&>30!8L_$VD7J7
M#)>"+[,H:9;A6A:-3T8AP" ?7I0 T^*='_LJ'4TO!+:SR&.%HD9S*P)!"JH)
M;[IZ#MF@!/\ A*='_LTWWVEO*$OD[/*?S?,_N>7C=NQSC'3F@"]IVI6FJV@N
M;.7S(]Q4Y4JRL#@@@\@CT- %N@ H * "@ H * "@#QKXP_\ (UZ#_N?^SU]!
ME7\&?]=#RL=_$B>O75C:7J;+NUAG3TD0,/UKP8SE#6+L>HXJ6Z(;/1]-T]MU
MGI]M;MZQ1*I_054JLY_%)L481CLBX0""",@]JS*&0V\%N"(88X@>NQ0,_E3<
MF]V))+8DI#(FMH'E$K01M(.CE02/QJN9I6N*RW)2 1@C(J1F//X4\/W,IEFT
M6R>0\EC N3^E;K$UHJRD_O,G1IO5Q1H6EA::?%Y5G:Q6\?\ =B0*/TK*4Y3=
MY.YHHJ*LD22P0SJ%FB210<@.H-)-K8&D]SR;XX*J6FA*BA5#2@ # '"5[N3Z
MRG\OU/-S#:/S/0] MK>[\(:5%<P1S1FTBRLBAA]T=C7DUI.-:3B[:L[J:3II
M/L6K;0=(LY?-MM+M(9!T9(5!'XXJ)5JDE:4G]Y2IPCLC0K(L@NK*UOH?*N[:
M*>/^[(@8?K51G*#O%V$XJ2LT9:^#_#:/O&AV(;_K@O\ A6WUJOMSO[S/V-/^
M5&O#!#;1+%!$D4:]%10 /P%8-N3NS1)+1$E(84 % !0 4 % !0 4 % !0 4
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M@ H * ,_4-"TK59XI[^PAN)8AA&D7)7G/%:PK5*::@[$2IPD[R1H5D6% !0
M4 % !0 4 % !0 4 4-2T73-8$8U*QANA%G8)5SMSUQ^0K6G6J4O@=B)4XS^)
M7+D,,=M!'#"@2*-0JJO10.@K-MMW925E9#Z0PH * "@ H * "@ H * "@ H
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MN_3% &GH.K1:]HEKJL,+Q1W*[E2088#)'/OQ0!HT % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M)4\<L3_6@#3H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>g242176dsp95.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g242176dsp95.jpg
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M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M0 4 % !0 @96)"L"1P<'I0 M !0 4 )N7=MR-V,X[T +0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M:YT&#SFAN^JHC12 *WH0QQ[YSWH ZSXG>"M>N?$>E>-/"*I)K&G@(]NY \U
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M#<QQQT&"#0!T?AJRNK#3'@NPN_SG<,!AG!.=S?,WS9)[GMTZ  V* "@ H *
M"@ H XB]/B%?B#"UN;PZ=Y\8=0&\LQ>4=W7Y1\^">_'% %*P771H^9GU0WQO
MK+<&\WB/[4GF=1C&S.<<;<YXH U=7NM8NKRX%I::A;PPW-A&#C'F?Z6/-*[2
M25\O[QZ;3ST( !3QXPB\4VBJTDVE37US(S-QY""*541O5&;RV!Z@Y'3% %GP
M4/$$<K1ZPU[-F!6FENL+B?/S*J@8V\G!4D8 [YH Z;5?/_L>^^R[OM'D/Y6S
M[V[:<8]\T >?V<?C"71)[?;>R3?;XO*,T[09B,0WC?M+J ^>2#VQQT )K^Z\
M60^'X8K>VU.>_O=*\E) JJ;>ZW8W2<X&-WWAD$(?49 -*Y;Q(/%&JPQ_:WLI
M;63[-*B*HMV"+MP"=LA+%B"2I[$8P: ,I6\2RZ18QSQZE 8KR1))%:1FEC$8
MVOA1O4%CC!SR#R1B@#I["[NX=4OK:6.^:-UC-J[PLRC$0SDG@'.<Y(YH C\%
MOK1T^YCUI9S-'*%6>8;?.&T$L$_@^;(QDCT.* +/B\7Y\.2#33<"X\^WW&VS
MY@C\Y/,QCG[F[I0!AQ7OB#38;:[>RU*]LH[V54B&#<& Q_(74XS\^<=\%2><
MT 9(3QG;7V@B9[^1DL[ 70B.5>3S'^T9.-N=NS.>WW>: .BTVX\1_P#"97-Q
M=V\PT6Z9X(4./W/E@;7(ZC>1)R>QC]Z -7PG]L_X0W0_[0\[[=]@@^T>?GS/
M,\M=V[/.[.<YYS0!1UJQUB]\36*V<TL5@D!:8K.\8+;U_NCDXSP: ,^R_P"$
MBM/%5W=W27;:7MN6CC20R^:0PV#85'E\9V[20V><<"@"E"OC4^'[VQN6FAU.
M2ZM)X;E,2+&DDR><@]0@#\''R$=>: &74GCFYTT-;P26M\;R<2J'R!$(P,QD
MC')!V;N 2,]"* -BTLM6N?$Z7"S7<>DQ0PE4GGD5B=K9RO1CG;G)H R;>X\5
MS^'9+1K34(]0LM-,+S2,%%Q<[P-R$9)X4G=CHX[Y% $OV'Q)/X<BCGGU"&_C
MU:-&2*<MMMS,@;$F%,B^7N;<0",D=10!WL:>5$D89FV@#+')./4^M &%K-QJ
MCZ[HUII]O<");@RW4V (C%Y,HVDYSG>8^,?R- ''0CQH+.^\O^U/M/\ 84WV
MCS]NP7^/D\C'/7=T^7&WOF@#<N&\4?8M4MU20W=S)##;R0DJL2%!YCJ6! (^
M;KQNQ0!3O;CQI):Z7/:V\HNK2RNEO+=L!;F56B5,-V+#S'0_@<<T 17B>-5N
M+>2TDG>V==/CGB88=#YBF5U/?Y0RL/\ :![<@%WRM;DGU]4N=0AN'2X6U8([
MJF3\C*&PAP.0,T 9&HR>+Y/#5GY"7\%[']I7<AD<N0!Y3, ,@$]F_$GK0!KW
MMWXD_M6*S@L;\"YN;*83@KY<,0*F='(/!PK# SG<,>P!4@A\:1W.LLCSQE[6
MX-DK2><KR^:=A(95\LA<87)5@V<\4 ;_ (0&I1P74-\;R2!&7R)[T_O9./FR
M,#'(^G/'% '24 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % '&
M:;KVJ:C*[2*;1KXW,6GL=KQ1F-F"LZ@AB2%W=?4<=2 -CU;581-&-0:XMY;F
MUM[>[ECC5SN.V1U50 5SPI(ZD]1C(!I6>H75UI_B""65S)I]Q)!'. %9QY22
M \<9&_;Q_=H Q#J5]9>&;O69I;Q?L^C/-Y$LZ_Z2WEJYD5ANVE=K#_@7(Z4
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MR1QPWD$CR!V14D!+!&"N0.^TD ^A.#0 ?VC8B18_ML&]I#"J^:,EP"Q4<_>
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M*<XZH#T[T 59?!=[?PZF=1O+*26ZMX+>)(K=HXXUB;<#\KAMVXD@AAMXQGN
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M<$GYB6;)]-H[9(!N4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MXADEB5U1A'M&W)QN8L0%4=22>!0!FCQQI_\ ;MAI!C\NZO+:&Y027,(^61F
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MECV&$(SZX'>@#(B\>Z?+HDVJ)9W?E10POY950[2R,5$ &?\ 6!@ 0>/F'/7
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M8DC:X@^TP>8 /.BR 649S@;EZX/S"@#3H * "@ H * "@ H * "@ H * "@
MH * ,F[\-Z9>ZM%JD\<K7<081G[1(%0E=I8)G:&VDC.,\T 5K7P3X<L(GCL=
M*@LTD1(Y!;KY?F!6#*6Q]X@CJ>>3ZT 7]/T33M*%\MC;+ M].US.%SAI&4!F
MQVR%'3OSWH :F@Z<FDV.EBWS9V(C6&,L3M$8 4'/7&!UZT 4;CP1X<O;>&WO
M=*@NXK>$P0K<CS1$A.<)NSM/09'. /2@"2;PCHEQ*)9[/S91=Q7H=W8L)HE5
M4<'/]U%!]><]30!%+X*T5[;6((8IK9=6BECN/*G;:/,!#LJ$E%8YR2%Y/7-
M%N;PWI5QK2:M/;M+=HK*OF2NT:[EVL1&3M!*\$@9QQ0! ?!VB/I4VF26\LEI
M*5.R2YE<IM.5V$ME-IZ;2,=J -'3-+M-(M/LUFCA"Q=FDD:1W8]69F)+'W)H
M 74=.M]4LWM;GS1&W>*9HF'T92"/SH RHO!FC6UY975HES:/9PQ6\:V]W+&A
MCC8LBLJL X!9OO9SDYH EL_"6B:?J<VH6UH4FE=Y"IE<QJ[_ 'V6,G:K-W(
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MLTM&L%>W2WFMMCLS;DE96DW$G+,S(I+')SSGDT :UM;QVEK#;0KMBA0(@SG
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MP* +VC>';ZTO]-N-0NHIO[+L6LH#&"#*&*;G<8X.(DX'')]L '34 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
@0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>g242176g1123070735341.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g242176g1123070735341.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "B =(# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#F?'FO7?AOPI<:E8B,SQLH
MD&1R<5Y+_P +E\3_ //.Q_[]FO1_BY_R3V]_WT_]"KYU/6O1PE*$H7DC@Q52
M<9VBST+_ (7+XG_YYV/_ '[-'_"Y?$__ #SL?^_9KSVKD^EWEMIT%_/"8K>=
MBL)?@OCJ0.N/>NGV%+L<_MJO<[;_ (7+XG_YYV/_ '[-'_"Y?$__ #SL?^_9
MKSVBCV%+^47MJG<]"_X7+XG_ .>=C_W[-(WQF\3A2?*L>!_SS->?4U_]6WT-
M/V%+^4/;5.Y]::!?2ZEH%C>SA1+/"KOM'&36C6)X0_Y%#2?^O9/Y5MUXTU:3
M/6C\*"BBBI*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** .&^+G_)/;W_?3_P!"KYU/6OHKXN?\D]O?]]/_ $*O
MG4]:]7!?P_F>;B_XGR-/P_9QWNMP1S#="F977U"C./SQ6CXON);I],FD)*M;
ML0.P.X\#\*J>%G$>OP*_"SH\0)]2/_K5IW]HU_H4D04FYL6,JKW*=''X=:J<
MK5E?8X)3Y:D8O9I_?H<G11172:A37_U;?0TZFO\ ZMOH: /JKPA_R*&D_P#7
MLG\JVZQ/"'_(H:3_ ->R?RK;KP9_$SVH?"@HHHJ2@HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#AOBY_R3V]_W
MT_\ 0J^=6. Q] 37T5\7/^2>WO\ OI_Z%7SJPR&'J,5ZN"_A_,\W%_Q/D=-X
MBT\:7I7AVXMN)/L^Z1AVESN'Z$5IB\\T6^M6G E/[Q?[DG\2GV/7\:=((M5T
M6Q@E8+'=6BA)#_!*A(!_I^-<WIE_+H=_/:7T3&W<^7=0]QCHR^XZCUJ6O:Q:
MZH\^M%5DTM&G_P -]X[7M+2UD6^LU/V"Y)VC_GD_=#_3VK&KNBJ6H:&8"[TV
M[3.5Z2+V8>C"N6U?29-+G4J_G6DW,$X'##T/HP[BM:%;F7++<*-7VBM+22W1
MG4U_]6WT-.IK_P"K;Z&N@V/JKPA_R*&E?]>R?RK(\0^+=;\-V4E_=^'EELXV
MPTD-T"5&>"1MK7\(?\BAI/\ U[)_*J?Q#&?A_K0_Z=_ZBO%5O:6:ZGKN_L[I
M]#C8/C6+N98+7PW<S3-]U$E!)_2IKKXO7FG -?\ A*]MXS_$[X'YXK@OA3_R
M4&Q_ZY2?R%?1-U:6]]:O;74*30N,,CKD&MZT:5*?+R_B8474J1OS''>'?BGX
M?U^Y2T9I+*Z<X5+@8#'T#5W%?+_CGP\OACQ7<V$!/V<XF@.>54]OP->[?#O6
M)];\$V%U<L6F4&)V/5BIQFIKT8QBIPV9=&M*4G">Z.I;(4E1EL<#/6N(\1>-
M=9\+V@O-0\.*]J6VF2"[#;3VS\M=Q7%?%=0WP\U'V*'_ ,>%8TK.:36YK5NH
MMI['-P_&U+B410>'+J60]$24$G\,5.WQ@N$'S>$=2'US_P#$UP7PI_Y*#9?]
M<Y/Y5]'=1S717C2I2Y>6_P S"BZE2-^;\#S_ ,(?$J3Q9XB.FII+6L:1-([R
M298$=!C KT&L"+PY'!XS?7(4BC62T\EU5<%FW$Y/X5OUS5'%OW%8Z*:DE[QR
M7CSQ=+X/LK&[2W6>.6X$<JDX.W&3CWK?TC5[+7--AO["82P2C((Z@^A]#7G7
MQQ/_ !3^F#UNC_Z#7G'@CQK=>$-2W#=+ITQ_TB#/_CR^]=$,/[2CS1W.>5?D
MJ\LMCZ:HJIINI6FK:?#?6,RS6\R[D=3_ )YJW7&U8ZT[F!K.JZYIPGFM-$CO
M+:)=P*W.UV'?Y<?UKCM(^+D^O:G%IVG>')9+J3. UP % ZDG'05Z;*-T+CU4
M_P J\'^%" ?$N]&/N).!_P!]UU4HPE"3:V.:K*49Q2>Y[C827DMJKWUO';SY
M.4CDW@?C@5:HHKE9TC)9$AB>61@J(I9B>P%<1X$\??\ "6ZGJMI*B1F"0O;!
M>K19QS[YH^*VO?V-X/E@B?%Q?'R$QUP?O'\J\4\&ZTWASQ98WI)6-7\J8'CY
M&X.?YUV4</STG+KT.6K7Y*BC]Y]2T4U&#HKJ<JPR#ZBG5QG4%<)XF^)VFZ)?
M_P!F6-O)J>I;MIAAZ*WH3Z^U;_C#4I='\(ZI?PG$L4!*'T)X_K7D'P8CMI_%
MMW+=$/=K;[XB_)))^8_6NFC23@ZDMD85:C4E"/4ZV3Q7\1O*-POA&(18SL+Y
M;'TS4W@WXFW/B+Q NB7ND&UN"K,6#_=*CD$$9KTBN4N/#FSXC6&O6UN%5K:2
M*Y=>,G'RD^_:DITY)IQL#A.+34KG5T445SFY6U"]BTW3KB]G($4$9D;GT%<I
M\._&K^,-/NFN42.ZMY3E$Z&,_=-8WQFUTV?A^#1X6/G7[_.!U\L=?S.*\X^&
MNN_V#XSM_,;;;W?^CR@]L]#^!KLIX?FHN77H<M2ORU5'H?2E%%%<9U%:_N#:
M:?<7"J&:*-G /? KE? ?CVV\7V;1RA(-3B_UL /##^\OJ*Z+7CC0-0/I;O\
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M^6/-992 6QS@5/\ \*8\*XX2[!['SCQ7HE%1]8J_S%^PI]CY.O[:Z\->))H
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MTG_P*;_"KO4O?F_$FU.UN7\#/;X.^$R.(KL?]O!J!O@MX7/1KT?]MS6O]O\
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M+RZM<-G?;R;&/MFN0D^$7A>:5YIUO999&W.[W))8^IJ[]O\ '?\ T!=)_P#
MIO\ "C[?X[_Z ND_^!3?X5<>>/PRM\R)<DMU^ :=\/-.T=&CTO4=5M(V.62.
MZ.TGUQ76QIY<:IN9MH W,<D_6N2^W^._^@+I/_@4W^%+]O\ '?\ T!=)_P#
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M@HHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
EHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>g242176g1123074951482.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g242176g1123074951482.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  / &4# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#T+4/&'B/4
M/$>I:3X1T:SNTTHJMW<WLYC1I",^6@ Z@=2>/TS9UWQM?:#X;TF:YT0GQ!JD
MBV]OI:SA@)F[&0<;1QD^_P"-5KOPKXITGQ'J>I^$=3TR.#57$MU:ZE"[+'*!
M@R1E#G)'8\?TL^(?!FI:_H>CM+K$<?B/2I5N(+]+?$;2#J"F?NGC/TZ=J *^
MF>,]=LO%=CX>\7:3:6<VI([6-U93&2)V3ED;<,@@8Y]QZU'8_$@Q6'BXZY:Q
M6E]X==M\2,<31D?NF&?[QX_$>M.T_P (>(]4\5:=K_C#4=.E;2P_V*STV)UC
M#L,%V+G). ..F?UI>-_A=+XJ\9Z?JUO=Q06,BI%J\#,P-S&CAU  !!/&.<8P
M* -!_&NK6G@[PUK%]IL$5WJ]_;V[VX9L1),QP?7=MP<>IQ47B_XF1>#O&^F:
M1?6@.F75N)9[Q2<V^7*!B.FW.,_7\*VO&7ARZ\06FCPV3P1_8M5MKU_-) ,<
M9)(7 //H.![U4UCP6=:\>)JMZMK-I#:1)I\]NY.]F9]V0,8QCOG(- ":5XY2
M[U[QA:W<<45AX?2&47",6,B/&SLQ^@7M7.V?Q%\6WPLM7'A[2K+P]>2A8)+_
M %)(9GC)_P!9R<=,G&"?3/4V/ _PMD\,-XLL+^\2]TG6(X[>#YV\X0JLBE7R
M, A7 &">G;I65J?PO\7:AX;A\*RZOH=SH]J,6EU<6CF[C4#Y5'\(X^7<.<?E
M0!T7Q$\9>(?"%@VL:;I5A>Z-'#&TD\EP0^]GV@!1U'*G/N:FN/&>L>&_!U[K
MGBO2;:":-U2UMK*<R&<M@*,D<')_(5+XT\(:AXC^&+^&K.:V2],5N@>9F$>8
MV0GD*3_"<<5I^+?"D/BWPM)HT]P]N_R/%<1C)BD7E6QW^GH: .8/CKQ5H-]I
M3>+] LK33=3G6V2:SN"[VTC#Y5D!&#WR1Z'\;&N?$Z#P[\2;?PUJ-LL>GSVR
M2&^!/[IV8J-_8+D 9[$BJTW@OQ?XEN]+A\7:QI<FF:;<I="/3X'62Z=/NF0M
MPO4Y"\<_B-#4? 1UCXA:AJ^I"UFT:]T3^S7@+-YN_P U7W8Q@ 8X.<@XXH T
M/"/BJ?Q)J'B*VEMHX5TK4GLHV1B?,5?XC[T5F_#/P->^!;76+6[O8[Q+J\,T
2$JLQ<I@ ;\@8;CMD>]% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>d242176d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="rnst-20211117.xsd" xlink:type="simple"/>
    <context id="duration_2021-11-17_to_2021-11-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000715072</identifier>
        </entity>
        <period>
            <startDate>2021-11-17</startDate>
            <endDate>2021-11-17</endDate>
        </period>
    </context>
    <dei:EntityRegistrantName
      contextRef="duration_2021-11-17_to_2021-11-17"
      id="Hidden_dei_EntityRegistrantName">RENASANT CORP</dei:EntityRegistrantName>
    <dei:AmendmentFlag contextRef="duration_2021-11-17_to_2021-11-17">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2021-11-17_to_2021-11-17"
      id="Hidden_dei_EntityCentralIndexKey">0000715072</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2021-11-17_to_2021-11-17">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2021-11-17_to_2021-11-17">2021-11-17</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2021-11-17_to_2021-11-17">MS</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2021-11-17_to_2021-11-17">001-13253</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2021-11-17_to_2021-11-17">64-0676974</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2021-11-17_to_2021-11-17">209 Troy Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2021-11-17_to_2021-11-17">Tupelo</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2021-11-17_to_2021-11-17">MS</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2021-11-17_to_2021-11-17">38804-4827</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2021-11-17_to_2021-11-17">(662)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2021-11-17_to_2021-11-17">680-1001</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2021-11-17_to_2021-11-17">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2021-11-17_to_2021-11-17">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2021-11-17_to_2021-11-17">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2021-11-17_to_2021-11-17">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2021-11-17_to_2021-11-17">Common stock, $5.00 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2021-11-17_to_2021-11-17">RNST</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2021-11-17_to_2021-11-17">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2021-11-17_to_2021-11-17">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139743427724104">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Nov. 17, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">RENASANT CORP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000715072<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov. 17,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">MS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-13253<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">64-0676974<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">209 Troy Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Tupelo<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MS<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">38804-4827<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(662)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">680-1001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common stock, $5.00 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">RNST<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>17
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
M@(-W4][$UG8O!   .A   !@   !X;"]W;W)K<VAE971S+W-H965T,2YX;6R5
MF&]OZC84QE_??0H+[<4FM4UL_O:*(E':;NC>4@9L5]JT%R8Q8#6),]N!\NUW
MG-"DV\()XP7$B?WD9Q^?QS;#@]*O9B>$)6]QE)B[UL[:]+/GF6 G8FYN5"H2
M>+)1.N86BGKKF50+'N:-XLACOM_S8BZ3UFB8WYOKT5!E-I*)F&MBLCCF^G@O
M(G6X:]'6^XV%W.ZLN^&-ABG?BJ6POZ9S#26O5 EE+!(C54*TV-RUQO3S/>NX
M!GF-WZ0XF _7Q'5EK=2K*TS#NY;OB$0D NLD./SLQ41$D5,"CK].HJWRG:[A
MQ^MW]:>\\]"9-3=BHJ)O,K2[N]:@14*QX5ED%^KPLSAUJ.OT A69_)L<BKH=
MOT6"S%@5GQH#02R3XI>_G0;BD@;LU(#EW,6+<LH';OEHJ-6!:%<;U-Q%WM6\
M-<#)Q$5E:34\E=#.CAY4D,$@6\*3D#PF5MHCF29%M&'4AIZ%E[BJ7G 2O"\$
MV1G!F=K?$-J_(LQG])_-/6 K 5D)R'*]]AF]B=H+3?X8KXW5$,(_$<EV*=G.
M)3MG)$_=7(BM=*+0^1F/15U7<9W%XVR\',]69/*RF"-<G9*K@^J-(1!A'HRG
MB&_K>/#V&QX9@7!T2X[N)>,S 1+-(Y@.H7@C7\2QC@A7\N'3IUV_SQ"L7HG5
M0\7*J;HZIK71PIL/KK\@$/T2HG\9Q%QHJ5S*A 02KY8'5WI/E.\^?6I(E4')
M-K@D;M,D4#I5.D]@LK1 1R8J@V!"3%58BXH+/R\1NMN2[O82NB<9"3++XK70
M=2"XAN_3:]IFW3;"0_W*^OQ+B%;\C4Q#B*G<R* 8M/-\#9*]SK7?Z_=N^QV,
M\(,YTTL(QV&HA3%7[Q?D*]0C+TEM*!LDF7]+5EH=86)H6#0PS,JB*?M?F!-7
M4IJLU*%^!<'E5ED*NP6,K')Z>I'5EV1%-@#:7*N]3(+Z$<0UT6R@E=E3W*W_
MC397QH+;_B[3LUG:H-@>#/S.=6? ^AA@M0I0W+SS*(YAJW>>!Q?XH==C/V(H
ME?-3W+N_J@"&9KY3">8=#2*]@7]-P4$PHFH9H+A[?]/26I' T,1QEIQ\P]12
MX4)-BS:MW)_B+KU4D0RDE<F6/,,LUY)'M3RX2B-/Y?<4-^NY%OGP"$BS8MV&
M[0WLY5XVFS/QP_6:R%AE_ QWZ?^038W)@*P)L$&V$;#R?8:;]%($F7;I1]F:
MK*2-:M.O0<3U$-8R.$($KU?D^^Z-[Y.4:[+G429("ATU.ZY1X ^;] ;+UCQT
M$V]YC->J=MHU""QFRQ5&4CD^P]VY'+K'MV#'DZTXN[EO$(*]_</X%XRILGIV
MD=4_QD)OW2C]! IVYZ9@RI/:;76#X-F9YGTX";I3]3-W;S0D$AL0\F_ZX-BZ
M.*@6!:O2_'"X5A:.FOGE#@[W0KL*\'RCE'TON/-F^7?!Z&]02P,$%     @
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M-^2!8ECFS_A[QA?_&\[Q$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @
M@(-W4P=!36*!    L0   !               ( !     &1O8U!R;W!S+V%P
M<"YX;6Q02P$"% ,4    " " @W=3W=K*L>T    K @  $0
M@ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " " @W=3F5R<(Q &
M  "<)P  $P              @ '+ 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+
M 0(4 Q0    ( ("#=U/>Q-9V+P0  #H0   8              " @0P(  !X
M;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " " @W=3GZ ;\+$"
M  #B#   #0              @ %Q#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0
M   ( ("#=U.7BKL<P    !,"   +              "  4T/  !?<F5L<R\N
M<F5L<U!+ 0(4 Q0    ( ("#=U,<.&7J/P$  #P"   /              "
M 380  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " " @W=3)!Z;HJT   #X
M 0  &@              @ &B$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E
M;'-02P$"% ,4    " " @W=399!YDAD!  #/ P  $P              @ &'
L$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  #1$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d242176d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.renasantbank.com//20211117/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d242176d8k.htm">d242176d8k.htm</File>
    <File>d242176dex11.htm</File>
    <File>d242176dex42.htm</File>
    <File>d242176dex51.htm</File>
    <File>d242176dex52.htm</File>
    <File>d242176dex991.htm</File>
    <File>rnst-20211117.xsd</File>
    <File>rnst-20211117_lab.xml</File>
    <File>rnst-20211117_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>23
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d242176d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "d242176d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "rnst-20211117_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "rnst-20211117_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "rnst-20211117.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 3,
    "total": 3
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "rnst",
   "nsuri": "http://www.renasantbank.com/20211117",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d242176d8k.htm",
      "contextRef": "duration_2021-11-17_to_2021-11-17",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.renasantbank.com//20211117/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d242176d8k.htm",
      "contextRef": "duration_2021-11-17_to_2021-11-17",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.renasantbank.com//20211117/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.renasantbank.com//20211117/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.renasantbank.com//20211117/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.renasantbank.com//20211117/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.renasantbank.com//20211117/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.renasantbank.com//20211117/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.renasantbank.com//20211117/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.renasantbank.com//20211117/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.renasantbank.com//20211117/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.renasantbank.com//20211117/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.renasantbank.com//20211117/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.renasantbank.com//20211117/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.renasantbank.com//20211117/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.renasantbank.com//20211117/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.renasantbank.com//20211117/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.renasantbank.com//20211117/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.renasantbank.com//20211117/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.renasantbank.com//20211117/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.renasantbank.com//20211117/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.renasantbank.com//20211117/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.renasantbank.com//20211117/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.renasantbank.com//20211117/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>24
<FILENAME>0001193125-21-338512-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-21-338512-xbrl.zip
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MH-MOVO$#2Z) ^NR[%OVS=?K/[]K[K9.WS7C10CNK%^H\>B%GVEV8A,UO@ T
M-?5$_BZ.VX?YYP$?RV!ZW)-CD;!K,6'=:,S#$WHVT7#WH\ _J4#/3]=7O<L+
M=ML[ZUW>+@:G]4S@W%Z>_]2]ZEU=WK*SZPMV^<OYO\ZN?[@$L?_IT]7M[=7-
M]1?!V'D*&'_FR0CLUC0*:^RB<=Y@G=;>[M$,7#.+KJ+,,D&LXJA*RMQ_%&4V
M6C"L3)PGFDL[[>_G=[\FEQ:;L4*B"F$:'<] 51]NNI_8VR3F82Z(1C(5=?C&
M$Z \)XK'H$P661$7D9>A$>&86NMK:C+CRBKZ;1-!.7VEF*]",4_"XR"%P.3L
ML>[EYYMN[^5ESN=,)1D8SRR-V*WPD.;TB;5WV$V7M?>V_3<O#V4T8.E((("9
MDJF$]R\?O!$/AX*=>2F#Q^VCG=W%<#X;>E>R^F>RB"ZUH;0ISS/M8;[; J_T
MV(<)QO#ZR.?3J>!@EFZ=7D?W8MP7RJ#PH,;P[7DQ\=+XQ,TCUI2((Y6R;?L9
MMA$ =E,F[F&D>2SF*/!5HCV)1.OL/@4NR_J/8;2D+A_JVE$\7N7/EQWPF^Y9
MCTPQTF/LBPBU]12;V[Y\X"!@D(\UO5K@&4]8$@L/_2R?R9#)-&$@DH!<U2NY
MKDFN7W(P&,[B_4 P3P0!VEL4\6UMT>>8^[[];-8R>_6B(.!Q(H[M'\MIQ"$H
M-!CU:;1;K>_-V1VW#)C'+>M'(F!*_\<ONZ<[N]]C9"'U9Y[>"Y5*CP?F=/6&
M*T>:>3H;S&-AKGYE=D+XEX%=V2$Q'XIZ7PE^AZ%>Z8MC?A\!A:Q]<&U"77E=
MYE 3*Y'3,1$2F]D+T 1 Z J:6>Y=HGNUX+D*O4B!/B$=>YN"QCF/LC!5T_/(
M_R)-C!(/PR2IB%5TC\NB*OXDDP3_%\=RH9F^+B58LI\;_U6.\='NC#[G#S(0
M\ RLD$<$'^&_.YV]G84G]F<^N!Y_N#*A.X].ZI&GN+];;^T?[!\=[*YQC%^#
MX0^?B-\?J_J?Q+7?)A'!(L4B<#T4^PT\C\27Y"%M9)>TOP)P8(I(5YR]T>KU
M9=CB9=%T'HW'*&>_ :R@Y&.::?_""+EJ=!NW#78YCH-H*M2+8Z4L4]EUU"B0
M0](/_H6&Y!>$#I[$U5BA'<Y\7XDD,?_Y",9^>V/-T&D=L9Z*INPV54*DL^JA
MMOB^LP3#.?QYHWK1)-P8@EX6BR!Z[,(DDF_49S"S)-V5/Z/1MB:(GR.8-/@_
M&3_&JCS=.3QL[=9W#SL'3QFS>1J^-AM$-SA6</PRY@$3#\++4GF/WC&PF$C>
M;,/>&6Y^2=CPV7BJ"#;\\[O#3OO@) &!&HAX%(6"A22I:ZA)@PS=1<;!Z &4
M@<6S&-M(_&<P[E'XW=[?[[R9IZQ'&XX?(Q#]GW$WC[45#UMU<&<K0H2O-PE?
M[R9A%6UOG9Z/A'=',6\>@X "AD-CM!\]L#[(SPF3.B#^ 03::O*AFR(=41O(
M  E=)D#UJ0A]X6/@/Y'C+$AY**(L":8L :I)!E-:P;P0]>&\M (UL7@G%);!
M/(KQ<&J?#:( @,3W4+A*-,Z2XX6TM/_HT,]3A7;:Q17^<<L)\LP'DV:"3>MY
M3K/.D%X @T$+[3X]9._[DTH_=)$X^%G)%+"*)G$6&H,G^6(MV8^BH,\!HRG0
M'\(,GN7NR;S$6&7LSMJFK(QT]L4:82;Q8^O4G <<@'L@+';NO+H9T-%N9\\0
M\<PM$UXN;;</V/F'+NOLM!HP<+7Q^$K93T_9MR#+/<!)./P$@A"D8? 7)NOB
M,&!J?1KS-+U2*[1W>;W=L8JA(/_2S:HE_I6S=79;#3WC&\=V>.639^:3STJ@
M],<414HL016O;@:#S4W#/Q&_K"1>.+6ZYQR;98I5>F,-'O/KG>W^FZ?E,CWG
M*Y]].WQVE2294*_<]L+<MB/JN]O>TW*;F7-M;GMR5] Q1[7/)11X;?'"O"V4
M#=81@^TN]KM>[]S_O'?NC[F"6R.(LF"W%;SSHB'_'A8WZ7PR;\2\@"?)<]W'
M//807_C6IJ<X,N^+7];<3L?P:#MYMONS/RB^KDU"&A&X,-KMQ;$7A0QD 4!4
M**JROORS9189W3QM=_HD<S:.OZ,1&>'*D7=78__8 _IC,5?LG@>98#'6?XVX
MFJL5_,83818=EY$RFLDW+]6\ONW]20["THVU2Q]3NCKG,J 8L!>9/3#^KL]N
M+\[^A]TB;;%/7-V)E'W\>+[L")_-J+T*?33T!>M/F4=W'3#C'4@/0<DV,Q<,
M,F%PS. LX*)#-E31)!VAOQ#CI0-/F"\&,M1YN#J@V]IC\S4#1:G 3NX$(#T<
MG%!LM[7W!M-]UO0U.OUZ'CQ;KSQA?<?# (7N!R[SIF$7NJP^ DW4AK277U/;
M&7Z@"<[U^\_FK7[-"V$@JL$2,L%[WDJ:DW/W62.@*!& 4P44%4;D8F6)H%%P
M1N;6# O^)5V(Z2)7/!-:*YCBXA,)2R-UA@ ?/%'B7B;P'M I#SV,V'+/P_Q3
M'(RE_SY7?J+OR_RE_MW.-L_].Y?,&BX5Y!A8Y/NM4]6Z1M7J'[@\5E_BFJO<
MO_\-E$$E98KQ'&'B5X[MTA> >K!=@@F?)ENZ:@&;+N1V#KB]D3K^[HC^.;$;
MBA]*\:^F 6+Y-?G3UCS__6]S$;[W-]V+RV[]_.;CQ[//MY?']H]O.\+7;E?&
M[QC]"80T'YB:5]97J1@;%FNTVHT*R\*=[:7";<O,<+W-2\QIQ^O]B'%F;\O8
M!6I(29DZ9T,E*/#68)M$L_87B&@" &0K3'B\^_V&(GN3E&H],?Y]+%/8L;=U
M^A-&^"9*WX7E^YI)<UXQ1ZY<;S YL*I^KL:ZIE4..R]R;MDV2F#,*^JT3LZM
M(H9/[9,WC-B5#!)$0ZA#D190;@$M35&]EWQ&4B@_"C$0-?9>95.1IL+(>CZ.
M3]C/4>0G-785>HT:FD1*Q$HD, ,WZ5FD,'(XA$I8@#Z:SV KV,K'1[OG"O4-
M#JR&ID9:#I_+!-63)V!SP(M<AUO^T6FU-$R [0#/B _AU2$JW2)GC(]1[^%X
MK)D"P=[Z?HT4J%4#/L@'X0.AUC\$$4\IEN%2 >LB$+<92B90P;COZR@%8O3!
MS^JT=MHE7- C>_1PG"FP4ISU@5XPSPTXBE);)&Q?_">#+<&AH8RSI[Q\USB"
M%F@L*7!;:!%]$;NA6Y!OP 6%>4&4:%HH\T!G1_- @^&[(;@08*)X0H"M,E#1
MF&:PZ"]F,T1DN()-@!=T(M.#Q!OK8,K^T3XZ*)$*G/( J)(-Y3T")P!*+[43
ME=C'EXEGS[+=Z.Q]3S0HDI3FAK\>8A$F(K$@56Y8[\<"J).A$M?2J]JJ3(K)
MD!&&(A0*<&LS\06:;3$<)#"B#H2,^=3D%PICV^&['H]1^E#J5193":QS7'FJ
M8J2&/ 22,X8L+JC_2D<JRH8CAO9J"G:K!\;D?S*I[5%8&R0/\"MM&2W/F)-)
MBD33AP,*10)CC"%*W]_#X2%[P]<6-#I$7Z89"!$Z7]RO,Y)<+2L5W_/PKE:Y
MA<DH"H)I/9J@=Y9D?5#DDJNID5##+.!I!-K*K/HR#*%)=L1!2O;!>=8HGC'!
M.6(/ZSW3+"&<!48>^D:45.L-0[[.NWK\C9=&Q?!./GP$DF8"1S.0 8R"/V*N
M<IEADUE)^5 J-.D0^+!>&N!M?<<*PVTJ55CYQG5DG(J=G9UZ9[_5/CRLN%RK
M]K )Q7RLO257MI:'%T+6C1R:32;Y)HM#(3TXLRS29^X*%04A;-LN>7F>ZU$<
MB]8O=FH#NPU$45]X&$W5$H=T95B-H)<ASVI-3!X[!\NXI.B)^R=<H1MK#\8#
MV@16Q_+D+,%]DW58&"%&3H)LPVY=)!<3L<&L'&0[>LDS;^"L PXT#\)$AGEK
M/&0)+48BL$!X/\I*L@\%%EH%N:B0*$MQP6I% U#CVGQF=<U)&$H2Y,WC&.)M
M7,+0B0QI'CA'7[J)K0:2LH+@01+I(_/U#GPQ#J7)D2T957R(6 '\@&, ?X&1
MQ?LR,'2J0$:C5,Z(34BB(@"A=O +VI[;Z,N0'OJUPXATKD@\)6/WG!;0I<$(
M14)$JNU#^ [-I%*M/!;E*)%.,1J3MU6S C-_FWJI+5T0J .&QY1[K$4(1@O3
ME*-)BS+H\F$D^S(%4Z&MIX?GYYE2"&Q7]Y]86X0ZF=2TK[P&#Y9"8H.]N=MY
M?JQ]H3]U1<MF2J.-**]L1FNNF-68Z S "9@\\+*574RI51\GR7"6#4$8&1.3
MQ&M[OZ0EWG,00OF[N?2&TT7(^B*=X,*NY,#O?Y;!6'?08CT%"]38-<D#D$%G
M21)YDCZ1:DKQN1"E17OZ.\?P=Y4] -^?:LEBF?M#E"E@V=M\#"Q4O>%JJ[JV
M<"?XN5<!XM(5#>!Z@FBH8^FY4"D?*6TNQK"D2?I?ND^I0*2ML<U*O*ZQQUIY
M/=#M():_YH+FL[-F;R356DO>BCAU<*E1V5IWESDFYXA;\Q8HD7%25G*H81-P
M1T < RIEJ!5BDH&L*P8,@<!42+BK5: [!V4I ;VD 3X!/Q#SF1%8X-\+X;DF
M=8V<] ;[@)Z8D;VF:FL1:X&P[X.B%0]V8,64G7UF AI^J061(A]J'&MQ4?)E
M$<R8:Y]18:^B*'1PE8#?5>=AF)%IB786:!H.=@&,HLOZ_\Y"$[=ITSYF@&(F
M,P[A=882K!T3B1A@J(/I10HPR/_,PQ$45JD\KLI3J#@MW!.A0X*2]DTM_/SI
MT*.-CDCOP41IZ(X;MS*>V0!G[^$81G1%0T^V<^V.OBE=SB#,P%PC, 7JGX#*
M1JP'W,-N;SYTW[!M.N[RY2 "D1,[R/<X )>L?=1F?9[ Q#'8.N@$ ^P4$P=8
ML)]/-2(_<>6-\D,LX6I&0JQ$-$Q9G@U0<G"27P;5V"B:B'NL522)93:B>V01
MJY=/"G828*4F# [9[T)%M:I1R0A(%,\/8P7Y8>+PEY$"EGK&?(IJ$>8/\XLT
MBCA:8@+LD*5I.78!0>.91]KBKWZ5W ,*.MF(24&D>%M(P0MAK'1TQ&LF#@30
MDR4)_ZVAI_*;B51%?50DEG=B)>%5BGK= TD;B?X^XJ!EX,,/)*_1"3)//@ (
M&$SJ@ANCP+*ZG8+*&)>5?WE(;A5M1TJ[V\CH UP3K#FD8(UXE04Z&D8JR:DG
M!!7B :$ F-@#W@W(\"$0R_2-M<?IVC/5*B??$7J,(U!X"AN'J]S^*ZU8M3&
M5L^T<GDC[QQALR3H6H1:S06<<[]'%UU_W4N^K]5"#2>OB&L#]R(3:)["0!I*
M6>YY*B.UA802<^D7;)F"A"HIGUI))1?X+SOE&%PEQWR6>XEL8 !QJN9#3<A2
MY2K-K?O.ARP0)586:"C1O<TEPH;L7\$+?U+.A=ULRS?Z(+F-N< +-A:*@;8B
M$A/P"8L\+U.),<JC+/#)/4'H,Q.!!UV8>:F.61<2G51UR<+ 6/5/V(1D8#:
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MK!GH?CPN6#.%39HG=0D7D.A 86_*PAXA@ZB@PI/9NG'3-Q<;&5DAG6MPTV;
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M=+)F*ERAM\U^Y$_AFU$Z#D[_'U!+ P04    " " @W=3Q0O2NS.!   )<@(
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M>77!D1TG,8*T=4O*=A,3K8!0N,G021!K#R^/R3^7%L&: SREOJ)AS1,*&E5
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MXLHP0<*;QR'[AZ:AW0L;E[1./%"T!_?%=1+^&[\$<RU  ;-G4"VX.LG=Q%9
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MM7>+#+LXW, S?8&+I=1RQ++>"H$5G!:+J<,'MD!0VQ+I<P$$VB L$,XQ_9F
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M+, =47$JT!B1 O!"C/' /!9RS2F?G%O7D#QHS>7%)7FTXR<@$' 7&"B[7FI
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MXY?K9#2_?/G[SM,D_26()LE%^H]?)O%X_@N-=6(>FT;Y19(^FF>SE[NS^:M
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M%T:?050.C#<;-H6E\#2ZP:?CZ2 ;)2QE2)G!%Z5#'EZ'"9P*QB=R,4!%9YZ
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M1K?'*I>5;:EO@[3)R7Z*_@;Z'@A,+3F;H[2*4T2M,!:#(@%]/[\Q^CN6@5V
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MU'Y0%'-J%Z+R!;PV42S<"BYYYRG?>%WHT5'H]FF3M\HJ2-[:&Z8)YE,+X/4
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MR8W\;4Y)Z'6N*=*6@,*R-(E#2<JJM"ZSLU!?,[T9?7B;=,1:&)Q<F 3:G7R
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M\*&.%Y==X,L.'8I,-.FX\ZOB1-OH]B[G3?Z$%+J]X&'NQRQ(RFM3X&18**S
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M19&W?S3\Q1E4EN(K0"2Y9L1EK*:56'H]U+#=8 ?+(M+(3S.JL=*6FTA6YYD
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MJ>,A(<Z"H\LJ71XDZ!PN@45-N:[A),F_9A0L.(<"1&2>=MQKP<4$0=ZY):O
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MB75<JTW,Q\]V'XVB&V,PTD&0%GFF[N(ZGL >KQ[)&VB*LJ1HMQ:SZMXV7<;
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MQXV;;!&_4\VX_5*Y:U)H);2P#=>&!]2:#+M I8B#1)56Y(!(?+>((#U/,NX
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M_66F&;5;@+2YQ58B*(T)B&]F=EMH$MG';$FSP4XV0W-A.CZ(_4]@TIKC$ 8
MUJG@G!Z^(OUD"83&%C=OIX:%="$!_;9]G3%+E1PQF@ I:\*P#'A!32TN'"Z
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M2Q2]&M:^9=:H* NDBEZ4MSUN:TBDF;D;KJZLD$_<F+)V]*#(F],4)74!YZ+
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M   0    9#(T,C$W-F1E>#4Q+FAT;>U;^6_;.!;^W8#_!\*S,V@!Y^ZVF5Q
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M6[TA98>NLB]Z219NV<85K1' >RO*?D)%*\FO=Z BBUAID,"=AI0IG"XA02Y
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M1D.80>[M0<D=YI!E;+3/O"9D^4&:9_MP\AD^!3,*KD2%0ZRN%T;,KQV\+?Z
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M*BH^+7$D1'TYOFC;X?P?ME&NHH/4W&&!?8YS<\2^V:<2L>0O4$L! A0#%
M  @ @(-W4]4Q>74N(@  Q;H   X              ( !     &0R-#(Q-S9D
M.&LN:'1M4$L! A0#%     @ @(-W4\4+TKLS@0  "7(" !
M ( !6B(  &0R-#(Q-S9D97@Q,2YH=&U02P$"% ,4    " " @W=3]&KEEKU^
M   ;FP( $               @ &[HP  9#(T,C$W-F1E>#0R+FAT;5!+ 0(4
M Q0    ( ("#=U,?D2BF]0\  &\U   0              "  :8B 0!D,C0R
M,3<V9&5X-3$N:'1M4$L! A0#%     @ @(-W4[F46@5=#0  73$  !
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I<W0M,C R,3$Q,3=?<')E+GAM;%!+!08     "0 ) #@"   J8@$    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
